FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Gong, H
   Wang, H
   Wang, YX
   Bai, X
   Liu, B
   He, JF
   Wu, JH
   Qi, WM
   Zhang, WG
AF Gong, Husile
   Wang, Hong
   Wang, YueXing
   Bai, Xue
   Liu, Bin
   He, JinFeng
   Wu, JiangHong
   Qi, WangMei
   Zhang, WenGuang
TI Skin transcriptome reveals the dynamic changes in the Wnt pathway during
   integument morphogenesis of chick embryos
SO PLOS ONE
LA English
DT Article
ID PLANAR CELL POLARITY; HAIR FOLLICLE; GENE-EXPRESSION; SIGNALING PATHWAY;
   WNT/BETA-CATENIN; FEATHER BUDS; STEM-CELLS; RNA-SEQ; DIFFERENTIATION;
   PROLIFERATION
AB Avian species have a unique integument covered with feathers. Skin morphogenesis is a successive and complex process. To date, most studies have focused on a single developmental point or stage. Fewer studies have focused on whole transcriptomes based on the time-course of embryo integument development. To analyze the global changes in gene expression profiles, we sequenced the transcriptome of chicken embryo skin samples from day 6 to day 21 of incubation and identified 5830 differentially expressed genes (DEGs). Hierarchical clustering showed that E6 to E14 is the critical period of feather follicle morphogenesis. According to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the DEGs, two kinds of Wnt signaling pathways (a canonical pathway and a non-canonical pathway) changed during feather follicle and feather morphogenesis. The gene expression level of inhibitors and ligands related to the Wnt signaling pathway varied significantly during embryonic development. The results revealed a staggered phase relationship between the canonical pathway and the non-canonical pathway from E9 to E14. These analyses shed new light on the gene regulatory mechanism and provided fundamental data related to integument morphogenesis of chickens.
C1 [Gong, Husile; Wang, Hong; Wang, YueXing; Bai, Xue; Liu, Bin; Zhang, WenGuang] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Peoples R China.
   [Gong, Husile; Wu, JiangHong] Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China.
   [He, JinFeng; Qi, WangMei] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China.
   [Wu, JiangHong] Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China.
RP Zhang, WG (reprint author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Peoples R China.; Wu, JH (reprint author), Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China.; Qi, WM (reprint author), Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China.; Wu, JH (reprint author), Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China.
EM wujianghonglong@126.com; qiwangmei@imau.edu.cn; atcgnmbi@aliyun.com
FU National Natural Science Foundation of China [31260538, 30960246,
   31560622, 31672385, 31560623]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 31260538, 30960246, 31560622, and 31672385 to WZ) and
   (Grant No. 31560623 to JW). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501
   Angonin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074666
   Bak SS, 2015, EXP DERMATOL, V24, P550, DOI 10.1111/exd.12707
   Beaton H, 2016, AM J PHYSL RENAL PHY, V311
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015
   Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x
   Cai SX, 2014, J CELL PHYSIOL, V229, P791, DOI 10.1002/jcp.24500
   Chang H, 2016, DEV BIOL, V409, P181, DOI 10.1016/j.ydbio.2015.10.027
   Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835
   Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003
   DAVIDSON D, 1983, J EMBRYOL EXP MORPH, V74, P245
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Devenport D, 2011, NAT CELL BIOL, V13, P893, DOI 10.1038/ncb2284
   Fu HD, 2016, J MOL HISTOL, V47, P1
   Ghosh S, 2016, ANAL RNA SEQ DATA US, P339
   Guha U, 2004, AM J PATHOL, V165, P729, DOI 10.1016/S0002-9440(10)63336-6
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1
   Ishida K, 2016, DEV GROWTH DIFFER, V58, P303, DOI 10.1111/dgd.12275
   Johansson JA, 2014, SEMIN CELL DEV BIOL, V25, P3, DOI 10.1016/j.semcdb.2013.12.007
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044
   Kim JY, 2005, DIFFERENTIATION, V73, P240, DOI 10.1111/j.1432-0436.2005.00020.x
   Komiya Yuko, 2008, Organogenesis, V4, P68
   Kwack MH, 2017, EXPT DERMATOLOGY
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853
   Li Y, 2016, CHINESE MED J-PEKING, V129, P1200, DOI 10.4103/0366-6999.181974
   Lin CM, 2006, CURR OPIN CELL BIOL, V18, P730, DOI 10.1016/j.ceb.2006.10.009
   LINSENMAYER TF, 1972, DEV BIOL, V27, P244, DOI 10.1016/0012-1606(72)90101-7
   Liu QY, 2016, BIOL TRACE ELEM RES, V171, P380, DOI 10.1007/s12011-015-0555-5
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905
   Lyros O, 2016, DYSREGULATION WNT5A
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007
   Mukhopadhyay A, 2013, DEV BIOL, V373, P373, DOI 10.1016/j.ydbio.2012.10.024
   Nalesso G, 2017, ANN RHEUM DIS, V76, P218, DOI 10.1136/annrheumdis-2015-208577
   Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3
   Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84
   Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737
   Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005
   SENGEL P, 1990, International Journal of Developmental Biology, V34, P33
   Shin D, 2014, J MOL CELL BIOL, V6, P338, DOI 10.1093/jmcb/mju023
   Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129
   Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117
   Takabayashi Y, 2016, CLIN COSMET INVESTI, V9, P127, DOI 10.2147/CCID.S108187
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Van AR, 2012, DEV BIOL, V369, P101
   Wang YS, 2010, DEVELOPMENT, V137, P4091, DOI 10.1242/dev.057455
   Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238
   Xing YZ, 2016, INT J MED SCI, V13, P603, DOI 10.7150/ijms.15571
   Xu ZJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10567
   Yan L, 2016, EXPT THERAPEUTIC MED, V12
   Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196
   Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560
   Zhang HH, 2016, BIOCHIMIE, V127, P10, DOI 10.1016/j.biochi.2016.04.015
   Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011
NR 59
TC 2
Z9 2
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 19
PY 2018
VL 13
IS 1
AR e0190933
DI 10.1371/journal.pone.0190933
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT1QM
UT WOS:000422911300032
PM 29351308
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Pietila, I
   Prunskaite-Hyyrylainen, R
   Kaisto, S
   Tika, E
   van Eerde, AM
   Salo, AM
   Garma, L
   Miinalainen, I
   Feitz, WF
   Bongers, EMHF
   Juffer, A
   Knoers, NVAM
   Renkema, KY
   Myllyharju, J
   Vainio, SJ
AF Pietila, Ilkka
   Prunskaite-Hyyrylainen, Renata
   Kaisto, Susanna
   Tika, Elisavet
   van Eerde, Albertien M.
   Salo, Antti M.
   Garma, Leonardo
   Miinalainen, Ilkka
   Feitz, Wout F.
   Bongers, Ernie M. H. F.
   Juffer, Andre
   Knoers, Nine V. A. M.
   Renkema, Kirsten Y.
   Myllyharju, Johanna
   Vainio, Seppo J.
TI Wnt5a Deficiency Leads to Anomalies in Ureteric Tree Development,
   Tubular Epithelial Cell Organization and Basement Membrane Integrity
   Pointing to a Role in Kidney Collecting Duct Patterning
SO PLOS ONE
LA English
DT Article
ID METANEPHRIC MESENCHYME; ORGANOGENESIS; EXPRESSION; TRANSFORMATION;
   MORPHOGENESIS; INDUCTION; PATHWAYS; COLLAGEN; NEPHRON; CATENIN
AB The Wnts can be considered as candidates for the Congenital Anomaly of Kidney and Urinary Tract, CAKUT diseases since they take part in the control of kidney organogenesis. Of them Wnt5a is expressed in ureteric bud (UB) and its deficiency leads to duplex collecting system (13/90) uni-or bilateral kidney agenesis (10/90), hypoplasia with altered pattern of ureteric tree organization (42/90) and lobularization defects with partly fused ureter trunks (25/90) unlike in controls. The UB had also notably less tips due to Wnt5a deficiency being at E15.5 306 and at E16.5 765 corresponding to 428 and 1022 in control (p<0.02; p<0.03) respectively. These changes due to Wnt5a knock out associated with anomalies in the ultrastructure of the UB daughter epithelial cells. The basement membrane (BM) was malformed so that the BM thickness increased from 46.3 nm to 71.2 nm (p<0.01) at E16.5 in the Wnt5a knock out when compared to control. Expression of a panel of BM components such as laminin and of type IV collagen was also reduced due to the Wnt5a knock out. The P4ha1 gene that encodes a catalytic subunit of collagen prolyl 4-hydroxylase I (C-P4H-I) in collagen synthesis expression and the overall C-P4H enzyme activity were elevated by around 26% due to impairment in Wnt5a function from control. The compound Wnt5a(+/-); P4ha1(+/-) embryos demonstrated Wnt5a(-/-) related defects, for example local hyperplasia in the UB tree. A R260H WNT5A variant was identified from renal human disease cohort. Functional studies of the consequence of the corresponding mouse variant in comparison to normal ligand reduced Wnt5a-signalling in vitro. Together Wnt5a has a novel function in kidney organogenesis by contributing to patterning of UB derived collecting duct development contributing putatively to congenital disease.
C1 [Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Vainio, Seppo J.] Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dev Biol Lab, Oulu, Finland.
   [Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Vainio, Seppo J.] Infotech Oulu, Oulu, Finland.
   [Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Salo, Antti M.; Myllyharju, Johanna; Vainio, Seppo J.] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.
   [Tika, Elisavet; van Eerde, Albertien M.; Knoers, Nine V. A. M.; Renkema, Kirsten Y.] Univ Med Ctr Utrecht, Dept Genet, Ctr Mol Med, Utrecht, Netherlands.
   [Salo, Antti M.; Myllyharju, Johanna] Bioctr Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland.
   [Garma, Leonardo; Juffer, Andre] Univ Oulu, Fac Biochem & Mol Med, Bioctr Oulu, Oulu, Finland.
   [Miinalainen, Ilkka] Univ Oulu, Bioctr Oulu, Oulu, Finland.
   [Feitz, Wout F.] Radboud Univ Nijmegen, Med Ctr, Radboudumc Amalia Childrens Hosp, Dept Urol, NL-6525 ED Nijmegen, Netherlands.
   [Bongers, Ernie M. H. F.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.
RP Vainio, SJ (reprint author), Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dev Biol Lab, Oulu, Finland.; Vainio, SJ (reprint author), Infotech Oulu, Oulu, Finland.; Vainio, SJ (reprint author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.
EM Seppo.Vainio@oulu.fi
RI Feitz, W.F.J./H-8028-2014
OI Vainio, Seppo/0000-0001-9319-3566; Juffer, Andre/0000-0003-3533-0520;
   Garma, Leonardo Daniel/0000-0003-1220-8397
FU Academy of Finland [206038, 121647, 250900, 260056]; Centre of
   Excellence grant of the Academy of Finland [251314]; Sigrid Juselius
   Foundation; European Community [305608]; Dutch Kidney Foundation
   [KSTP10.004, KSTP12.010, CP11.18]; Fonds NutsOhra [1303-070]
FX This work was supported by the Academy of Finland (206038, 121647,
   250900 and 260056), Centre of Excellence grant 2012-2017 of the Academy
   of Finland (251314), [http://www.aka.fi/en] to SV; the Sigrid Juselius
   Foundation, [http://www.sigridjuselius.fi/foundation] to SV; the
   European Community's Seventh Framework Program FP7/2009 under grant
   agreement 305608 (EURenOmics: European Consortium for High-Throughput
   Research in Rare Kidney Diseases) [http://eurenomics.eu/] to SV and NK;
   the Dutch Kidney Foundation (KSTP10.004, KSTP12.010, and CP11.18)
   [http://www.nierstichting.nl] to NK; and Fonds NutsOhra (1303-070)
   [http://www.fondsnutsohra.nl] to NK. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985
   Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016
   Chi LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027676
   Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008
   Enzo Maria Vittoria, 2015, Mol Cell Ther, V3, P1, DOI 10.1186/s40591-015-0038-2
   Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200
   Huang LW, 2014, NEPHRON EXP NEPHROL, V128, P80, DOI 10.1159/000368411
   Itaranta P, 2002, GENESIS, V32, P259, DOI 10.1002/gene.10079
   Jain S, 2009, ORGANOGENESIS, V5, P177, DOI 10.4161/org.5.4.10048
   Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879
   Kispert A, 1998, DEVELOPMENT, V125, P4225
   Kispert A, 1996, DEVELOPMENT, V122, P3627
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245
   Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68
   Lin YF, 2001, DEV DYNAM, V222, P26, DOI 10.1002/dvdy.1164
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miner JH, 2011, ORGANOGENESIS, V7, P75, DOI 10.4161/org.7.2.15275
   Myllymaki SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019453
   Nishita M, 2014, MOL CELL BIOL, V34, P3096, DOI 10.1128/MCB.00491-14
   O'Brien LL, 2014, SEMIN CELL DEV BIOL, V36, P31, DOI 10.1016/j.semcdb.2014.08.014
   Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090
   Pietila I, 2014, NEPHRON EXP NEPHROL, V126, P40, DOI 10.1159/000360659
   Queisser-Luft A., 2002, Archives of Gynecology and Obstetrics, V266, P163, DOI 10.1007/s00404-001-0265-4
   Railo A, 2008, EXP CELL RES, V314, P2389, DOI 10.1016/j.yexcr.2008.04.010
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786
   Seikaly MG, 2003, PEDIATR NEPHROL, V18, P796, DOI 10.1007/s00467-003-1158-5
   Shi S, 2015, KIDNEY INT
   Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151
   STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0
   Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211
   Yamamoto H, 2015, J CELL SCI, V128, P1051, DOI 10.1242/jcs.163683
   Yang DH, 2011, DEVELOPMENT, V138, P4535, DOI 10.1242/dev.071266
   Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087
   Yun K, 2014, HUM MOL GENET
   Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3
NR 37
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 21
PY 2016
VL 11
IS 1
AR e0147171
DI 10.1371/journal.pone.0147171
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB5CE
UT WOS:000368530300021
PM 26794322
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Podleschny, M
   Grund, A
   Berger, H
   Rollwitz, E
   Borchers, A
AF Podleschny, Martina
   Grund, Anita
   Berger, Hanna
   Rollwitz, Erik
   Borchers, Annette
TI A PTK7/Ror2 Co-Receptor Complex Affects Xenopus Neural Crest Migration
SO PLOS ONE
LA English
DT Article
ID RECEPTOR TYROSINE KINASE; PLANAR CELL POLARITY; TO-MESENCHYMAL
   TRANSITION; SIGNALING ACTIVITY; ROR2; PTK7; CANCER; EXPRESSION; PATHWAY;
   ACTIVATION
AB Neural crest cells are a highly migratory pluripotent cell population that generates a wide array of different cell types and failure in their migration can result in severe birth defects and malformation syndromes. Neural crest migration is controlled by various means including chemotaxis, repellent guidance cues and cell-cell interaction. Non-canonical Wnt PCP (planar cell polarity) signaling has previously been shown to control cell-contact mediated neural crest cell guidance. PTK7 (protein tyrosine kinase 7) is a transmembrane pseudokinase and a known regulator of Wnt/PCP signaling, which is expressed in Xenopus neural crest cells and required for their migration. PTK7 functions as a Wnt co-receptor; however, it remains unclear by which means PTK7 affects neural crest migration. Expressing fluorescently labeled proteins in Xenopus neural crest cells we find that PTK7 co-localizes with the Ror2 Wnt-receptor. Further, co-immunoprecipitation experiments demonstrate that PTK7 interacts with Ror2. The PTK7/Ror2 interaction is likely relevant for neural crest migration, because Ror2 expression can rescue the PTK7 loss of function migration defect. Live cell imaging of explanted neural crest cells shows that PTK7 loss of function affects the formation of cell protrusions as well as cell motility. Co-expression of Ror2 can rescue these defects. In vivo analysis demonstrates that a kinase dead Ror2 mutant cannot rescue PTK7 loss of function. Thus, our data suggest that Ror2 can substitute for PTK7 and that the signaling function of its kinase domain is required for this effect.
C1 [Podleschny, Martina; Grund, Anita; Berger, Hanna; Rollwitz, Erik; Borchers, Annette] Univ Marburg, Fac Biol, Mol Embryol, D-35043 Marburg, Germany.
RP Borchers, A (reprint author), Univ Marburg, Fac Biol, Mol Embryol, D-35043 Marburg, Germany.
EM borchers@uni-marburg.de
FU Deutsche Forschungsgemeinschaft [BO 1978/42]
FX This work was funded by Deutsche Forschungsgemeinschaft, grant number BO
   1978/42. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6
   ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7
   Andreeva A, 2014, DEV CELL, V29, P20, DOI 10.1016/j.devcel.2014.02.008
   Ataseven B, 2014, ONCOTARGETS THER, V7, P1723, DOI 10.2147/OTT.S62676
   Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434
   Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306
   Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2
   Becker SFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085717
   Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153
   Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984
   Bolande RP, 1997, PEDIATR PATHOL LAB M, V17, P1, DOI 10.1080/107710497174994
   Borchers A, 2001, DEVELOPMENT, V128, P3049
   Borchers A, 2000, DEV GENES EVOL, V210, P217, DOI 10.1007/s004270050307
   Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X
   Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012
   Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441
   Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000
   Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775
   Clay MR, 2013, DEVELOPMENT, V140, P3198, DOI 10.1242/dev.095448
   de Melker AA, 2004, DEV DYNAM, V230, P708, DOI 10.1002/dvdy.20091
   Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F
   Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109
   Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175
   Faber J., 1956, NORMAL TABLE XENOPUS
   Feike AC, 2010, BIOCH BIOPHYS RES CO
   Gartner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084472
   Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001
   Golubkov VS, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-15
   Golubkov VS, 2010, J BIOL CHEM
   Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710
   Hayes M, 2013, DEVELOPMENT, V140, P1807, DOI 10.1242/dev.090183
   He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767
   Hikasa H, 2002, DEVELOPMENT, V129, P5227
   Jin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090247
   Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200
   Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409
   Kim SH, 1998, DEVELOPMENT, V125, P4681
   Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806
   Kobayashi M, 2009, ORAL SURG ORAL MED O, V107, P398, DOI 10.1016/j.tripleo.2008.08.018
   Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.0.CO;2-K
   Kuriyama S, 2008, PHILOS T R SOC LON B
   Lara E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-170
   Linnemannstons K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004443
   Liu Q, 2014, NEUROONCOLOGY
   Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848
   Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025
   Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677
   Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350
   Mayor R, 2014, BIOCHEM J, V457, P19, DOI 10.1042/BJ20131182
   Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005
   Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9
   Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715
   Miller MA, 2000, DEV BIOL, V224, P286, DOI 10.1006/dbio.2000.9786
   Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x
   Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03
   Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127
   Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200
   O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305
   Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   Ossipova O, 2011, DEVELOPMENT, V138, P5441, DOI 10.1242/dev.067280
   Paudyal A, 2010, BMC DEV BIOL, V286, P20970
   Peradziryi H, 2012, ARCH BIOCHEM BIOPHYS, V524, P71, DOI 10.1016/j.abb.2011.12.019
   Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236
   Powell DR, 2013, WIRES SYST BIOL MED, V5, P511, DOI 10.1002/wsbm.1224
   Prebet T, 2010, BLOOD
   Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185
   Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817
   Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x
   Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016
   Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556
   SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F
   Snider TN, 2014, BIRTH DEFECTS RES C, V102, P324, DOI 10.1002/bdrc.21075
   Theveneau E, 2013, CELL MOL LIFE SCI, V70, P3481, DOI 10.1007/s00018-012-1251-7
   Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772
   Theveneau E, 2012, DEV BIOL, V366, P34, DOI [10.1016/j.ydbio2011.12.041, 10.1016/j.ydbio.2011.12.041]
   Theveneau Eric, 2010, Small GTPases, V1, P113, DOI 10.4161/sgtp.1.2.13673
   Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700
   Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012
   Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015
   Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964
   Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208
   Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291
   Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1
   Winkel A, 2008, CELL SIGNAL, V20, P2134, DOI 10.1016/j.cellsig.2008.08.009
   Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615
   Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116
   Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212
   Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x
   Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007
   Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601
   Zhang DC, 2014, BIRTH DEFECTS RES C, V102, P275, DOI 10.1002/bdrc.21081
   Zhang HT, 2014, INT J MOL SCI, V15, P11665, DOI 10.3390/ijms150711665
NR 95
TC 10
Z9 10
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 17
PY 2015
VL 10
IS 12
AR e0145169
DI 10.1371/journal.pone.0145169
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CY9JO
UT WOS:000366723400052
PM 26680417
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Kokkinopoulos, I
   Ishida, H
   Saba, R
   Ruchaya, P
   Cabrera, C
   Struebig, M
   Barnes, M
   Terry, A
   Kaneko, M
   Shintani, Y
   Coppen, S
   Shiratori, H
   Ameen, T
   Mein, C
   Hamada, H
   Suzuki, K
   Yashiro, K
AF Kokkinopoulos, Ioannis
   Ishida, Hidekazu
   Saba, Rie
   Ruchaya, Prashant
   Cabrera, Claudia
   Struebig, Monika
   Barnes, Michael
   Terry, Anna
   Kaneko, Masahiro
   Shintani, Yasunori
   Coppen, Steven
   Shiratori, Hidetaka
   Ameen, Torath
   Mein, Charles
   Hamada, Hiroshi
   Suzuki, Ken
   Yashiro, Kenta
TI Single-Cell Expression Profiling Reveals a Dynamic State of Cardiac
   Precursor Cells in the Early Mouse Embryo
SO PLOS ONE
LA English
DT Article
ID 2ND HEART FIELD; HOLT-ORAM-SYNDROME; TRANSCRIPTION FACTOR TBX5;
   CONDUCTION SYSTEM; PHARYNGEAL MESODERM; MYOCARDIAL-CELLS;
   PRIMITIVE-STREAK; VERTEBRATE HEART; MAMMALIAN HEART; CRE-RECOMBINASE
AB In the early vertebrate embryo, cardiac progenitor/precursor cells (CPs) give rise to cardiac structures. Better understanding their biological character is critical to understand the heart development and to apply CPs for the clinical arena. However, our knowledge remains incomplete. With the use of single-cell expression profiling, we have now revealed rapid and dynamic changes in gene expression profiles of the embryonic CPs during the early phase after their segregation from the cardiac mesoderm. Progressively, the nascent mesodermal gene Mesp1 terminated, and Nkx2-5(+)/Tbx5(+) population rapidly replaced the Tbx5(low+) population as the expression of the cardiac genes Tbx5 and Nkx2-5 increased. At the Early Headfold stage, Tbx5-expressing CPs gradually showed a unique molecular signature with signs of cardiomyocyte differentiation. Lineage-tracing revealed a developmentally distinct characteristic of this population. They underwent progressive differentiation only towards the cardiomyocyte lineage corresponding to the first heart field rather than being maintained as a progenitor pool. More importantly, Tbx5 likely plays an important role in a transcriptional network to regulate the distinct character of the FHF via a positive feedback loop to activate the robust expression of Tbx5 in CPs. These data expands our knowledge on the behavior of CPs during the early phase of cardiac development, subsequently providing a platform for further study.
C1 [Kokkinopoulos, Ioannis; Ishida, Hidekazu; Saba, Rie; Ruchaya, Prashant; Kaneko, Masahiro; Shintani, Yasunori; Coppen, Steven; Ameen, Torath; Suzuki, Ken; Yashiro, Kenta] Queen Mary Univ London, Translat Med & Therapeut, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.
   [Ruchaya, Prashant] Univ Sao Paulo State UNESP, Physiol & Pathol, Araraquara Sch Dent, Sao Paulo, Brazil.
   [Cabrera, Claudia] Queen Mary Univ London, Clin Pharmacol, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.
   [Cabrera, Claudia; Struebig, Monika; Barnes, Michael; Terry, Anna; Mein, Charles] Queen Mary Univ London, Genome Ctr, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.
   [Cabrera, Claudia] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, Barts & London Sch Med & Dent, London, England.
   [Hamada, Hiroshi] Osaka Univ, Dept Dev Genet, Grad Sch Frontier Biosci, Suita, Osaka, Japan.
RP Yashiro, K (reprint author), Queen Mary Univ London, Translat Med & Therapeut, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.
EM k.yashiro@qmul.ac.uk
RI Hamada, Hiroshi/N-6374-2015
OI Hamada, Hiroshi/0000-0002-7196-5948; Barnes,
   Michael/0000-0001-9097-7381; ruchaya, prashant/0000-0001-9580-4746;
   Mein, Charles/0000-0003-0811-9658; Terry, Anna/0000-0002-1946-8223
FU Medical Research Council (MRC) [G0900105, MR/J007625/1]; British Heart
   Foundation [RG/15/3/31236]; Medical Research Council [G0900105,
   MR/J007625/1, G1000461]
FX This work was supported by the Medical Research Council (MRC) New
   Investigator Research Grant (G0900105) and the MRC Research Grant
   (MR/J007625/1 to KY) (http://www.mrc.ac.uk/). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565
   Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768
   Brouilette S, 2012, DEV DYNAM, V241, P1584, DOI 10.1002/dvdy.23850
   Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298
   Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7
   Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710
   Cagavi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110752
   Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304
   Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848
   DOWNS KM, 1993, DEVELOPMENT, V118, P1255
   Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124
   Fijnvandraat AC, 2003, J MUSCLE RES CELL M, V24, P211, DOI 10.1023/A:1026063409656
   Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1
   Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843
   He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108
   Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030
   INAGAKI T, 1993, DEV DYNAM, V197, P57, DOI 10.1002/aja.1001970106
   Jensen B, 2013, BBA-MOL CELL RES, V1833, P783, DOI 10.1016/j.bbamcr.2012.10.004
   Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009
   Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5
   Kelly RG, 2012, CURR TOP DEV BIOL, V100, P33, DOI 10.1016/B978-0-12-387786-4.00002-6
   Kinder SJ, 1999, DEVELOPMENT, V126, P4691
   Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614
   Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050
   Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906
   Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024
   Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308
   Liang XQ, 2013, CIRC RES, V113, P399, DOI 10.1161/CIRCRESAHA.113.301588
   Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013
   McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562
   Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9
   Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409
   Moorman AFM, 2007, PHILOS T R SOC B, V362, P1257, DOI 10.1098/rstb.2007.2113
   Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029
   Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265
   Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103
   Nelson DO, 2014, DEV DYNAM, V243, P381, DOI 10.1002/dvdy.24078
   OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157
   Park EJ, 2008, DEV DYNAM, V237, P447, DOI 10.1002/dvdy.21415
   Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042
   Rana MS, 2013, ACTA PHYSIOL, V207, P588, DOI 10.1111/apha.12061
   Saga Y, 1999, DEVELOPMENT, V126, P3437
   Schoenwolf GC, 1995, CELL MOL BIOL RES, V41, P233
   Shen MM, 1997, DEVELOPMENT, V124, P429
   Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110
   Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Spaeter D, 2013, NAT CELL BIOL, V15, P1098, DOI 10.1038/ncb2824
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181
   Sun GF, 2004, J CELL BIOCHEM, V92, P189, DOI 10.1002/jcb.20039
   Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251
   Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039
   Tam PPL, 1997, DEVELOPMENT, V124, P1631
   Tian Y, 2010, PEDIATR CARDIOL, V31, P342, DOI 10.1007/s00246-009-9606-z
   Tzahor E, 2011, CARDIOVASC RES, V91, P196, DOI 10.1093/cvr/cvr116
   Uehara M, 2009, GENE DEV, V23, P1689, DOI 10.1101/gad.1776209
   Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041
   Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035
   Wang W, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001725
   Watanabe Y, 2012, P NATL ACAD SCI USA, V109, P18273, DOI 10.1073/pnas.1215360109
   Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062
   Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1
   Xie LL, 2012, DEV CELL, V23, P280, DOI 10.1016/j.devcel.2012.06.006
   Yamahara K, 2008, BIOCHEM BIOPH RES CO, V371, P615, DOI 10.1016/j.bbrc.2008.04.021
   Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0
NR 72
TC 9
Z9 9
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 15
PY 2015
VL 10
IS 10
AR e0140831
DI 10.1371/journal.pone.0140831
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CU0CX
UT WOS:000363184600121
PM 26469858
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Snow-Lisy, DC
   Diaz, EC
   Bury, MI
   Fuller, NJ
   Hannick, JH
   Ahmad, N
   Sharma, AK
AF Snow-Lisy, Devon C.
   Diaz, Edward C.
   Bury, Matthew I.
   Fuller, Natalie J.
   Hannick, Jessica H.
   Ahmad, Nida
   Sharma, Arun K.
TI The Role of Genetically Modified Mesenchymal Stem Cells in Urinary
   Bladder Regeneration
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL-CELLS; BLOOD-VESSELS; SELF-RENEWAL; WNT PROTEINS;
   SPINA-BIFIDA; PHASE-II; ANGIOGENESIS; CCN1; MUSCLE; TISSUE
AB Recent studies have demonstrated that mesenchymal stem cells (MSCs) combined with CD34(+) hematopoietic/stemprogenitor cells (HSPCs) can function as surrogate urinary bladder cells to synergistically promote multi-faceted bladder tissue regeneration. However, themolecular pathways governing these events are unknown. The pleiotropic effects of Wnt5a and Cyr61 are known to affect aspects of hematopoiesis, angiogenesis, and muscle and nerve regeneration. Within this study, the effects of Cyr61 and Wnt5a on bladder tissue regeneration were evaluated by grafting scaffolds containing modified human bone marrow derived MSCs. These cell lines were engineered to independently over-express Wnt5a or Cyr61, or to exhibit reduced expression of Cyr61 within the context of a nude rat bladder augmentation model. At 4 weeks post-surgery, data demonstrated increased vessel number (similar to 250 vs similar to 109 vessels/mm(2)) and bladder smooth muscle content (similar to 42% vs similar to 36%) in Cyr61OX (over-expressing) vs Cyr61KD (knock-down) groups. Muscle content decreased to similar to 25% at 10 weeks in Cyr61KD groups. Wnt5aOX resulted in high numbers of vessels and muscle content (similar to 206 vessels/mm(2) and similar to 51%, respectively) at 4 weeks. Over-expressing cell constructs resulted in peripheral nerve regeneration while Cyr61KD animals were devoid of peripheral nerve regeneration at 4 weeks. At 10 weeks post-grafting, peripheral nerve regeneration was at a minimal level for both Cyr61OX and Wnt5aOX cell lines. Blood vessel and bladder functionality were evident at both time-points in all animals. Results from this study indicate that MSC-based Cyr61OX and Wnt5aOX cell lines play pivotal roles with regards to increasing the levels of functional vasculature, influencing muscle regeneration, and the regeneration of peripheral nerves in a model of bladder augmentation. Wnt5aOX constructs closely approximated the outcomes previously observed with the co-transplantation of MSCs with CD34(+) HSPCs and may be specifically targeted as an alternate means to achieve functional bladder regeneration.
C1 [Snow-Lisy, Devon C.; Diaz, Edward C.; Bury, Matthew I.; Fuller, Natalie J.; Ahmad, Nida; Sharma, Arun K.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Urol, Chicago, IL 60611 USA.
   [Hannick, Jessica H.] Loyola Univ Hlth Syst, Dept Urol, Maywood, IL USA.
   [Sharma, Arun K.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.
   [Sharma, Arun K.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
   [Sharma, Arun K.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Sharma, AK (reprint author), Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Urol, Chicago, IL 60611 USA.
EM arun-sharma@northwestern.edu
CR Abdollah F, 2013, CANCER EPIDEMIOL, V37, P219, DOI 10.1016/j.canep.2013.02.002
   Andersson ER, 2013, P NATL ACAD SCI USA, V110, pE602, DOI 10.1073/pnas.1208524110
   Arderiu G, 2014, J MOL CELL BIOL, V6, P380, DOI 10.1093/jmcb/mju036
   Ascheim DD, 2014, CIRCULATION, V129, P2287, DOI 10.1161/CIRCULATIONAHA.113.007412
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Austin JC, 2007, J UROLOGY, V178, P798, DOI 10.1016/j.juro.2007.05.055
   Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009
   Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685
   Bury MI, 2014, BIOMATERIALS, V35, P9311, DOI 10.1016/j.biomaterials.2014.07.057
   Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158
   Cheng EY, 2014, J UROLOGY, V191, P1395, DOI 10.1016/j.juro.2013.10.157
   Cully Megan, 2013, Nat Rev Rheumatol, V9, P136, DOI 10.1038/nrrheum.2013.22
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Deng FM, 2001, P NATL ACAD SCI USA, V98, P154, DOI 10.1073/pnas.98.1.154
   Deng KL, 2015, AM J PHYSIOL-RENAL, V308, pF92, DOI 10.1152/ajprenal.00510.2014
   Diez-Tejedor E, 2014, J STROKE CEREBROVASC, V23, P2694, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.011
   Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701
   Farhat WA, 2014, J UROLOGY, V191, P1394, DOI 10.1016/j.juro.2013.10.156
   Frey SP, 2012, INT ORTHOP, V36, P2387, DOI 10.1007/s00264-012-1659-6
   GILMOUR RF, 1993, J UROLOGY, V150, P1200, DOI 10.1016/S0022-5347(17)35727-0
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Green JL, 2013, P NATL ACAD SCI USA, V110, P6991, DOI 10.1073/pnas.1303671110
   Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202
   Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441
   Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689
   Hoke A, 2001, EXP NEUROL, V172, P398, DOI 10.1006/exnr.2001.7808
   HOULE AM, 1993, J UROLOGY, V149, P561, DOI 10.1016/S0022-5347(17)36148-7
   Ishikawa T, 2001, DEVELOPMENT, V128, P25
   Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045
   Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Jung YS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.48
   Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340
   Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Lazzeri M, 2006, UROL INT, V76, P289, DOI 10.1159/000092049
   Li XR, 2010, ONCOTARGET, V1, P309
   MacNeily AL, 2007, J UROLOGY, V178, P1752, DOI 10.1016/j.juro.2007.03.157
   Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297
   Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100
   Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200
   Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929
   Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009
   O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x
   Osborn DJ, 2014, UROLOGY, V83, P1433, DOI 10.1016/j.urology.2014.02.030
   Park YS, 2015, J CELL PHYSIOL, V230, P140, DOI 10.1002/jcp.24690
   Planutis K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-12
   Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9
   Prager GW, 2012, TRANSL LUNG CANCER R, V1, P14, DOI 10.3978/j.issn.2218-6751.2011.11.02
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   Schlomer BJ, 2014, J PEDIATR UROL, V10, P1043, DOI 10.1016/j.jpurol.2014.03.007
   Sharma AK, 2014, ADV DRUG DE IN PRESS
   Sharma AK, 2013, P NATL ACAD SCI USA, V110, P4003, DOI 10.1073/pnas.1220764110
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054
   Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053
   Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851
   Sloff M, 2014, J UROLOGY, V192, P1035, DOI 10.1016/j.juro.2014.03.116
   Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085
   Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316
   Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314
   Tran C, 2014, ADV DRUG DELIV REV
   Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007
   Vaegler M, 2012, EUR UROL, V61, P1263, DOI 10.1016/j.eururo.2012.03.025
   Van den Berg DJ, 1998, BLOOD, V92, P3189
   Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864
   Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211
   Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020
   Zhou DM, 2005, J APPL PHYSIOL, V98, P2344, DOI 10.1152/japplphysiol.01093.2004
NR 72
TC 7
Z9 7
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 23
PY 2015
VL 10
IS 9
AR e0138643
DI 10.1371/journal.pone.0138643
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS1BM
UT WOS:000361797500087
PM 26398705
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Tornero-Esteban, P
   Peralta-Sastre, A
   Herranz, E
   Rodriguez-Rodriguez, L
   Mucientes, A
   Abasolo, L
   Marco, F
   Fernandez-Gutierrez, B
   Lamas, JR
AF Tornero-Esteban, Pilar
   Peralta-Sastre, Ascension
   Herranz, Eva
   Rodriguez-Rodriguez, Luis
   Mucientes, Arkaitz
   Abasolo, Lydia
   Marco, Fernando
   Fernandez-Gutierrez, Benjamin
   Ramon Lamas, Jose
TI Altered Expression of Wnt Signaling Pathway Components in Osteogenesis
   of Mesenchymal Stem Cells in Osteoarthritis Patients
SO PLOS ONE
LA English
DT Article
ID HIGH BONE MASS; BETA-CATENIN; STROMAL CELLS; DKK1-MEDIATED INHIBITION;
   SUBCHONDRAL BONE; LRP5 GENE; OSTEOBLASTS; MUTATIONS; PROTEIN; DENSITY
AB Introduction
   Osteoarthritis (OA) is characterized by altered homeostasis of joint cartilage and bone, whose functional properties rely on chondrocytes and osteoblasts, belonging to mesenchymal stem cells (MSCs). WNT signaling acts as a hub integrating and crosstalking with other signaling pathways leading to the regulation of MSC functions. The aim of this study was to evaluate the existence of a differential signaling between Healthy and OA-MSCs during osteogenesis.
   Methods
   MSCs of seven OA patients and six healthy controls were isolated, characterised and expanded. During in vitro osteogenesis, cells were recovered at days 1, 10 and 21. RNA and protein content was obtained. Expression of WNT pathway genes was evaluated using RT-qPCR. Functional studies were also performed to study the MSC osteogenic commitment and functional and post-traslational status of beta-catenin and several receptor tyrosine kinases.
   Results
   Several genes were downregulated in OA-MSCs during osteogenesis in vitro. These included soluble Wnts, inhibitors, receptors, co-receptors, several kinases and transcription factors. Basal levels of beta-catenin were higher in OA-MSCs, but calcium deposition and expression of osteogenic genes was similar between Healthy and OA-MSCs. Interestingly an increased phosphorylation of p44/42 MAPK (ERK1/2) signaling node was present in OA-MSCs.
   Conclusion
   Our results point to the existence in OA-MSCs of alterations in expression of Wnt pathway components during in vitro osteogenesis that are partially compensated by post-translational mechanisms modulating the function of other pathways. We also point the relevance of other signaling pathways in OA pathophysiology suggesting their role in the maintenance of joint homeostasis through modulation of MSC osteogenic potential.
C1 [Tornero-Esteban, Pilar; Peralta-Sastre, Ascension; Herranz, Eva; Rodriguez-Rodriguez, Luis; Mucientes, Arkaitz; Abasolo, Lydia; Fernandez-Gutierrez, Benjamin; Ramon Lamas, Jose] Hosp Clin San Carlos, UGC Reumatol, Inst Invest Sanitaria, Madrid 28040, Spain.
   [Marco, Fernando] Hosp Clin San Carlos, UGC Traumatol, Inst Invest Sanitaria, Madrid 28040, Spain.
RP Lamas, JR (reprint author), Hosp Clin San Carlos, UGC Reumatol, Inst Invest Sanitaria, 4a Planta,C Prof Martin Lagos S-N, Madrid 28040, Spain.
EM jrlamas@gmail.com
RI Rodriguez-Rodriguez, Luis/H-5880-2013; Lamas, Jose Ramon/C-8318-2012
OI Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Lamas, Jose
   Ramon/0000-0003-1913-7261
FU ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo
   Regional (FEDER); RETICS Program (RIER) from Instituto de Salud Carlos
   III (ISCIII) [RD08/0075];  [CP10/00346]
FX This work was supported by project CP10/00346 included in the Plan
   Nacional de I+D+I (AES 2010) and co-financed by ISCIII-Subdireccion
   General de Evaluacion and Fondo Europeo de Desarrollo Regional (FEDER).
   PT is supported by RETICS Program, RD08/0075 (RIER) from Instituto de
   Salud Carlos III (ISCIII).
CR Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302
   Artigas N, 2014, J BIOL CHEM, V289, P27105, DOI 10.1074/jbc.M114.576793
   Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211
   Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074
   Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870
   Bhat BM, 2007, GENE, V391, P103, DOI 10.1016/j.gene.2006.12.014
   Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168
   Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444
   Buechling T, 2011, CURR TOP DEV BIOL, V97, P21, DOI 10.1016/B978-0-12-385975-4.00008-5
   Chapman K, 2012, BONE, V51, P258, DOI 10.1016/j.bone.2011.11.026
   Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904
   De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079
   Dequeker J, 2003, AGING CLIN EXP RES, V15, P426, DOI 10.1007/BF03327364
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200
   Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200
   Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347
   Guilak F, 2011, BEST PRACT RES CL RH, V25, P815, DOI 10.1016/j.berh.2011.11.013
   Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116
   Hardcastle SA, 2013, RHEUMATOLOGY, V52, P1042, DOI 10.1093/rheumatology/kes411
   Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546
   Kawaguchi H, 2009, J BONE MINER RES, V24, P8, DOI 10.1359/JBMR.081115
   Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52
   Korvala J, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-26
   Lajeunesse D, 2003, CURR OPIN RHEUMATOL, V15, P628, DOI 10.1097/00002281-200309000-00018
   Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008
   Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25
   Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197
   Lories RJU, 2008, BEST PRACT RES CL RH, V22, P209, DOI 10.1016/j.berh.2007.12.001
   Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642
   MacFarlane RJ, 2013, EXPERT OPIN THER TAR, V17, P243, DOI 10.1517/14728222.2013.746954
   Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653
   Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mills CN, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00047
   Pangrazio A, 2011, BONE, V49, P568, DOI 10.1016/j.bone.2011.05.006
   Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156
   Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.110777
   Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213
   Stagg J, 2013, CURR MOL MED, V13, P856, DOI 10.2174/1566524011313050016
   Suda T, 2008, CELL, V132, P729, DOI 10.1016/j.cell.2008.02.017
   Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004
   Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458
   Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277
   Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044
   Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279
   Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560
   Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377
NR 48
TC 11
Z9 13
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2015
VL 10
IS 9
AR e0137170
DI 10.1371/journal.pone.0137170
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ9KG
UT WOS:000360932800064
PM 26352263
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Moura, RS
   Carvalho-Correia, E
   daMota, P
   Correia-Pinto, J
AF Moura, Rute Silva
   Carvalho-Correia, Eduarda
   daMota, Paulo
   Correia-Pinto, Jorge
TI Canonical Wnt Signaling Activity in Early Stages of Chick Lung
   Development
SO PLOS ONE
LA English
DT Article
ID IDIOPATHIC PULMONARY-FIBROSIS; EMBRYONIC MOUSE LUNG; BETA-CATENIN;
   BRANCHING MORPHOGENESIS; EXPRESSION PATTERNS; LIMB DEVELOPMENT;
   CANCER-CELLS; PPAR-GAMMA; GENES; PATHWAY
AB Wnt signaling pathway is an essential player during vertebrate embryonic development which has been associated with several developmental processes such as gastrulation, body axis formation and morphogenesis of numerous organs, namely the lung. Wnt proteins act through specific transmembrane receptors, which activate intracellular pathways that regulate cellular processes such as cell proliferation, differentiation and death. Morphogenesis of the fetal lung depends on epithelial-mesenchymal interactions that are governed by several growth and transcription factors that regulate cell proliferation, fate, migration and differentiation. This process is controlled by different signaling pathways such as FGF, Shh and Wnt among others. Wnt signaling is recognized as a key molecular player in mammalian pulmonary development but little is known about its function in avian lung development. The present work characterizes, for the first time, the expression pattern of several Wnt signaling members, such as wnt-1, wnt-2b, wnt-3a, wnt-5a, wnt-7b, wnt-8b, wnt-9a, lrp5, lrp6, sfrp1, dkk1, beta-catenin and axin2 at early stages of chick lung development. In general, their expression is similar to their mammalian counterparts. By assessing protein expression levels of active/total beta-catenin and phospho-LRP6/LRP6 it is revealed that canonical Wnt signaling is active in this embryonic tissue. In vitro inhibition studies were performed in order to evaluate the function of Wnt signaling pathway in lung branching. Lung explants treated with canonical Wnt signaling inhibitors (FH535 and PK115-584) presented an impairment of secondary branch formation after 48 h of culture along with a decrease in axin2 expression levels. Branching analysis confirmed this inhibition. Wnt-FGF crosstalk assessment revealed that this interaction is preserved in the chick lung. This study demonstrates that Wnt signaling is crucial for precise chick lung branching and further supports the avian lung as a good model for branching studies since it recapitulates early mammalian pulmonary development.
C1 [Moura, Rute Silva; Carvalho-Correia, Eduarda; daMota, Paulo; Correia-Pinto, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.
   [Moura, Rute Silva; Carvalho-Correia, Eduarda; daMota, Paulo; Correia-Pinto, Jorge] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Moura, Rute Silva] Univ Minho, Sch Sci, Dept Biol, Braga, Portugal.
   [daMota, Paulo] Hosp Braga, Dept Urol, Braga, Portugal.
   [Correia-Pinto, Jorge] Hosp Braga, Dept Pediat Surg, Braga, Portugal.
RP Moura, RS (reprint author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.
EM rutemoura@ecsaude.uminho.pt
RI Correia-Pinto, Jorge/B-3344-2012; Moura, Rute S/B-4208-2011
OI Correia-Pinto, Jorge/0000-0002-9265-6896; Moura, Rute
   S/0000-0003-1763-9014; Mota, Paulo/0000-0002-2316-373X;
   Carvalho-Correia, Eduarda/0000-0001-5821-0893
FU ON.2 SR&TD Integrated Program [N-01-01-0124-01-07]
FX Rute S. Moura was supported by a grant of ON.2 SR&TD Integrated Program
   (N-01-01-0124-01-07), ref: UMINHO/BPD/31/2013. The funders had no role
   in study design, data collection and analysis,
CR Bellairs R, 2005, ATLAS CHICK DEV
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310
   Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491
   Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199
   Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87
   Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029
   Church VL, 2002, INT J DEV BIOL, V46, P927
   Colvin JS, 2001, DEVELOPMENT, V128, P2095
   De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023
   Fokina VM, 2006, DEV DYNAM, V235, P496, DOI 10.1002/dvdy.20621
   Foronjy R, 2010, AM J PATHOL, V177, P598, DOI 10.2353/ajpath.2010.090803
   Garriock RJ, 2007, DEV DYNAM, V236, P1249, DOI 10.1002/dvdy.21156
   Geetha-Loganathan Poongodi, 2008, Organogenesis, V4, P109
   Geetha-Loganathan P, 2009, DEV DYNAM, V238, P1150, DOI 10.1002/dvdy.21934
   Gibb S, 2009, DEV BIOL, V330, P21, DOI 10.1016/j.ydbio.2009.02.035
   Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005
   Gradl D, 1999, MOL CELL BIOL, V19, P5576
   Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063
   Hans C, 2006, CELL, V127, P469
   Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546
   Havens BA, 2006, ARCH ORAL BIOL, V51, P134, DOI 10.1016/j.archoralbio.2005.06.011
   He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4
   HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0
   Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063
   HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E
   Horowitz A, 2009, CIRC RES, V104, P784
   Huang CL, 2008, EUR J CANCER, V44, P2680, DOI 10.1016/j.ejca.2008.08.004
   Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089
   Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102
   Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001
   Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950
   Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142
   Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9
   Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729
   Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Loganathan PG, 2005, HISTOCHEM CELL BIOL, V123, P195, DOI 10.1007/s00418-005-0756-7
   Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504
   Maina JN, 2003, TISSUE CELL, V35, P375, DOI 10.1016/S0040-8166(03)00058-2
   Malpel S, 2000, DEVELOPMENT, V127, P3057
   Matsumoto K, 2008, DEV BIOL, V319, P234, DOI 10.1016/j.ydbio.2008.04.021
   McBride HJ, 2003, DEV BIOL, V256, P18, DOI 10.1016/S0012-1606(02)00118-5
   MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R
   Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miura T, 2009, MECH DEVELOP, V126, P160, DOI 10.1016/j.mod.2008.11.006
   Moura RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017660
   Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200
   MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911
   Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011
   Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013
   Pietila I, 2011, DEV BIOL, V353, P50, DOI 10.1016/j.ydbio.2011.02.019
   Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124
   Quinlan R, 2009, NEURAL DEV, V4, P1
   Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495
   Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712
   Sakiyama J, 2000, DEV BIOL, V227, P12, DOI 10.1006/dbio.2000.9880
   Sakurai R, 2011, EXP LUNG RES, V37, P144, DOI 10.3109/01902148.2010.490288
   Schmidt M, 2000, DEVELOPMENT, V127, P4105
   Shi ZD, 2012, J NEUROIMMUNE PHARM, V7, P892, DOI 10.1007/s11481-012-9354-3
   Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014
   Shu WG, 2002, DEVELOPMENT, V129, P4831
   Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002
   Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117
   Tebar M, 2001, MECH DEVELOP, V109, P437, DOI 10.1016/S0925-4773(01)00556-1
   Terry K, 2000, MECH DEVELOP, V97, P177, DOI 10.1016/S0925-4773(00)00407-X
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013
   Wang YP, 2011, DEV BIOL, V349, P250, DOI 10.1016/j.ydbio.2010.11.004
   Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005
   Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9
   Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746
   Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009
   Yates LL, 2013, DEV BIOL, V373, P267, DOI 10.1016/j.ydbio.2012.11.012
   Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104
   Zhang MF, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-21
NR 77
TC 4
Z9 6
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 2
PY 2014
VL 9
IS 12
AR e112388
DI 10.1371/journal.pone.0112388
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU8TQ
UT WOS:000345869700016
PM 25460002
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Easter, SL
   Mitchell, EH
   Baxley, SE
   Desmond, R
   Frost, AR
   Serra, R
AF Easter, Stephanie L.
   Mitchell, Elizabeth H.
   Baxley, Sarah E.
   Desmond, Renee
   Frost, Andra R.
   Serra, Rosa
TI Wnt5a Suppresses Tumor Formation and Redirects Tumor Phenotype in
   MMTV-Wnt1 Tumors
SO PLOS ONE
LA English
DT Article
ID MAMMARY-GLAND DEVELOPMENT; BREAST-CANCER; STEM-CELLS; SIGNALING PATHWAY;
   SELF-RENEWAL; P-CADHERIN; TGF-BETA; EXPRESSION; PROTEIN; WNT-5A
AB Wnt5a is a non-canonical signaling Wnt that has been implicated in tumor suppression. We previously showed that loss of Wnt5a in MMTV-PyVmT tumors resulted in a switch in tumor phenotype resulting in tumors with increased basal phenotype and high Wnt/beta-catenin signaling. The object of this study was to test the hypothesis that Wnt5a can act to inhibit tumors formed by activation of Wnt/beta-catenin signaling. To this end, we characterized tumor and non-tumor mammary tissue from MMTV-Wnt1 and double transgenic MMTV-Wnt1; MMTV-Wnt5a mice. Wnt5a containing mice demonstrated fewer tumors with increased latency when compared to MMTV-Wnt1 controls. Expression of markers for basal-like tumors was down-regulated in the tumors that formed in the presence of Wnt5a indicating a phenotypic switch. Reduced canonical Wnt signaling was detected in double transgenic tumors as a decrease in active beta-catenin protein and a decrease in Axin2 mRNA transcript levels. In non-tumor tissues, over-expression of Wnt5a in MMTV-Wnt1 mammary glands resulted in attenuation of phenotypes normally observed in MMTV-Wnt1 glands including hyperbranching and increased progenitor and basal cell populations. Even though Wnt5a could antagonize Wnt/beta-catenin signaling in primary mammary epithelial cells in culture, reduced Wnt/beta-catenin signaling was not detected in non-tumor MMTV-Wnt1; Wnt5a tissue in vivo. The data demonstrate that Wnt5a suppresses tumor formation and promotes a phenotypic shift in MMTV-Wnt1 tumors.
C1 [Easter, Stephanie L.; Mitchell, Elizabeth H.; Baxley, Sarah E.; Serra, Rosa] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.
   [Desmond, Renee] Univ Alabama Birmingham, Ctr Comprehens Canc, Dept Med, Biostat & Bioinformat Unit, Birmingham, AL 35294 USA.
   [Frost, Andra R.] Univ Alabama Birmingham, Dept Pathol, Div Anat Pathol, Birmingham, AL 35294 USA.
RP Serra, R (reprint author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.
EM rserra@uab.edu
FU National Cancer Institute [R01 CA126942]; UAB Comprehensive Cancer
   Center [P30 CA13148]
FX RS was supported by the National Cancer Institute, R01 CA126942.
   Statistical work was supported by the UAB Comprehensive Cancer Center
   (P30 CA13148). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594
   Baxley SE, 2011, BIOL REPROD, V85, P907, DOI 10.1095/biolreprod.111.091645
   Benhaj K, 2006, ONCOL REP, V15, P701
   Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030
   Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33
   Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147
   Byun JY, 2006, MOL VIS, V12, P949
   Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347
   DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165
   Dejmek J, 2005, CLIN CANCER RES, V11, P520
   Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329
   Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200
   Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803
   El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559
   ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x
   Ghebeh H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-289
   GUELSTEIN VI, 1988, INT J CANCER, V42, P147, DOI 10.1002/ijc.2910420202
   Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041
   Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76
   Jansson M, 2001, J CELL SCI, V114, P2043
   Jonsson M, 2002, CANCER RES, V62, P409
   Katoh M, 2005, ONCOL REP, V14, P1583
   Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045
   Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1
   Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310
   Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370
   Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/S0168-9525(00)02028-X
   Leris ACA, 2005, ANTICANCER RES, V25, P731
   Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100
   Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493
   Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101
   Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054
   Many AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101800
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Olson DJ, 1997, CELL GROWTH DIFFER, V8, P417
   Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030
   PALACIOS J, 1995, AM J PATHOL, V146, P605
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103
   RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250
   Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244
   Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537
   Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158
   Trifa F, 2013, TUMOR BIOL, V34, P1625, DOI 10.1007/s13277-013-0694-2
   TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6
   Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949
   van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0
   Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625
   Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/job.200303107
   WETZELS RHW, 1989, AM J PATHOL, V134, P571
NR 59
TC 1
Z9 1
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 17
PY 2014
VL 9
IS 11
AR e113247
DI 10.1371/journal.pone.0113247
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT8BL
UT WOS:000345158700126
PM 25401739
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Zhang, M
   Mahoney, E
   Zuo, T
   Manchanda, PK
   Davuluri, RV
   Kirschner, LS
AF Zhang, Mei
   Mahoney, Emilia
   Zuo, Tao
   Manchanda, Parmeet K.
   Davuluri, Ramana V.
   Kirschner, Lawrence S.
TI Protein Kinase A Activation Enhances beta-Catenin Transcriptional
   Activity through Nuclear Localization to PML Bodies
SO PLOS ONE
LA English
DT Article
ID INHIBITS OSTEOGENIC DIFFERENTIATION; MCCUNE-ALBRIGHT SYNDROME;
   MESENCHYMAL STEM-CELLS; CARNEY COMPLEX; CYCLIC-AMP; OSTEOBLASTIC CELLS;
   WNT; PATHWAY; PHOSPHORYLATION; PROLIFERATION
AB The Protein Kinase A (PKA) and Wnt signaling cascades are fundamental pathways involved in cellular development and maintenance. In the osteoblast lineage, these pathways have been demonstrated functionally to be essential for the production of mineralized bone. Evidence for PKA-Wnt crosstalk has been reported both during tumorigenesis and during organogenesis, and the nature of the interaction is thought to rely on tissue and cell context. In this manuscript, we analyzed bone tumors arising from mice with activated PKA caused by mutation of the PKA regulatory subunit Prkar1a. In primary cells from these tumors, we observed relocalization of beta-catenin to intranuclear punctuate structures, which were identified as PML bodies. Cellular redistribution of beta-catenin could be recapitulated by pharmacologic activation of PKA. Using 3T3-E1 pre-osteoblasts as a model system, we found that PKA phosphorylation sites on beta-catenin were required for nuclear re-localization. Further, beta-catenin's transport to the nucleus was accompanied by an increase in canonical Wnt-dependent transcription, which also required the PKA sites. PKA-Wnt crosstalk in the cells was bi-directional, including enhanced interactions between beta-catenin and the cAMP-responsive element binding protein (CREB) and transcriptional crosstalk between the Wnt and PKA signaling pathways. Increases in canonical Wnt/beta-catenin signaling were associated with a decrease in the activity of the non-canonical Wnt/Ror2 pathway, which has been shown to antagonize canonical Wnt signaling. Taken together, this study provides a new understanding of the complex regulation of the subcellular distribution of beta-catenin and its differential protein-protein interaction that can be modulated by PKA signaling.
C1 [Zhang, Mei; Mahoney, Emilia; Zuo, Tao; Manchanda, Parmeet K.; Davuluri, Ramana V.; Kirschner, Lawrence S.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.
   [Kirschner, Lawrence S.] Ohio State Univ, Div Endocrinol Diabets & Metab, Columbus, OH 43210 USA.
RP Kirschner, LS (reprint author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.
EM Lawrence.Kirschner@osumc.edu
FU National Institutes of Health [CA112268, AR057168, CA16058]
FX The work was supported by the following National Institutes of Health
   grants: CA112268 (LSK), AR057168 (LSK), and CA16058 (to the Ohio State
   University Comprehensive Cancer Center). The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Almeida MQ, 2010, MOL CELL ENDOCRINOL
   Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302
   Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277
   Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308
   Brudvik KW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-149
   Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126
   Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111
   de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016
   Ewan KBR, 2008, CURR DRUG TARGETS, V9, P532, DOI 10.2174/138945008784911787
   Gupta R, 2011, NUCLEIC ACIDS RES, V39, pD92, DOI 10.1093/nar/gkq1171
   Hildesheim J, 2005, J BIOL CHEM, V280, P17221, DOI 10.1074/jbc.M410440200
   Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005
   Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200
   Kang MA, 2012, J BIOL CHEM, V287, P16246, DOI 10.1074/jbc.M111.337212
   Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585
   Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06
   Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807
   Niehrs C, NAT REV MOL CELL BIO, V13, P767
   Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892
   Pavel E, 2008, MOL ENDOCRINOL, V22, P430, DOI 10.1210/me.2007-0369
   Regard J. B, 2012, COLD SPRING HARB PER, V4
   Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108
   Rudolf R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00290
   Salpea P, 2014, MOL CELL ENDOCRINOL, V386, P85, DOI 10.1016/j.mce.2013.08.022
   Satow R, 2012, GASTROENTEROLOGY, V142, P572, DOI 10.1053/j.gastro.2011.11.041
   Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504
   Siddappa R, 2009, TISSUE ENG PT A, V15, P2135, DOI 10.1089/ten.tea.2008.0512
   Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441
   Sun J, 2013, ONCOL REP, V30, P2785, DOI 10.3892/or.2013.2786
   Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200
   Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884
   Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013
   von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008
   Walkinshaw DR, 2013, J BIOL CHEM, V288, P5591, DOI 10.1074/jbc.M112.445668
   Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214
   WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403
   Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044
   Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443
   Zhang M, 2014, MOL ENDOCRINOL, V28, P295, DOI 10.1210/me.2013-1152
   Zhang S, 2012, HORM METAB RES, V44, P724, DOI 10.1055/s-0032-1321845
NR 42
TC 21
Z9 21
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 9
PY 2014
VL 9
IS 10
AR e109523
DI 10.1371/journal.pone.0109523
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS0AP
UT WOS:000343941200055
PM 25299576
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Bainbridge, TW
   DeAlmeida, VI
   Izrael-Tomasevic, A
   Chalouni, C
   Pan, B
   Goldsmith, J
   Schoen, AP
   Quinones, GA
   Kelly, R
   Lill, JR
   Sandoval, W
   Costa, M
   Polakis, P
   Arnott, D
   Rubinfeld, B
   Ernst, JA
AF Bainbridge, Travis W.
   DeAlmeida, Venita I.
   Izrael-Tomasevic, Anita
   Chalouni, Cecile
   Pan, Borlan
   Goldsmith, Joshua
   Schoen, Alia P.
   Quinones, Gabriel A.
   Kelly, Ryan
   Lill, Jennie R.
   Sandoval, Wendy
   Costa, Mike
   Polakis, Paul
   Arnott, David
   Rubinfeld, Bonnee
   Ernst, James A.
TI Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and
   ROR2 Kinase Domains
SO PLOS ONE
LA English
DT Article
ID RECEPTOR TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-ASSOCIATED
   ANTIGEN; TOXOPLASMA-GONDII; CELL-MIGRATION; CRD DOMAIN; ACTIVATION;
   BINDING; GROWTH; COMPLEX
AB Receptor tyrosine kinase-like orphan receptors (ROR) 1 and 2 are atypical members of the receptor tyrosine kinase (RTK) family and have been associated with several human diseases. The vertebrate RORs contain an ATP binding domain that deviates from the consensus amino acid sequence, although the impact of this deviation on catalytic activity is not known and the kinase function of these receptors remains controversial. Recently, ROR2 was shown to signal through a Wnt responsive, beta-catenin independent pathway and suppress a canonical Wnt/beta-catenin signal. In this work we demonstrate that both ROR1 and ROR2 kinase domains are catalytically deficient while CAM-1, the C. elegans homolog of ROR, has an active tyrosine kinase domain, suggesting a divergence in the signaling processes of the ROR family during evolution. In addition, we show that substitution of the non-consensus residues from ROR1 or ROR2 into CAM-1 and MuSK markedly reduce kinase activity, while restoration of the consensus residues in ROR does not restore robust kinase function. We further demonstrate that the membrane-bound extracellular domain alone of either ROR1 or ROR2 is sufficient for suppression of canonical Wnt3a signaling, and that this domain can also enhance Wnt5a suppression of Wnt3a signaling. Based on these data, we conclude that human ROR1 and ROR2 are RTK-like pseudokinases.
C1 [Bainbridge, Travis W.; Izrael-Tomasevic, Anita; Schoen, Alia P.; Quinones, Gabriel A.; Kelly, Ryan; Lill, Jennie R.; Sandoval, Wendy; Arnott, David; Ernst, James A.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.
   [DeAlmeida, Venita I.; Goldsmith, Joshua; Costa, Mike; Polakis, Paul; Rubinfeld, Bonnee] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA.
   [Chalouni, Cecile] Genentech Inc, Ctr Adv Light Microscopy, San Francisco, CA 94080 USA.
   [Pan, Borlan] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA.
RP Ernst, JA (reprint author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.
EM ernst.james@gene.com
OI Kelly, Ryan/0000-0001-5003-9104
CR Afzal AR, 2000, NAT GENET, V25, P419
   Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873
   Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717
   Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823
   Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571
   CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115
   Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487
   DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587
   DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266
   Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175
   Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721
   Forrester WC, 1999, NATURE, V400, P881
   Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028
   Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105
   Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001
   Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662
   Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006
   Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710
   HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115
   Henriquez JP, 2012, ACTA PHYSIOL, V204, P128, DOI 10.1111/j.1748-1716.2011.02295.x
   Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109
   Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987
   Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309
   Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007
   Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002
   Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005
   Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848
   Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5
   MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715
   Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415
   Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174
   Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127
   Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10
   Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200
   Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001
   Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606
   Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24
   Rajakulendran T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3111pe8
   Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018
   Shabani M, 2007, TUMOR BIOL, V28, P318, DOI 10.1159/000121405
   Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107
   Tice DA, 2002, J BIOL CHEM, V277, P6118, DOI 10.1074/jbc.M111255200
   Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509
   WHITE MF, 1984, J BIOL CHEM, V259, P255
   Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611
   Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116
   Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3
   Zhang XH, 2007, BBA-GEN SUBJECTS, V1770, P1490, DOI 10.1016/j.bbagen.2007.06.017
NR 52
TC 15
Z9 21
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 16
PY 2014
VL 9
IS 7
AR e102695
DI 10.1371/journal.pone.0102695
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO4KM
UT WOS:000341306600093
PM 25029443
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Many, AM
   Brown, AMC
AF Many, Alexander M.
   Brown, Anthony M. C.
TI Both Canonical and Non-Canonical Wnt Signaling Independently Promote
   Stem Cell Growth in Mammospheres
SO PLOS ONE
LA English
DT Article
ID MAMMARY STEM/PROGENITOR CELLS; N-TERMINAL KINASE; BETA-CATENIN;
   BREAST-CANCER; GLAND DEVELOPMENT; TRANSGENIC MICE; SELF-RENEWAL;
   TGF-BETA; PROGENITOR CELLS; IN-VIVO
AB The characterization of mammary stem cells, and signals that regulate their behavior, is of central importance in understanding developmental changes in the mammary gland and possibly for targeting stem-like cells in breast cancer. The canonical Wnt/beta-catenin pathway is a signaling mechanism associated with maintenance of self-renewing stem cells in many tissues, including mammary epithelium, and can be oncogenic when deregulated. Wnt1 and Wnt3a are examples of ligands that activate the canonical pathway. Other Wnt ligands, such as Wnt5a, typically signal via non-canonical, beta-cateninin-dependent, pathways that in some cases can antagonize canonical signaling. Since the role of non-canonical Wnt signaling in stem cell regulation is not well characterized, we set out to investigate this using mammosphere formation assays that reflect and quantify stem cell properties. Ex vivo mammosphere cultures were established from both wild-type and Wnt1 transgenic mice and were analyzed in response to manipulation of both canonical and non-canonical Wnt signaling. An increased level of mammosphere formation was observed in cultures derived from MMTV-Wnt1 versus wild-type animals, and this was blocked by treatment with Dkk1, a selective inhibitor of canonical Wnt signaling. Consistent with this, we found that a single dose of recombinant Wnt3a was sufficient to increase mammosphere formation in wild-type cultures. Surprisingly, we found that Wnt5a also increased mammosphere formation in these assays. We confirmed that this was not caused by an increase in canonical Wnt/beta-catenin signaling but was instead mediated by non-canonical Wnt signals requiring the receptor tyrosine kinase Ror2 and activity of the Jun N-terminal kinase, JNK. We conclude that both canonical and non-canonical Wnt signals have positive effects promoting stem cell activity in mammosphere assays and that they do so via independent signaling mechanisms.
C1 [Many, Alexander M.; Brown, Anthony M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA.
RP Brown, AMC (reprint author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA.
EM amcbrown@med.cornell.edu
FU New York Stem Cell Science [C024286]; National Institutes of Health [R25
   CA105012, R01 CA123238]; Strang Cancer Prevention Institute
FX This work was supported by New York Stem Cell Science
   (http://stemcell.ny.gov/) grant C024286 (AB and AM), National Institutes
   of Health (http://www.nih.gov/) grant R25 CA105012 (AM), Strang Cancer
   Prevention Institute, and National Institutes of Health grant R01
   CA123238 (AB). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972
   Alexander CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008037
   Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594
   Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081
   Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854
   Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21907
   Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455
   Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298
   Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33
   Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440
   Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012
   DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53
   de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096
   DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266
   Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710
   Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329
   Dong QX, 2013, STEM CELL RES, V10, P396, DOI 10.1016/j.scr.2013.01.007
   Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920
   Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803
   Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107
   Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370
   Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108
   Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004
   Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106
   Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710
   Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603
   Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI200112466
   He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652
   Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004
   Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561
   Incassati A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2723
   Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153
   Jonsson M, 2002, CANCER RES, V62, P409
   Kordon EC, 1998, DEVELOPMENT, V125, P1921
   Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207
   Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067811
   Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273
   Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100
   Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493
   Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008
   Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101
   Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005
   Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054
   Macdonald Bryan T, 2007, Cell, V131, P1204
   Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027
   Many AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2631
   Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108
   Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655
   McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821
   Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797
   Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104
   Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470
   Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10
   Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200
   Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035
   O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   Pavlovich AL, 2011, EXP CELL RES, V317, P1872, DOI 10.1016/j.yexcr.2011.03.017
   Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017
   Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007
   Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948
   Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250
   Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244
   Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029
   Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011
   Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1
   Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5
   Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372
   Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606
   Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349
   Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496
   Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552
   Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537
   Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158
   TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6
   van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914
   van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020
   van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023
   van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9
   Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8
   Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573
   Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903
   Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020
   Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353
NR 87
TC 22
Z9 22
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 14
PY 2014
VL 9
IS 7
AR e101800
DI 10.1371/journal.pone.0101800
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM1PC
UT WOS:000339618600029
PM 25019931
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Kumawat, K
   Menzen, MH
   Slegtenhorst, RM
   Halayko, AJ
   Schmidt, M
   Gosens, R
AF Kumawat, Kuldeep
   Menzen, Mark H.
   Slegtenhorst, Ralph M.
   Halayko, Andrew J.
   Schmidt, Martina
   Gosens, Reinoud
TI TGF-beta-Activated Kinase 1 (TAK1) Signaling Regulates TGF-beta-Induced
   WNT-5A Expression in Airway Smooth Muscle Cells via Sp1 and beta-Catenin
SO PLOS ONE
LA English
DT Article
ID EXTRACELLULAR-MATRIX PRODUCTION; GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B;
   TRANSCRIPTION FACTOR; SMAD PATHWAYS; WNT5A; GENE; INHIBITION; SECRETION;
   PROMOTER
AB WNT-5A, a key player in embryonic development and post-natal homeostasis, has been associated with a myriad of pathological conditions including malignant, fibroproliferative and inflammatory disorders. Previously, we have identified WNT-5A as a transcriptional target of TGF-beta in airway smooth muscle cells and demonstrated its function as a mediator of airway remodeling. Here, we investigated the molecular mechanisms underlying TGF-beta-induced WNT-5A expression. We show that TGF-beta-activated kinase 1 (TAK1) is a critical mediator of WNT-5A expression as its pharmacological inhibition or siRNA-mediated silencing reduced TGF-beta induction of WNT-5A. Furthermore, we show that TAK1 engages p38 and c-Jun N-terminal kinase (JNK) signaling which redundantly participates in WNT-5A induction as only simultaneous, but not individual, inhibition of p38 and JNK suppressed TGF-beta-induced WNT-5A expression. Remarkably, we demonstrate a central role of beta-catenin in TGF-beta-induced WNT-5A expression. Regulated by TAK1, beta-catenin is required for WNT-5A induction as it silencing repressed WNT-5A expression whereas a constitutively active mutant augmented basal WNT-5A abundance. Furthermore, we identify Sp1 as the transcription factor for WNT-5A and demonstrate its interaction with beta-catenin. We discover that Sp1 is recruited to the WNT-5A promoter in a TGF-beta-induced and TAK1-regulated manner. Collectively, our findings describe a TAK1-dependent, beta-catenin- and Sp1-mediated signaling cascade activated downstream of TGF-beta which regulates WNT-5A induction.
C1 [Kumawat, Kuldeep; Menzen, Mark H.; Slegtenhorst, Ralph M.; Schmidt, Martina; Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands.
   [Kumawat, Kuldeep; Menzen, Mark H.; Slegtenhorst, Ralph M.; Schmidt, Martina; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Groningen, Netherlands.
   [Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada.
   [Halayko, Andrew J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.
RP Kumawat, K (reprint author), Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands.
EM k.kumawat@rug.nl
FU Compex Medical SA, Ecublens VD
FX The myostimulator Compex 3 Professional was sponsored by Compex Medical
   SA, Ecublens VD. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002
   Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011
   Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V300, pL910, DOI 10.1152/ajplung.00232.2010
   Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood.2004-08-2661
   Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111
   BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474
   Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94
   Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571
   Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007
   Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4
   Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881
   Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377
   CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0
   D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200
   Dai L, 2012, IUBMB LIFE, V64, P825, DOI 10.1002/iub.1078
   Danielson KG, 1995, J BIOL CHEM, V270, P31225, DOI 10.1074/jbc.270.52.31225
   Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558
   Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605
   Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331
   Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200
   Fujio Y, 2004, FEBS LETT, V573, P202, DOI 10.1016/j.febslet.2004.07.082
   Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006
   Gosens R, 2008, N-S ARCH PHARMACOL, V378, P185, DOI 10.1007/s00210-008-0269-8
   Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006
   Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325
   He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566
   Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568
   IOZZO RV, 1995, CANCER RES, V55, P3495
   Jansen SR, 2010, AM J PHYSIOL-LUNG C, V299, pL204, DOI 10.1152/ajplung.00020.2010
   Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106
   Katoh M, 2007, INT J MOL MED, V19, P273
   Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190
   Katula KS, 2012, DNA CELL BIOL, V31, P1585, DOI 10.1089/dna.2012.1698
   Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x
   Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181
   Kim J, 2012, CYTOKINE, V60, P242, DOI 10.1016/j.cyto.2012.06.013
   Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142
   Kolligs FT, 1999, MOL CELL BIOL, V19, P5696
   Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539
   Lam AP, 2011, AM J RESP CELL MOL, V45, P915, DOI 10.1165/rcmb.2010-0113OC
   Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144
   Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729
   Li X, 2013, GENES CELLS, V18, P608, DOI 10.1111/gtc.12064
   Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200
   MacLeod RJ, 2007, AM J PHYSIOL-GASTR L, V293, pG403, DOI 10.1152/ajpgi.00119.2007
   Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023
   Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821
   Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001
   Pera T, 2012, AM J PHYSIOL-LUNG C, V303, pL272, DOI 10.1152/ajplung.00291.2011
   Pera T, 2011, AM J PHYSIOL-LUNG C, V301, pL822, DOI 10.1152/ajplung.00017.2011
   Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438
   Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488
   Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255
   Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250
   Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007
   Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033
   Tan SH, 2009, J BIOL CHEM, V284, P18047, DOI 10.1074/jbc.M109.002691
   Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC
   Woldt E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2087
   Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012
   Wu XQ, 2004, J BIOL CHEM, V279, P36158, DOI 10.1074/jbc.M402454200
   Xian-Peng G, 2011, OSTEOARTHR CARTILAGE, V19, P111, DOI 10.1016/j.joca.2010.10.016
   Xiong WJ, 2012, WORLD J GASTROENTERO, V18, P1745, DOI 10.3748/wjg.v18.i15.1745
   Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211
   Yeganeh B, 2013, PULM PHARMACOL THER, V26, P50, DOI 10.1016/j.pupt.2012.07.006
   Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903
   Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328
NR 69
TC 26
Z9 26
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 11
PY 2014
VL 9
IS 4
AR e94801
DI 10.1371/journal.pone.0094801
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI3CI
UT WOS:000336736200132
PM 24728340
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Liu, B
   Tahk, S
   Yee, KM
   Yang, R
   Yang, YH
   Mackie, R
   Hsu, C
   Chernishof, V
   O'Brien, N
   Jin, YS
   Fan, GP
   Lane, TF
   Rao, JY
   Slamon, D
   Shuai, K
AF Liu, Bin
   Tahk, Samuel
   Yee, Kathleen M.
   Yang, Randy
   Yang, Yonghui
   Mackie, Ryan
   Hsu, Cary
   Chernishof, Vasili
   O'Brien, Neil
   Jin, Yusheng
   Fan, Guoping
   Lane, Timothy F.
   Rao, Jianyu
   Slamon, Dennis
   Shuai, Ke
TI PIAS1 Regulates Breast Tumorigenesis through Selective Epigenetic Gene
   Silencing
SO PLOS ONE
LA English
DT Article
ID CYCLIN D2 EXPRESSION; CANCER STEM-CELLS; NF-KAPPA-B; PROMOTER
   HYPERMETHYLATION; TUMOR-SUPPRESSOR; SELF-RENEWAL; WNT5A; METHYLATION;
   PROTEIN; ACTIVATION
AB Epigenetic gene silencing by histone modifications and DNA methylation is essential for cancer development. The molecular mechanism that promotes selective epigenetic changes during tumorigenesis is not understood. We report here that the PIAS1 SUMO ligase is involved in the progression of breast tumorigenesis. Elevated PIAS1 expression was observed in breast tumor samples. PIAS1 knockdown in breast cancer cells reduced the subpopulation of tumor-initiating cells, and inhibited breast tumor growth in vivo. PIAS1 acts by delineating histone modifications and DNA methylation to silence the expression of a subset of clinically relevant genes, including breast cancer DNA methylation signature genes such as cyclin D2 and estrogen receptor, and breast tumor suppressor WNT5A. Our studies identify a novel epigenetic mechanism that regulates breast tumorigenesis through selective gene silencing.
C1 [Liu, Bin; Tahk, Samuel; Yang, Yonghui; Mackie, Ryan; Chernishof, Vasili; O'Brien, Neil; Slamon, Dennis; Shuai, Ke] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.
   [Yee, Kathleen M.; Yang, Randy; Shuai, Ke] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.
   [Hsu, Cary] Univ Calif Los Angeles, Dept Gen Surg, Los Angeles, CA USA.
   [Jin, Yusheng; Rao, Jianyu] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA.
   [Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA.
   [Lane, Timothy F.] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA.
RP Liu, B (reprint author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.
EM bliu@ucla.edu; kshuai@mednet.ucla.edu
FU NIH [R01AI063286, R01GM085797]; Margaret E. Early Medical Research
   Trust; UCLA Jonsson Comprehensive Cancer Center; Research Scientist
   Development Award from the NIH [K01 AR52717-01]; UCLA Tumor Immunology
   Training Fellowship
FX This research was supported by grants from the NIH (R01AI063286 and
   R01GM085797), Margaret E. Early Medical Research Trust, and the UCLA
   Jonsson Comprehensive Cancer Center (K.S.). B.L. was supported by a
   Research Scientist Development Award from the NIH (K01 AR52717-01). S.T.
   was supported by a UCLA Tumor Immunology Training Fellowship. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007
   Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008
   Blanc E, 2005, CANCER LETT, V228, P117, DOI 10.1016/j.canlet.2004.11.061
   Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730
   Connolly R, 2012, J MAMMARY GLAND BIOL
   Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854
   Dedeurwaerder S, 2011, CURR OPIN ONCOL, V23, P559, DOI 10.1097/CCO.0b013e32834bd481
   Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803
   Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207
   Evron E, 2001, CANCER RES, V61, P2782
   Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014
   Hautala LC, 2008, INT J CANCER, V123, P2279, DOI 10.1002/ijc.23773
   Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009
   Huang Y, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2925
   Inoue M, 2005, FEBS LETT, V579, P604, DOI 10.1016/j.febslet.2004.12.030
   Jansson M, 2001, J CELL SCI, V114, P2043
   Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029
   Jonsson M, 2002, CANCER RES, V62, P409
   Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002
   Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931
   Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030
   Li LC, 2000, CANCER RES, V60, P702
   Li XX, 2008, J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123
   Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X
   Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104
   Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626
   Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005
   Liu B, 2008, CURR OPIN CELL BIOL, V20, P288, DOI 10.1016/j.ceb.2008.03.014
   Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056
   Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787
   LOKE SL, 1988, AM J PATHOL, V131, P29
   Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835
   Mandelin E, 2003, CANCER RES, V63, P6258
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mimeault M, 2007, J CELL MOL MED, V11, P981, DOI 10.1111/j.1582-4934.2007.00088.x
   Miyoshi H, 1998, J VIROL, V72, P8150
   Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004
   Olson DJ, 1997, CELL GROWTH DIFFER, V8, P417
   Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495
   Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319
   Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250
   Sakuma M, 2007, CANCER SCI, V98, P380, DOI 10.1111/j.1349-7006.2007.00394.x
   Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667
   Szyf M, 2012, GENOME MED, V4, DOI 10.1186/gm325
   Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104
   Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906
   Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110
   Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104
   Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644
   Ying J, 2007, BLOOD, V110, P4130, DOI 10.1182/blood-2007-06-094870
   Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054
   Yu J, 2003, BRIT J CANCER, V88, P1560, DOI 10.1038/sj.bjc.6600940
NR 52
TC 13
Z9 14
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2014
VL 9
IS 2
AR e89464
DI 10.1371/journal.pone.0089464
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AB6EP
UT WOS:000331880700049
PM 24586797
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Chandrakesan, P
   Jakkula, LUMR
   Ahmed, I
   Roy, B
   Anant, S
   Umar, S
AF Chandrakesan, Parthasarathy
   Jakkula, Laxmi Uma Maheswar Rao
   Ahmed, Ishfaq
   Roy, Badal
   Anant, Shrikant
   Umar, Shahid
TI Differential Effects of beta-catenin and NF-kappa B Interplay in the
   Regulation of Cell Proliferation, Inflammation and Tumorigenesis in
   Response to Bacterial Infection
SO PLOS ONE
LA English
DT Article
ID TOLL-LIKE RECEPTOR-4; COLONIC-MUCOSA HYPERPROLIFERATION;
   CITROBACTER-RODENTIUM INFECTION; HYPERPLASIA AND/OR COLITIS; FUNCTIONAL
   CROSS-TALK; WNT PATHWAY; NUCLEAR TRANSLOCATION; EPITHELIAL-CELLS;
   ACTIVATION; EXPRESSION
AB Both beta-catenin and NF-kappa B have been implicated in our laboratory as candidate factors in driving proliferation in an in vivo model of Citrobacter rodentium (CR)-induced colonic crypt hyper-proliferation and hyperplasia. Herein, we test the hypothesis that beta-catenin and not necessarily NF-kappa B regulates colonic crypt hyperplasia or tumorigenesis in response to CR infection. When C57Bl/6 wild type (WT) mice were infected with CR, sequential increases in proliferation at days 9 and 12 plateaued off at day 19 and paralleled increases in NF-kappa B signaling. In Tlr4(-/-) (KO) mice, a sequential but sustained proliferation which tapered off only marginally at day 19, was associated with TLR4-dependent and independent increases in NF-kappa B signaling. Similarly, increases in either activated or total beta-catenin in the colonic crypts of WT mice as early as day 3 post-infection coincided with cyclinD1 and c-myc expression and associated crypt hyperplasia. In KO mice, a delayed kinetics associated predominantly with increases in non-phosphorylated (active) beta-catenin coincided with increases in cyclinD1, c-myc and crypt hyperplasia. Interestingly, PKCf-catalyzed Ser-9 phosphorylation and inactivation of GSK-3 beta and not loss of wild type APC protein accounted for beta-catenin accumulation and nuclear translocation in either strain. In vitro studies with Wnt2b and Wnt5a further validated the interplay between the Wnt/beta-catenin and NF-kappa B pathways, respectively. When WT or KO mice were treated with nanoparticle-encapsulated siRNA to beta-catenin (si- beta-Cat), almost complete loss of nuclear beta-catenin coincided with concomitant decreases in CD44 and crypt hyperplasia without defects in NF-kappa B signaling. si-beta-Cat treatment to Apc(Min/+) mice attenuated CR-induced increases in beta-catenin and CD44 that halted the growth of mutated crypts without affecting NF-kappa B signaling. The predominant beta-catenin-induced crypt proliferation was further validated in a Castaneus strain (B6.CAST.11M) that exhibited significant crypt hyperplasia despite an attenuated NF-kappa B signaling. Thus, beta-catenin and not necessarily NF-kappa B regulates crypt hyperplasia in response to bacterial infection.
C1 [Chandrakesan, Parthasarathy] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Div Digest Dis & Nutr, Oklahoma City, OK USA.
   [Jakkula, Laxmi Uma Maheswar Rao; Ahmed, Ishfaq; Roy, Badal; Anant, Shrikant; Umar, Shahid] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.
RP Umar, S (reprint author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.
EM sumar@kumc.edu
FU National Institutes of Health from National Cancer Institute [R01
   CA131413]; University of Kansas Medical Center
FX This work was supported by The National Institutes of Health Grant R01
   CA131413 (to SU) from The National Cancer Institute and by start-up
   funds from The University of Kansas Medical Center. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Ahmed I, 2013, AM J PHYSIOL-GASTR L, V304, pG356, DOI 10.1152/ajpgi.00372.2012
   Ahmed I, 2012, INFECT IMMUN, V80, P3107, DOI 10.1128/IAI.00236-12
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   BARTHOLD SW, 1978, VET PATHOL, V15, P223, DOI 10.1177/030098587801500209
   Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2
   Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046
   Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb
   Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200
   Chandrakesan P, 2014, ONCOGENE, V33, P2639, DOI 10.1038/onc.2013.210
   Chandrakesan P, 2010, J BIOL CHEM
   Chandrakesan P, 2012, INFECT IMMUN, V80, P753, DOI 10.1128/IAI.06101-11
   Cun DM, 2011, EUR J PHARM BIOPHARM, V77, P26, DOI 10.1016/j.ejpb.2010.11.008
   Davis RC, 2007, GENOMICS, V90, P306, DOI 10.1016/j.ygeno.2007.05.009
   DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493
   Du Qiang, 2010, For Immunopathol Dis Therap, V1, P155
   Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004
   Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008
   Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527
   FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959
   George SJ, 2008, ARTERIOSCL THROM VAS, V28, P400, DOI 10.1161/ATVBAHA.107.160952
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005
   Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636
   Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574
   Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497
   Katoh M, 2005, INT J MOL MED, V16, P1103
   Katoh M, 2009, INT J ONCOL, V34, P1411, DOI 10.3892/ijo_00000269
   Kawai T, 2010, NATURE IMMUNOLOGY, V11
   KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L
   Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006
   Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477
   Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860
   Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Moayeri M, 2004, INFECT IMMUN, V72, P4439, DOI 10.1128/IAI.72.8.4439-4447.2004
   Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x
   PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9
   Peleg S, 2010, AM J PHYSL
   Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X
   Santaolalla R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063298
   Sellin JH, 2001, CANCER RES, V61, P2899
   Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019
   Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297
   Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441
   Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045
   Tanaka A, 2001, J AUTOIMMUN, V17, P89, DOI 10.1006/jaut.2001.0522
   Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200
   Terra JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002469
   Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158
   Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123
   Umar S, 2008, ONCOGENE, V27, P5599, DOI 10.1038/onc.2008.169
   Umar S, 2005, ONCOGENE, V24, P6709, DOI 10.1038/sj.onc.1208820
   Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x
   Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG765
   Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG753
   Umar S, 2000, AM J PHYSIOL-GASTR L, V279, pG223
   Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006
   Umar S, 2009, J BIOL CHEM, V284, P22274, DOI 10.1074/jbc.M109.020941
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349
   Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250
   Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866
   You J, 2008, DIGEST DIS SCI, V53, P1013, DOI 10.1007/s10620-007-9973-3
   Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7
NR 68
TC 17
Z9 18
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2013
VL 8
IS 11
AR e79432
DI 10.1371/journal.pone.0079432
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259PW
UT WOS:000327539800008
PM 24278135
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Bauer, M
   Benard, J
   Gaasterland, T
   Willert, K
   Cappellen, D
AF Bauer, Matthieu
   Benard, Jean
   Gaasterland, Terry
   Willert, Karl
   Cappellen, David
TI WNT5A Encodes Two Isoforms with Distinct Functions in Cancers
SO PLOS ONE
LA English
DT Article
ID TYROSINE KINASE ROR2; BETA-CATENIN; CELL-MIGRATION; SIGNALING PATHWAY;
   DIFFERENTIAL EXPRESSION; COLORECTAL-CANCER; TUMOR-SUPPRESSOR;
   EPITHELIAL-CELLS; WNT-5A PROTEIN; RECEPTOR
AB WNT5A, a member of the WNT family of secreted lipid-modified glycoproteins, is a critical regulator of a host of developmental processes, including limb formation, lung morphogenesis, intestinal elongation and mammary gland development. Altered WNT5A expression has been associated with a number of cancers. Interestingly, in certain types of cancers, such as hematological malignancies and colorectal carcinoma, WNT5A is inactivated and exerts a tumor suppressive function, while in other cancers, such as melanoma and gastric carcinoma, WNT5A is overexpressed and promotes tumor progression. The mechanism by which WNT5A achieves these distinct activities in cancers is poorly understood. Here, we provide evidence that the WNT5A gene produces two protein isoforms, WNT5A-long (WNT5A-L) and WNT5A-short (WNT5A-S). Amino-terminal sequencing and a WNT5A-L specific antibody demonstrate that the mature and secreted isoforms are distinct, with WNT5A-L carrying an additional 18 N-terminal amino acids. Biochemical analysis indicates that both purified proteins are similar with respect to their stability, hydrophobicity and WNT/beta-catenin signaling activity. Nonetheless, modulation of these two WNT5A isoforms, either through ectopic expression or knockdown, demonstrates that they exert distinct activities in cancer cell lines: while WNT5A-L inhibits proliferation of tumor cell lines, WNT5A-S promotes their growth. Finally, we show that expression of these two WNT5A isoforms is altered in breast and cervix carcinomas, as well as in the most aggressive neuroblastoma tumors. In these cancers, WNT5A-L is frequently down-regulated, whereas WNT5A-S is found overexpressed in a significant fraction of tumors. Altogether, our study provides evidence that the distinct activities of WNT5A in cancer can be attributed to the production of two WNT5A isoforms.
C1 [Bauer, Matthieu; Benard, Jean; Cappellen, David] Univ Paris, Inst Cancerol Gustave Roussy, CNRS, Villejuif, France.
   [Bauer, Matthieu; Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   [Benard, Jean] Inst Cancerol Gustave Roussy, Dept Pathol & Biol Med, Villejuif, France.
   [Gaasterland, Terry] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Gaasterland, Terry] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.
   [Cappellen, David] Univ Bordeaux, Ctr Hosp Univ Bordeaux, Bordeaux, France.
   [Cappellen, David] Univ Bordeaux, Bordeaux, France.
RP Willert, K (reprint author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
EM kwillert@ucsd.edu; david.cappellen@u-bordeaux2.fr
FU Association pour la Recherche sur le Cancer (DC); Institut National du
   Cancer (JB); Societe Francaise des Cancers de l'Enfant (JB); European
   Connective Tissue Cancer Network (DC and MB); California Institute for
   Regenerative Medicine [CIRM, RB1-01406, KW]; Ministere de l'Enseignement
   Superieur et de la Recherche and from CIRM [TG2-01154]
FX This work was supported by grants from the Association pour la Recherche
   sur le Cancer (DC), the Institut National du Cancer (JB), Societe
   Francaise des Cancers de l'Enfant (JB), the European Connective Tissue
   Cancer Network (DC and MB) and by the California Institute for
   Regenerative Medicine (CIRM, RB1-01406, KW). MB was awarded fellowships
   from the Ministere de l'Enseignement Superieur et de la Recherche and
   from CIRM (TG2-01154). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0
   Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115
   Bunaciu RP, 2008, ONCOL REP, V20, P195
   Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849
   Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104
   Danielson KG, 1995, J BIOL CHEM, V270, P31225, DOI 10.1074/jbc.270.52.31225
   Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710
   Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05
   Fear MW, 2000, BIOCHEM BIOPH RES CO, V278, P814, DOI 10.1006/bbrc.2000.3852
   FERRANDIS E, 1994, CANCER RES, V54, P2256
   Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179
   Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370
   GOILLOT E, 1992, CANCER RES, V52, P3194
   Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004
   Green JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058395
   He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767
   Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003
   Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879
   Jonsson M, 2002, CANCER RES, V62, P409
   Katula KS, 2012, DNA CELL BIOL, V31, P1585, DOI 10.1089/dna.2012.1698
   KEMSHEAD JT, 1982, BRAIN RES, V236, P451, DOI 10.1016/0006-8993(82)90727-2
   Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389
   Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784
   Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359
   Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X
   Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0
   Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200
   Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   MOON RT, 1993, DEVELOPMENT, V119, P97
   Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310
   Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
   Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127
   OCONNELL MP, 2009, ONCOGENE, V29, P34, DOI DOI 10.1038/0NC.2009.305.PUBMED:19802008
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124
   Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011
   Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255
   Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016
   Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003
   Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117
   Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329
   Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089
   Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611
   Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2
   Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211
   YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087
   Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644
   Ying J, 2007, BLOOD, V110, P4130, DOI 10.1182/blood-2007-06-094870
   Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522
NR 56
TC 11
Z9 12
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 18
PY 2013
VL 8
IS 11
AR UNSP e80526
DI 10.1371/journal.pone.0080526
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 256KH
UT WOS:000327308500149
PM 24260410
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Angonin, D
   Van Raay, TJ
AF Angonin, Diane
   Van Raay, Terence J.
TI Nkd1 Functions as a Passive Antagonist of Wnt Signaling
SO PLOS ONE
LA English
DT Article
ID PLANAR CELL-POLARITY; CONVERGENT EXTENSION; NEGATIVE REGULATOR;
   INDUCIBLE ANTAGONIST; BETA-CATENIN/TCF; ZEBRAFISH DKK1; AXIS FORMATION;
   EXPRESSION; PATHWAY; PROTEIN
AB Wnt signaling is involved in many aspects of development and in the homeostasis of stem cells. Its importance is underscored by the fact that misregulation of Wnt signaling has been implicated in numerous diseases, especially colorectal cancer. However, how Wnt signaling regulates itself is not well understood. There are several Wnt negative feedback regulators, which are active antagonists of Wnt signaling, but one feedback regulator, Nkd1, has reduced activity compared to other antagonists, yet is still a negative feedback regulator. Here we describe our efforts to understand the role of Nkd1 using Wnt signaling compromised zebrafish mutant lines. In several of these lines, Nkd1 function was not any more active than it was in wild type embryos. However, we found that Nkd1's ability to antagonize canonical Wnt/beta-catenin signaling was enhanced in the Wnt/Planar Cell Polarity mutants silberblick (slb/wnt11) and trilobite (tri/vangl2). While slb and tri mutants do not display alterations in canonical Wnt signaling, we found that they are hypersensitive to it. Overexpression of the canonical Wnt/beta-catenin ligand Wnt8a in slb or tri mutants resulted in dorsalized embryos, with tri mutants being much more sensitive to Wnt8a than slb mutants. Furthermore, the hyperdorsalization caused by Wnt8a in tri could be rescued by Nkd1. These results suggest that Nkd1 functions as a passive antagonist of Wnt signaling, functioning only when homeostatic levels of Wnt signaling have been breached or when Wnt signaling becomes destabilized.
C1 [Angonin, Diane; Van Raay, Terence J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.
RP Van Raay, TJ (reprint author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.
EM tvanraay@uoguelph.ca
RI angonin, diane/M-8081-2014
FU NSERC Discovery Grant
FX The work was supported by an NSERC Discovery Grant. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717
   Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065
   Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460
   Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375
   Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097
   Erter CE, 2001, DEVELOPMENT, V128, P3571
   Fekany K, 1999, DEVELOPMENT, V126, P1427
   Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333
   Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003
   Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6
   Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303
   Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537
   Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068
   Henderson DJ, 2006, TRENDS CARDIOVAS MED, V16, P38, DOI 10.1016/j.tcm.2005.11.005
   Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057
   Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   KELLY GM, 1995, DEVELOPMENT, V121, P1787
   Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389
   Li SD, 2011, P NATL ACAD SCI USA, V108, P2264, DOI 10.1073/pnas.1013170108
   Lum WM, 2011, ZEBRAFISH, V8, P65, DOI 10.1089/zeb.2011.0691
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Marek M, 2005, ADV DEV BIOL BIOCH
   Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788
   Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104
   Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892
   Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716
   Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201
   Schepers A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007989
   Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040
   SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843
   Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6
   Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0
   Solnica-Krezel L, 2001, INT J DEV BIOL, V45, P299
   Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5
   STACHEL SE, 1993, DEVELOPMENT, V117, P1261
   Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3
   Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003
   Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123
   Van Raay TJ, 2007, DEV BIOL, V309, P151, DOI 10.1016/j.ydbio.2007.04.018
   Van Raay TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018650
   Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277
   Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/job.200303107
   Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238
   Wu SY, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001403
   Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898
   Zeng WL, 2000, NATURE, V403, P789
   Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177
   Zhang S, 2007, MOL CELL BIOL, V27, P4454, DOI 10.1128/MCB.00133-07
NR 53
TC 16
Z9 16
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2013
VL 8
IS 8
AR e74666
DI 10.1371/journal.pone.0074666
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 209DO
UT WOS:000323734600086
PM 24009776
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Wada, N
   Hashinaga, T
   Otabe, S
   Yuan, XH
   Kurita, Y
   Kakino, S
   Ohoki, T
   Nakayama, H
   Fukutani, T
   Tajiri, Y
   Yamada, K
AF Wada, Nobuhiko
   Hashinaga, Toshihiko
   Otabe, Shuichi
   Yuan, Xiaohong
   Kurita, Yayoi
   Kakino, Satomi
   Ohoki, Tsuyoshi
   Nakayama, Hitomi
   Fukutani, Tomoka
   Tajiri, Yuji
   Yamada, Kentaro
TI Selective Modulation of Wnt Ligands and Their Receptors in Adipose
   Tissue by Chronic Hyperadiponectinemia
SO PLOS ONE
LA English
DT Article
ID NF-KAPPA-B; BETA-CATENIN; SIGNALING PATHWAY; FRIZZLED HOMOLOGS;
   CELL-ADHESION; PPAR-GAMMA; ADIPONECTIN; ACTIVATION; DIFFERENTIATION;
   ADIPOGENESIS
AB Background: Adiponectin-transgenic mice had many small adipocytes in both subcutaneous and visceral adipose tissues, and showed higher sensitivity to insulin, longer life span, and reduced chronic inflammation. We hypothesized that adiponectin regulates Wnt signaling in adipocytes and thereby modulates adipocyte proliferation and chronic inflammation in adipose tissue.
   Materials and Methods: We examined the expression of all Wnt ligands and their receptors and the activity of Wnt signaling pathways in visceral adipose tissue from wild-type mice and two lines of adiponectin-transgenic mice. The effects of adiponectin were also investigated in cultured 3T3-L1 cells.
   Results: The Wnt5b, Wnt6, Frizzled 6 (Fzd6), and Fzd9 genes were up-regulated in both lines of transgenic mice, whereas Wnt1, Wnt2, Wnt5a, Wnt9b, Wnt10b, Wnt11, Fzd1, Fzd2, Fzd4, Fzd7, and the Fzd coreceptor low-density-lipoprotein receptor-related protein 6 (Lrp6) were reduced. There was no difference in total beta-catenin levels in whole-cell extracts, non-phospho-beta-catenin levels in nuclear extracts, or mRNA levels of beta-catenin target genes, indicating that hyperadiponectinemia did not affect canonical Wnt signaling. In contrast, phosphorylated calcium/calmodulin-dependent kinase II (p-CaMKII) and phosphorylated Jun N-terminal kinase (p-JNK) were markedly reduced in adipose tissue from the transgenic mice. The adipose tissue of the transgenic mice consisted of many small cells and had increased expression of adiponectin, whereas cyclooxygenase-2 expression was reduced. Wnt5b expression was elevated in preadipocytes of the transgenic mice and decreased in diet-induced obese mice, suggesting a role in adipocyte differentiation. Some Wnt genes, Fzd genes, and p-CaMKII protein were down-regulated in 3T3-L1 cells cultured with a high concentration of adiponectin.
   Conclusion: Chronic hyperadiponectinemia selectively modulated the expression of Wnt ligands, Fzd receptors and LRP coreceptors accompanied by the inhibition of the Wnt/Ca2+ and JNK signaling pathways, which may be involved in the altered adipocyte cellularity, endogenous adiponectin production, and anti-inflammatory action induced by hyperadiponectinemia.
C1 [Wada, Nobuhiko; Hashinaga, Toshihiko; Otabe, Shuichi; Yuan, Xiaohong; Kurita, Yayoi; Kakino, Satomi; Ohoki, Tsuyoshi; Nakayama, Hitomi; Fukutani, Tomoka; Tajiri, Yuji; Yamada, Kentaro] Kurume Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Kurume, Fukuoka 830, Japan.
RP Yamada, K (reprint author), Kurume Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Kurume, Fukuoka 830, Japan.
EM yamada@med.kurume-u.ac.jp
FU Japan Society for the Promotion of Science [21591154]
FX This study was supported by Grant-in-Aid for Scientific Research (C)
   21591154 from the Japan Society for the Promotion of Science. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004
   Behrens J, 2000, ANN NY ACAD SCI, V910, P21
   Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6
   Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338
   Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046
   Endo H, 2009, GUT, V58, P1637, DOI 10.1136/gut.2009.183624
   Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001
   Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105
   Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2
   Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200
   He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117
   HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770
   Jung MY, 2012, J IMMUNOL, V188, P2592, DOI 10.4049/jimmunol.1102588
   Katoh M, 2005, INT J ONCOL, V26, P1129
   Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190
   Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860
   Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181
   Koyanagi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005765
   Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701
   Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200
   Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019
   Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510
   Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miyazaki T, 2005, BIOCHEM BIOPH RES CO, V333, P79, DOI 10.1016/j.bbrc.2005.05.076
   Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P
   Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006
   Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296
   Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280
   Papkoff J, 1996, MOL CELL BIOL, V16, P2128
   Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950
   Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322
   Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016
   Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437
   Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297
   Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441
   Swain Rajeeb Kumar, 2005, Cell Commun Signal, V3, P12, DOI 10.1186/1478-811X-3-12
   Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647
   van Tienen FHJ, 2009, BIOCHEM BIOPH RES CO, V387, P207, DOI 10.1016/j.bbrc.2009.07.004
   Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339
NR 44
TC 9
Z9 10
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 4
PY 2013
VL 8
IS 7
AR e67712
DI 10.1371/journal.pone.0067712
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 204FO
UT WOS:000323350700026
PM 23861788
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Wang, CL
   Zhao, Y
   Su, YY
   Li, RM
   Lin, YF
   Zhou, XD
   Ye, L
AF Wang, Chenglin
   Zhao, Yuan
   Su, Yingying
   Li, Ruimin
   Lin, Yunfeng
   Zhou, Xuedong
   Ye, Ling
TI C-Jun N-Terminal Kinase (JNK) Mediates Wnt5a-Induced Cell Motility
   Dependent or Independent of RhoA Pathway in Human Dental Papilla Cells
SO PLOS ONE
LA English
DT Article
ID WNT SIGNALING PATHWAY; CONVERGENT EXTENSION MOVEMENTS; BETA-CATENIN;
   TOOTH DEVELOPMENT; TYROSINE PHOSPHORYLATION; FOCAL ADHESIONS; TISSUE
   INTERACTIONS; ACTIN ORGANIZATION; APICAL PAPILLA; EXPRESSION
AB Wnt5a plays an essential role in tissue development by regulating cell migration, though the molecular mechanisms are still not fully understood. Our study investigated the pathways involved in Wnt5a-dependent cell motility during the formation of dentin and pulp. Over-expression of Wnt5a promoted cell adhesion and formation of focal adhesion complexes (FACs) in human dental papilla cells (hDPCs), while inhibiting cell migration. Instead of activating the canonical Wnt signal pathway in hDPCs, Wnt5a stimulation induced activation of the JNK signal in a RhoA-dependent or independent manner. Inhibiting JNK abrogated Wnt5a-induced FACs formation but not cytoskeletal rearrangement. Both dominant negative RhoA (RhoA T19N) and constitutively active RhoA mutants (RhoA Q63L) blocked the Wnt5a-dependent changes in hDPCs adhesion, migration and cytoskeletal rearrangement here too, with the exception of the formation of FACs. Taken together, our study suggested that RhoA and JNK signaling have roles in mediating Wnt5a-dependent adhesion and migration in hDPCs, and the Wnt5a/JNK pathway acts both dependently and independently of the RhoA pathway.
C1 [Wang, Chenglin; Zhao, Yuan; Su, Yingying; Li, Ruimin; Lin, Yunfeng; Zhou, Xuedong; Ye, Ling] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China.
   [Wang, Chenglin; Zhao, Yuan; Su, Yingying; Li, Ruimin; Lin, Yunfeng; Zhou, Xuedong; Ye, Ling] Sichuan Univ, West China Sch Stomatol, Chengdu 610064, Sichuan, Peoples R China.
RP Ye, L (reprint author), Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China.
EM yeling@scu.edu.cn
RI ZHOU, XUE/F-6129-2013; Lin, Yunfeng/H-3393-2011
OI Lin, Yunfeng/0000-0003-1224-6561
FU NSFC [81070801, 81200759]; New Century Excellent Talents Fund
   [NCET-10-0577]; Innovative Research Team of Education Department of
   Sichuan Province [13TD0038]; Sichuan Province Science and Technology
   Support Program [2012SZ0034]; Scientific Research Foundation of Sichuan
   University Young Teachers [2012SCU11900-4]
FX This work was supported by NSFC Grant 81070801 and 81200759, New Century
   Excellent Talents Fund NCET-10-0577, Innovative Research Team of
   Education Department of Sichuan Province 13TD0038, Sichuan Province
   Science and Technology Support Program 2012SZ0034 and Scientific
   Research Foundation of Sichuan University Young Teachers 2012SCU11900-4.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075
   Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147
   Allen WE, 1997, J CELL SCI, V110, P707
   Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014
   Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308
   Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338
   Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964
   Biz MT, 2010, CELL TISSUE RES, V340, P459, DOI 10.1007/s00441-010-0961-0
   Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012
   Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X
   Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004
   Chai Y, 2003, MICROSC RES TECHNIQ, V60, P469, DOI 10.1002/jemt.10287
   Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7
   Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265
   Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710
   Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021
   Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200
   Even-Ram S, 2009, EXTRACELLULAR MATRIX
   Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159
   Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745
   Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871
   Huang GTJ, 2008, J ENDODONT, V34, P645, DOI 10.1016/j.joen.2008.03.001
   Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101
   Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200
   Katoh M, 2005, ONCOL REP, V14, P1583
   Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190
   Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x
   Kikuchi A., 2011, ACTA PHYSL OXF, V204, P17
   Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003
   Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262
   Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284
   Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022
   Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370
   Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359
   Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090
   Lin MK, 2011, DEV DYNAM, V240, P432, DOI 10.1002/dvdy.22550
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677
   Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1
   Nakamura K, 2000, J BIOL CHEM, V275, P27155
   Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200
   Obara N, 2006, CELL TISSUE RES, V325, P197, DOI 10.1007/s00441-005-0136-6
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   Peng L, 2010, INT ENDOD J, V43, P404, DOI 10.1111/j.1365-2591.2010.01693.x
   Peng L, 2010, ARCH ORAL BIOL, V55, P108, DOI 10.1016/j.archoralbio.2009.12.002
   Peng L, 2009, BIOCHEM BIOPH RES CO, V390, P1072, DOI 10.1016/j.bbrc.2009.10.136
   Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665
   Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7
   Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0
   Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725
   Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731
   THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x
   Thesleff I, 1996, ANAT REC, V245, P151
   Thesleff I, 1995, CONNECT TISSUE RES, V32, P9, DOI 10.3109/03008209509013700
   THOMAS HF, 1989, ARCH ORAL BIOL, V34, P27, DOI 10.1016/0003-9969(89)90043-5
   Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158
   Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117
   Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4
   Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653
   Wang CL, 2010, J ENDODONT, V36, P238, DOI 10.1016/j.joen.2009.09.007
   Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59
   Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496
   Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008
   YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1
   Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314
NR 79
TC 2
Z9 2
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 3
PY 2013
VL 8
IS 7
AR e69440
DI 10.1371/journal.pone.0069440
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 182HT
UT WOS:000321733000035
PM 23844260
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Serrat, R
   Lopez-Domenech, G
   Mirra, S
   Quevedo, M
   Garcia-Fernandez, J
   Ulloa, F
   Burgaya, F
   Soriano, E
AF Serrat, Roman
   Lopez-Domenech, Guillermo
   Mirra, Serena
   Quevedo, Marti
   Garcia-Fernandez, Jordi
   Ulloa, Fausto
   Burgaya, Ferran
   Soriano, Eduardo
TI The Non-Canonical Wnt/PKC Pathway Regulates Mitochondrial Dynamics
   through Degradation of the Arm-Like Domain-Containing Protein Alex3
SO PLOS ONE
LA English
DT Article
ID BETA-CATENIN; KINASE-C; COLON-CANCER; HIPPOCAMPAL-NEURONS;
   EPITHELIAL-CELLS; PROGENITOR CELLS; STEM-CELLS; PKC-DELTA; WNT5A;
   DIFFERENTIATION
AB The regulation of mitochondrial dynamics is vital in complex cell types, such as neurons, that transport and localize mitochondria in high energy-demanding cell domains. The Armcx3 gene encodes a mitochondrial-targeted protein (Alex3) that contains several arm-like domains. In a previous study we showed that Alex3 protein regulates mitochondrial aggregation and trafficking. Here we studied the contribution of Wnt proteins to the mitochondrial aggregation and dynamics regulated by Alex3. Overexpression of Alex3 in HEK293 cells caused a marked aggregation of mitochondria, which was attenuated by treatment with several Wnts. We also found that this decrease was caused by Alex3 degradation induced by Wnts. While the Wnt canonical pathway did not alter the pattern of mitochondrial aggregation induced by Alex3, we observed that the Wnt/PKC non-canonical pathway regulated both mitochondrial aggregation and Alex3 protein levels, thereby rendering a mitochondrial phenotype and distribution similar to control patterns. Our data suggest that the Wnt pathway regulates mitochondrial distribution and dynamics through Alex3 protein degradation.
C1 [Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain.
   [Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Inst Res Biomed Barcelona, Dev Neurobiol & Regenerat Lab, Barcelona, Spain.
   [Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.
   [Garcia-Fernandez, Jordi] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.
   [Garcia-Fernandez, Jordi] Univ Barcelona, Inst Biomed, Barcelona, Spain.
   [Soriano, Eduardo] Fdn CIEN, Madrid, Spain.
RP Soriano, E (reprint author), Univ Barcelona, Dept Cell Biol, Barcelona, Spain.
EM esoriano@ub.edu
RI Serrat Rene, Roman/A-2500-2017; Garcia-Fernandez, Jordi/B-3839-2013;
   UBneuro, UBneuro/U-8656-2017
OI Serrat Rene, Roman/0000-0001-5530-2135; Garcia-Fernandez,
   Jordi/0000-0001-5677-5970; Lopez Domenech, Guillermo/0000-0002-3114-2082
FU Ministerio de Economia y Competitividad [MINECO], Spain [BFU2008-3980];
   MINECO [BFU2010-21507]; Instituto de Salud Carlos III [PI12-02108]
FX This work was supported by grants BFU2008-3980 (Ministerio de Economia y
   Competitividad [MINECO], Spain) to ES, BFU2010-21507 (MINECO) to FU and
   PI12-02108 (Instituto de Salud Carlos III) to FB. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR An JH, 2010, BONE, V47, P140, DOI 10.1016/j.bone.2010.04.593
   Brocardo M, 2008, J BIOL CHEM, V283, P5950, DOI 10.1074/jbc.M708775200
   Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004
   Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804
   Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429
   Deng L, 2009, CELL PROLIFERAT, V42, P721, DOI 10.1111/j.1365-2184.2009.00639.x
   Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200
   Garcia-Frigola C, 2004, MOL BRAIN RES, V122, P133, DOI 10.1016/j.molbrainres.2003.12.014
   GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33
   Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91
   Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745
   Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303
   Kowalczyk JE, 2009, NEUROCHEM INT, V55, P157, DOI 10.1016/j.neuint.2009.01.009
   Koyanagi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005765
   Kurochkin IV, 2001, BIOCHEM BIOPH RES CO, V280, P340, DOI 10.1006/bbrc.2000.4125
   Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Liang HL, 2007, J EXP MED, V204, P3077, DOI 10.1084/jem.20062692
   Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2
   Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013
   Lopez-Domenech G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1829
   MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002
   MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030
   MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0
   Medrano EE, 2007, PIGM CELL RES, V20, P258, DOI 10.1111/j.1600-0749.2007.00383.x
   Mezhybovska M, 2009, BRIT J CANCER, V101, P1596, DOI 10.1038/sj.bjc.6605342
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787
   Mou ZM, 2009, J BIOL CHEM, V284, P13629, DOI 10.1074/jbc.M901177200
   Nicholls DG, 2000, PHYSIOL REV, V80, P315
   Nishiki T, 2010, ACTA MED OKAYAMA, V65, P1
   Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Rintoul GL, 2003, J NEUROSCI, V23, P7881
   Robles-Flores M, 2011, IUBMB LIFE, V63, P873
   Samarzija I, 2009, BIOCHEM BIOPH RES CO, V386, P449, DOI 10.1016/j.bbrc.2009.06.033
   Santos A, 2010, CYTOTHERAPY, V12, P924, DOI 10.3109/14653241003774011
   Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Smalley MJ, 1999, CANCER METAST REV, V18, P215, DOI 10.1023/A:1006369223282
   Spinsanti P, 2008, J NEUROCHEM, V104, P1588, DOI 10.1111/j.1471-4159.2007.05111.x
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018
   Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253
   Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54
   WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278
   Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038
   Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3
   Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603
NR 56
TC 8
Z9 12
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 2
PY 2013
VL 8
IS 7
AR e67773
DI 10.1371/journal.pone.0067773
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 176XV
UT WOS:000321341000095
PM 23844091
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Li, MD
   Cao, JR
   Wang, SL
   Wang, J
   Sarkar, S
   Vigorito, M
   Ma, JZ
   Chang, SL
AF Li, Ming D.
   Cao, Junran
   Wang, Shaolin
   Wang, Ju
   Sarkar, Sraboni
   Vigorito, Michael
   Ma, Jennie Z.
   Chang, Sulie L.
TI Transcriptome Sequencing of Gene Expression in the Brain of the HIV-1
   Transgenic Rat
SO PLOS ONE
LA English
DT Article
ID ACTIVE ANTIRETROVIRAL THERAPY; GROWTH-FACTOR; POSSIBLE INVOLVEMENT; TAT
   PROTEIN; IN-VIVO; NICOTINE; RECEPTOR; MEMORY; CELLS; MODEL
AB The noninfectious HIV-1 transgenic (HIV-1Tg) rat was developed as a model of AIDs-related pathology and immune dysfunction by manipulation of a noninfectious HIV-1(gag-pol) virus with a deleted 3-kb SphI-MscI fragment containing the 3'-region of gag and the 5' region of pol into F344 rats. Our previous studies revealed significant behavioral differences between HIV-1Tg and F344 control rats in their performance in the Morris water maze and responses to psychostimulants. However, the molecular mechanisms underlying these behavioral differences remain largely unknown. The primary goal of this study was to identify differentially expressed genes and enriched pathways affected by the gag-pol-deleted HIV-1 genome. Using RNA deep sequencing, we sequenced RNA transcripts in the prefrontal cortex, hippocampus, and striatum of HIV-1Tg and F344 rats. A total of 72 RNA samples were analyzed (i.e., 12 animals per group x 2 strains x 3 brain regions). Following deep-sequencing analysis of 50-bp paired-end reads of RNA-Seq, we used Bowtie/Tophat/Cufflinks suites to align these reads into transcripts based on the Rn4 rat reference genome and to measure the relative abundance of each transcript. Statistical analyses on each brain region in the two strains revealed that immune response-and neurotransmission-related pathways were altered in the HIV-1Tg rats, with brain region differences. Other neuronal survival-related pathways, including those encoding myelin proteins, growth factors, and translation regulators, were altered in the HIV-1Tg rats in a brain region-dependent manner. This study is the first deep-sequencing analysis of RNA transcripts associated the HIV-1Tg rat. Considering the functions of the pathways and brain regions examined in this study, our findings of abnormal gene expression patterns in HIV-1Tg rats suggest mechanisms underlying the deficits in learning and memory and vulnerability to drug addiction and other psychiatric disorders observed in HIV-positive patients.
C1 [Li, Ming D.; Cao, Junran; Wang, Shaolin; Wang, Ju] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA.
   [Wang, Shaolin] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China.
   [Sarkar, Sraboni; Vigorito, Michael; Chang, Sulie L.] Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA.
   [Sarkar, Sraboni; Chang, Sulie L.] Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA.
   [Vigorito, Michael] Seton Hall Univ, Dept Psychol, S Orange, NJ 07079 USA.
   [Ma, Jennie Z.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA.
RP Li, MD (reprint author), Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA.
EM ml2km@virginia.edu; sulie.chang@shu.edu
RI Cao, Junran/E-7354-2013; Wang, Shaolin/M-2282-2013
OI Wang, Shaolin/0000-0003-0866-4584
FU U.S. National Institutes of Health [DA-013783, DA-016149, DA-026356]
FX The project was supported by U.S. National Institutes of Health grants
   DA-013783 to MDL, DA-016149 to SLC, and DA-026356 to SLC and MDL. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agbottah E, 2006, VIROLOGY, V345, P373, DOI 10.1016/j.virol.2005.09.062
   Aksenov MY, 2001, NEUROSCI LETT, V305, P5, DOI 10.1016/S0304-3940(01)01786-4
   Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496
   Ansari AW, 2011, EUR J IMMUNOL, V41, P3412, DOI 10.1002/eji.201141676
   Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135
   Barbaro G, 2005, CURR PHARM DESIGN, V11, P1805, DOI 10.2174/1381612053764869
   Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200
   Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   BERGER JR, 1992, ANN NEUROL, V31, P34, DOI 10.1002/ana.410310107
   Beuten J, 2005, AM J HUM GENET, V76, P859, DOI 10.1086/429839
   Bjorkqvist M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029868
   Borjabad A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002213
   Cao JR, 2011, INT J NEUROPSYCHOPH, V14, P157, DOI 10.1017/S1461145710000179
   CARPENTER GA, 1993, TRENDS NEUROSCI, V16, P131, DOI 10.1016/0166-2236(93)90118-6
   Chesik D, 2007, INT REV NEUROBIOL, V79, P203, DOI 10.1016/S0074-7742(07)79009-8
   Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999
   Clapham PR, 2001, BRIT MED BULL, V58, P43, DOI 10.1093/bmb/58.1.43
   Cohen RI, 2000, J NEUROSCI RES, V61, P273, DOI 10.1002/1097-4547(20000801)61:3<273::AID-JNR5>3.0.CO;2-I
   Corvol JC, 2007, NEUROPSYCHOPHARMACOL, V32, P1109, DOI 10.1038/aj.npp.1301230
   Cui WY, 2012, AMINO ACIDS, V43, P1157, DOI 10.1007/s00726-011-1171-0
   Cui WY, 2012, HUM GENET, V131, P843, DOI 10.1007/s00439-011-1108-4
   Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105
   Du YZ, 2002, J NEUROSCI RES, V68, P647, DOI 10.1002/jnr.10245
   Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500
   Gendelman HE, 1998, J INFECT DIS, V178, P1000, DOI 10.1086/515693
   Gianotti N, 2005, NEW MICROBIOL, V28, P281
   Gisslen M, 1998, LANCET, V352, P402
   Godefroy D, 2012, TOXICOL SCI, V125, P209, DOI 10.1093/toxsci/kfr252
   HERVE D, 1993, J NEUROSCI, V13, P2237
   Hollander A, 2012, INVEST OPHTH VIS SCI, V53, P3973, DOI 10.1167/iovs.11-8350
   Homji NF, 2012, INT J CLIN EXP MED, V5, P105
   Homji NF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-3
   Huang JY, 2009, J NEUROCHEM, V109, P1400, DOI 10.1111/j.1471-4159.2009.06061.x
   Jiang JY, 2006, VIROLOGY, V346, P460, DOI 10.1016/j.virol.2005.11.008
   Jones LE, 2005, B MATH BIOL, V67, P1227, DOI 10.1016/j.bulm.2005.01.006
   Kanno M, 2005, J NEUROIMMUNOL, V167, P72, DOI 10.1016/j.jneuroim.2005.06.028
   Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9
   Khurdayan VK, 2004, EUR J NEUROSCI, V19, P3171, DOI 10.1111/j.1460-9568.2004.03416.x
   Kim H, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.013
   Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996
   Lauzon NM, 2011, CEREB CORTEX
   Li MD, 2004, MOL BRAIN RES, V132, P168, DOI 10.1016/j.molbrainres.2004.09.009
   Li MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007055
   Liege S, 2000, J NEUROIMMUNOL, V110, P134, DOI 10.1016/S0165-5728(00)00331-3
   Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011
   Lucas S, 2001, Intensive Crit Care Nurs, V17, P155, DOI 10.1054/iccn.2000.1541
   Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07
   Maragos WF, 2002, J NEUROCHEM, V83, P955, DOI 10.1046/j.1471-4159.2002.01212.x
   Mazzucchelli R, 2004, MOL IMMUNOL, V41, P979, DOI 10.1016/j.molimm.2004.06.02
   McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109
   Midde NM, 2011, PHARMACOL BIOCHEM BE, V98, P587, DOI 10.1016/j.pbb.2011.03.013
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   NARUO K, 1993, J BIOL CHEM, V268, P2857
   Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309
   Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21
   O'Neill C, 2012, BIOCHEM SOC T, V40, P721, DOI 10.1042/BST20120080
   Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937
   Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix
   Portegies P, 1995, Drugs, V49 Suppl 1, P25, DOI 10.2165/00003495-199500491-00007
   Portegies P, 1995, DRUGS S1, V49, P38
   Potula R, 2004, AM J PATHOL, V165, P815, DOI 10.1016/S0002-9440(10)63344-5
   Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200
   Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101
   Ray PE, 2003, KIDNEY INT, V63, P2242, DOI 10.1046/j.1523-1755.2003.00028.x
   Reid W, 2004, VIROLOGY, V321, P111, DOI 10.1016/j.virol.2003.12.010
   Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298
   Ribeiro AF, 2012, PHARMACOL BIOCHEM BE, V102, P224, DOI 10.1016/j.pbb.2012.04.010
   Richards AB, 2007, EUR J NEUROSCI, V25, P2619, DOI 10.1111/j.1460-9568.2007.05523.x
   Royal W, 2012, J NEUROIMMUNOL, V247, P16, DOI 10.1016/j.jneuroim.2012.03.015
   Sarkar S, 2012, ALCOHOL CLIN EXP RES
   SCHMIDBAUER M, 1992, NEUROPATH APPL NEURO, V18, P489, DOI 10.1111/j.1365-2990.1992.tb00816.x
   Sleasman JW, 2003, J ALLERGY CLIN IMM S, V111, P582
   Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594
   Sui YJ, 2003, J MED PRIMATOL, V32, P229, DOI 10.1034/j.1600-0684.2003.00030.x
   Sun DX, 2007, NEUROPSYCHOPHARMACOL, V32, P110, DOI 10.1038/sj.npp.1301134
   Tawk M, 2011, J NEUROSCI, V31, P3729, DOI 10.1523/JNEUROSCI.4270-10.2011
   Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72
   Torensma R, 2002, MED HYPOTHESES, V58, P386, DOI 10.1054/mehy.2001.1541
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Treutlein J, 2009, SCHIZOPHR RES, V111, P123, DOI 10.1016/j.schres.2009.03.011
   Trkola A, 2004, CURR OPIN MICROBIOL, V7, P555, DOI 10.1016/j.mib.2004.08.001
   Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406
   Verani A, 2005, MOL IMMUNOL, V42, P195, DOI 10.1016/j.molimm.2004.06.020
   Vigano A, 2006, J PEDIATR-US, V148, P389, DOI 10.1016/j.jpeds.2005.11.037
   Vigorito M, 2007, J NEUROIMMUNE PHARM, V2, P319, DOI 10.1007/s11481-007-9078-y
   Vuoristo JT, 2000, MOL PSYCHIATR, V5, P495, DOI 10.1038/sj.mp.4000758
   Wang Ju, 2011, Front Psychiatry, V2, P5, DOI 10.3389/fpsyt.2011.00005
   Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356
   Wei JX, 2011, INT J NEUROPSYCHOPH, V14, P91, DOI 10.1017/S1461145710000416
   Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085
   Wise RA, 2000, PROG BRAIN RES, V126, P255
   Wu QF, 2012, CELL, V149, P1549, DOI 10.1016/j.cell.2012.04.046
   Yoshioka M, 1997, Nihon Rinsho, V55, P897
   Yuen EY, 2010, P NATL ACAD SCI USA, V107, P22308, DOI 10.1073/pnas.1010025108
   Zill P, 2002, PSYCHIATR GENET, V12, P17, DOI 10.1097/00041444-200203000-00002
NR 97
TC 11
Z9 11
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 25
PY 2013
VL 8
IS 3
AR e59582
DI 10.1371/journal.pone.0059582
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 123NP
UT WOS:000317397200030
PM 23536882
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Green, JL
   Bauer, M
   Yum, KW
   Li, YC
   Cox, ML
   Willert, K
   Wahl, GM
AF Green, Jennifer L.
   Bauer, Matthieu
   Yum, Kyu Won
   Li, Yao-Cheng
   Cox, Miranda L.
   Willert, Karl
   Wahl, Geoffrey M.
TI Use of a Molecular Genetic Platform Technology to Produce Human Wnt
   Proteins Reveals Distinct Local and Distal Signaling Abilities
SO PLOS ONE
LA English
DT Article
ID ACUTE LYMPHOBLASTOID LEUKEMIA; HEMATOPOIETIC STEM-CELLS;
   WNT/BETA-CATENIN; PATHWAY; RECEPTORS; LGR5; TRANSFORMATION; ENDOCYTOSIS;
   ACTIVATION; INHIBITION
AB Functional and mechanistic studies of Wnt signaling have been severely hindered by the inaccessibility of bioactive proteins. To overcome this long-standing barrier, we engineered and characterized a panel of Chinese hamster ovary (CHO) cell lines with inducible transgenes encoding tagged and un-tagged human WNT1, WNT3A, WNT5A, WNT7A, WNT11, WNT16 or the soluble Wnt antagonist Fzd8CRD, all integrated into an identical genomic locus. Using a quantitative real-time bioluminescence assay, we show that cells expressing WNT1, 3A and 7A stimulate Wnt/beta-catenin reporter activity, while the other WNT expressing cell lines interfere with this activation. Additionally, in contrast to WNT3A, WNT1 only exhibits activity when cell-associated, and thus only signals to neighboring cells. The reporter assay also revealed a rapid decline of Wnt activity at 37 degrees C, indicating that Wnt activity is highly labile. These engineered cell lines will reduce the cost of making and purifying Wnt proteins and serve as a continuous, reliable and regulatable source of Wnts to research laboratories around the world.
C1 [Green, Jennifer L.; Yum, Kyu Won; Li, Yao-Cheng; Cox, Miranda L.; Wahl, Geoffrey M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA.
   [Bauer, Matthieu; Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
RP Wahl, GM (reprint author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM wahl@salk.edu
FU Department of Defense (DoD) Breast Cancer Research Program (BCRP)
   [W81XWH-09-1-0326]; DOD [WH1210106]; National Cancer Institute
   [5P30CA014195]; Susan G. Komen Foundation; California Institute for
   Regenerative Medicine [RB1-01406]; CIRM training grant [TG2-01154]
FX This work was supported by grants from the Department of Defense (DoD)
   Breast Cancer Research Program (BCRP) (Award W81XWH-09-1-0326 to J.
   Green), DOD WH1210106 (to G. Wahl), National Cancer Institute
   5P30CA014195 (to G. Wahl), the Susan G. Komen Foundation (to G. Wahl),
   and the California Institute for Regenerative Medicine (to KW
   RB1-01406). MB is supported by a CIRM training grant awarded to
   University of California San Diego (UCSD) (TG2-01154). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238
   Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28
   BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x
   Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410
   Cajanek L, 2010, J CELL BIOCHEM, V111, P1077, DOI 10.1002/jcb.22771
   Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108
   Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808
   Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699
   de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337
   Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107
   Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175
   Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682
   Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019
   He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652
   Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109
   Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546
   JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321
   Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784
   Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100
   MASON JO, 1992, MOL BIOL CELL, V3, P521
   Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/j.onc.1208568
   McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109
   Najdi R, 2012, DIFFERENTIATION
   PAPKOFF J, 1989, MOL CELL BIOL, V9, P3377, DOI 10.1128/MCB.9.8.3377
   PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978
   Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005
   Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013
   Uysal-Onganer P, 2011, ACTA PHYSL OXF
   van Amerongen R, 2012, DEV BIOL
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917
   Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611
   Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2
   Wong ET, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni145
   Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026
   Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039
NR 44
TC 12
Z9 12
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 13
PY 2013
VL 8
IS 3
AR e58395
DI 10.1371/journal.pone.0058395
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 115YY
UT WOS:000316849200063
PM 23516471
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Ain, QU
   Seemab, U
   Rashid, S
   Nawaz, MS
   Kamal, MA
AF Ain, Qurrat U.
   Seemab, Umair
   Rashid, Sajid
   Nawaz, Muhammad Sulaman
   Kamal, Mohammad A.
TI Prediction of Structure of Human WNT-CRD (FZD) Complex for Computational
   Drug Repurposing
SO PLOS ONE
LA English
DT Article
ID PROTEIN-STRUCTURE PREDICTION; CATENIN PATHWAY; DOCKING; RECEPTOR;
   REFINEMENT; EXPRESSION; MUTATIONS; ACTIVATE; BINDING; DOMAIN
AB The observed genetic alterations of various extracellular and intracellular WNT (Wingless, Int-1 proto-oncogene) signaling components can result in an increase or decrease in gene expression, and hence can be obstructed proficiently. These genetics target sites may include the prevention of WNT-FZD (Frizzled) binding, destruction of beta-catenin and formation of Axin, APC and GSK-3 beta complex. Hence, the localized targeting of these interacting partners can help in devising novel inhibitors against WNT signaling. Our present study is an extension of our previous work, in which we proposed the coregulated expression pattern of the WNT gene cluster (WNT-1, WNT-6, WNT-10A and WNT-10B) in human breast carcinoma. We present here the computationally modeled three dimensional structure of human WNT-1 in complex with the FZD-1 CRD (Cysteine Rich Domain) receptor. The dimeric cysteine-rich domain was found to fit into the evolutionarily conserved U-shaped groove of WNT protein. The two ends of the U-shaped cleft contain N-terminal and C-terminal hydrophobic residues, thus providing a strong hydrophobic moiety for the frizzled receptor and serving as the largest binding pocket for WNT-FZD interaction. Detailed structural analysis of this cleft revealed a maximum atomic distance of similar to 28 angstrom at the surface, narrowing down to similar to 17 angstrom and again increasing up to similar to 27 angstrom at the bottom. Altogether, structural prediction analysis of WNT proteins was performed to reveal newer details about post-translational modification sites and to map the novel pharmacophore models for potent WNT inhibitors.
C1 [Ain, Qurrat U.; Nawaz, Muhammad Sulaman] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan.
   [Seemab, Umair] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea.
   [Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan.
   [Kamal, Mohammad A.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia.
   [Ain, Qurrat U.] Univ Cambridge, Dept Chem, Unilever Ctr Mol Informat, Cambridge CB2 1EW, England.
RP Kamal, MA (reprint author), King Abdulaziz Univ, Jeddah 21413, Saudi Arabia.
EM meu.fabg@hotmail.com
RI Rashid, Sajid/K-8640-2019; Kamal, Mohammad/J-4622-2013; Kamal, Mohammad
   Amjad/J-2918-2014
OI Kamal, Mohammad Amjad/0000-0003-0088-0565
CR AIN Q, 2011, BIOINFORMATION, V7, P339
   Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154
   Bienz M, 2012, SCIENCE, V337, P44, DOI 10.1126/science.1224468
   Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286
   Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451
   Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318
   Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601
   Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8
   Gopalakrishnan K, 2007, PROTEIN PEPTIDE LETT, V14, P669
   Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220
   Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   IOZZO RV, 1995, CANCER RES, V55, P3495
   Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036770
   Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Malinauskas T, 2008, LIPIDS, V43, P227, DOI 10.1007/s11745-007-3144-3
   Malinauskas T, 2011, NAT STRUCT MOL BIOL, V18, P886, DOI 10.1038/nsmb.2081
   Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186
   McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Millar JBA, 2002, GENOME BIOL, V3
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9
   Thompson J. D., 2002, CURR PROTOC BIOINFOR
   Voronkov AE, 2008, DOKL BIOCHEM BIOPHYS, V419, P75, DOI 10.1134/S1607672908020087
NR 35
TC 5
Z9 5
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 25
PY 2013
VL 8
IS 1
AR e54630
DI 10.1371/journal.pone.0054630
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 093RV
UT WOS:000315210400019
PM 23372744
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Nikaido, M
   Law, EWP
   Kelsh, RN
AF Nikaido, Masataka
   Law, Edward W. P.
   Kelsh, Robert N.
TI A Systematic Survey of Expression and Function of Zebrafish frizzled
   Genes
SO PLOS ONE
LA English
DT Article
ID CONVERGENT EXTENSION MOVEMENTS; NEURAL CREST DEVELOPMENT; WNT SIGNALING
   PATHWAY; CELL-MIGRATION; GASTRULATION MOVEMENTS; WNT/BETA-CATENIN;
   BETA-CATENIN; EMBRYONIC-DEVELOPMENT; VENTRICULAR SEPTUM; SPEMANN
   ORGANIZER
AB Wnt signaling is crucial for the regulation of numerous processes in development. Consistent with this, the gene families for both the ligands (Wnts) and receptors (Frizzleds) are very large. Surprisingly, while we have a reasonable understanding of the Wnt ligands likely to mediate specific Wnt-dependent processes, the corresponding receptors usually remain to be elucidated. Taking advantage of the zebrafish model's excellent genomic and genetic properties, we undertook a comprehensive analysis of the expression patterns of frizzled (fzd) genes in zebrafish. To explore their functions, we focused on testing their requirement in several developmental events known to be regulated by Wnt signaling, convergent extension movements of gastrulation, neural crest induction, and melanocyte specification. We found fourteen distinct fzd genes in the zebrafish genome. Systematic analysis of their expression patterns between 1-somite and 30 hours post-fertilization revealed complex, dynamic and overlapping expression patterns. This analysis demonstrated that only fzd3a, fzd9b, and fzd10 are expressed in the dorsal neural tube at stages corresponding to the timing of melanocyte specification. Surprisingly, however, morpholino knockdown of these, alone or in combination, gave no indication of reduction of melanocytes, suggesting the important involvement of untested fzds or another type of Wnt receptor in this process. Likewise, we found only fzd7b and fzd10 expressed at the border of the neural plate at stages appropriate for neural crest induction. However, neural crest markers were not reduced by knockdown of these receptors. Instead, these morpholino knockdown studies showed that fzd7a and fzd7b work co-operatively to regulate convergent extension movement during gastrulation. Furthermore, we show that the two fzd7 genes function together with fzd10 to regulate epiboly movements and mesoderm differentiation.
C1 [Nikaido, Masataka; Law, Edward W. P.; Kelsh, Robert N.] Univ Bath, Dept Biol & Biochem, Claverton Down, England.
RP Kelsh, RN (reprint author), Univ Bath, Dept Biol & Biochem, Claverton Down, England.
EM bssrnk@bath.ac.uk
RI Kelsh, Robert/B-6445-2008
OI Kelsh, Robert/0000-0002-9381-0066; Law, Edward/0000-0001-5089-6341
FU Uehara Memorial Foundation; University of Bath
FX This work was supported by a Uehara Memorial Foundation research
   fellowship (MN) and the University of Bath. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abu-Elmagd M, 2006, DEV BIOL, V298, P285, DOI 10.1016/j.ydbio.2006.06.037
   Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002
   Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717
   Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156
   Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306
   Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319
   Borello U, 1999, MECH DEVELOP, V89, P173, DOI 10.1016/S0925-4773(99)00205-1
   Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129
   CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13
   Conway SJ, 1997, DEVELOPMENT, V124, P505
   Djiane A, 2000, DEVELOPMENT, V127, P3091
   Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431
   Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515
   Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E
   Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620
   Dorsky RI, 2000, GENE DEV, V14, P158
   Dutton KA, 2001, DEVELOPMENT, V128, P4113
   Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461
   FoerstPotts L, 1997, DEV DYNAM, V209, P70, DOI 10.1002/(SICI)1097-0177(199705)209:1<70::AID-AJA7>3.0.CO;2-U
   Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933
   Forrester WC, 2004, GENETICS, V168, P1951, DOI 10.1534/genetics.104.031781
   Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467
   Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824
   Granato M, 1996, DEVELOPMENT, V123, P399
   Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226
   Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039
   Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064
   Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068
   Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003
   Hikasa H, 2002, DEVELOPMENT, V129, P5227
   Ikeya M, 1997, NATURE, V389, P966
   Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001
   Inoue T, 2007, DEV BIOL, V306, P669, DOI 10.1016/j.ydbio.2007.04.003
   Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025
   Kelsh RN, 1996, DEVELOPMENT, V123, P369
   Kelsh RN, 2000, DEVELOPMENT, V127, P515
   Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1
   Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198
   Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kuhlbrodt K, 1998, J NEUROSCI, V18, P237
   LaBonne C, 1998, DEVELOPMENT, V125, P2403
   Lamoreux ML, 2010, COLORS MICE MODEL GE
   Le Douarin NM, 1999, NEURAL CREST
   Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007
   Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2
   Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128
   Lister JA, 1999, DEVELOPMENT, V126, P3757
   Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019
   Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032
   Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3
   McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058
   Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0
   Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7
   Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449
   Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951
   Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291
   Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   PARR BA, 1993, DEVELOPMENT, V119, P247
   Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003
   Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989
   Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004
   Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428
   SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009
   Sisson BE, 2009, GENE EXPR PATTERNS, V9, P520, DOI 10.1016/j.gep.2009.07.003
   Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x
   STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q
   Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035
   Sumanas S, 2001, GENESIS, V30, P114, DOI 10.1002/gene.1043
   Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007
   Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6
   Takahashi K, 2001, DEV DYNAM, V222, P252, DOI 10.1002/dvdy.1185
   Thisse B, 2004, FAST RELEASE CLONES
   Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   van de Water S, 2001, DEVELOPMENT, V128, P3877
   Wada H, 2006, DEVELOPMENT, V133, P4749, DOI 10.1242/dev.02665
   Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1
   Wang YF, 2003, BIOESSAYS, V25, P317, DOI 10.1002/bies.10255
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9
   Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3
   Yamamoto A, 1998, DEVELOPMENT, V125, P3389
   Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522
   Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352
   Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001
   Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026533
NR 92
TC 11
Z9 13
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 22
PY 2013
VL 8
IS 1
AR e54833
DI 10.1371/journal.pone.0054833
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 077HS
UT WOS:000314019100100
PM 23349976
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Casanova, EA
   Okoniewski, MJ
   Cinelli, P
AF Casanova, Elisa A.
   Okoniewski, Michal J.
   Cinelli, Paolo
TI Cross-Species Genome Wide Expression Analysis during Pluripotent Cell
   Determination in Mouse and Rat Preimplantation Embryos
SO PLOS ONE
LA English
DT Article
ID KINASE RHO-KINASE; STEM-CELLS; SELF-RENEWAL; BETA-CATENIN;
   SIGNAL-TRANSDUCTION; MYOSIN PHOSPHATASE; SMOOTH-MUSCLE; STAT3;
   DIFFERENTIATION; ACTIVATION
AB The transition between morula and blastocyst stage during preimplantation development represents the first differentiation event of embryogenesis. Morula cells undergo the first cellular specialization and produce two well-defined populations of cells, the trophoblast and the inner cell mass (ICM). Embryonic stem cells (ESCs) with unlimited self-renewal capacity are believed to represent the in vitro counterpart of the ICM. Both mouse and rat ESCs can be derived from the ICM cells, but their in vitro stability differs. In this study we performed a microarray analysis in which we compared the transcriptome of mouse and rat morula, blastocyst, and ICM. This cross-species comparison represents a good model for understanding the differences in derivation and cultivation of ESCs observed in the two species. In order to identify alternative regulation of important molecular mechanisms the investigation of differential gene expression between the two species was extended at the level of signaling pathways, gene families, and single selected genes of interest. Some of the genes differentially expressed between the two species are already known to be important factors in the maintenance of pluripotency in ESCs, like for example Sox2 or Stat3, or play a role in reprogramming somatic cells to pluripotency like c-Myc, Klf4 and p53 and therefore represent interesting candidates to further analyze in vitro in the rat ESCs. This is the first study investigating the gene expression changes during the transition from morula to blastocyst in the rat preimplantation development. Our data show that in the pluripotent pool of cells of the rat and mouse preimplantation embryo substantial differential regulation of genes is present, which might explain the difficulties observed for the derivation and culture of rat ESCs using mouse conditions.
C1 [Casanova, Elisa A.; Cinelli, Paolo] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland.
   [Okoniewski, Michal J.] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland.
   [Okoniewski, Michal J.] ETH, Zurich, Switzerland.
   [Cinelli, Paolo] Univ Zurich, Ctr Appl Biotechnol & Mol Med, Zurich, Switzerland.
   [Cinelli, Paolo] Univ Zurich Hosp, Div Trauma Surg, Clin Res Ctr, CH-8091 Zurich, Switzerland.
RP Cinelli, P (reprint author), Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland.
EM paolo.cinelli@usz.ch
OI Cinelli, Paolo/0000-0002-0163-9055
FU Swiss National Science Foundation [31003A-118361]; University of Zurich
FX This work was supported by the Swiss National Science Foundation (Grant
   31003A-118361) and the University of Zurich. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Asanoma K, 2011, DEV BIOL, V351, P110, DOI 10.1016/j.ydbio.2010.12.038
   Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898
   Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007
   Canzian F, 1997, GENOME RES, V7, P262, DOI 10.1101/gr.7.3.262
   Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013
   Casanova EA, 2011, STEM CELLS, V29, P474, DOI 10.1002/stem.588
   Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838
   Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608
   Cinelli P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-57
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007
   Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064
   Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017
   FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840
   Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001
   Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4
   Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206
   Goldfarb Mitchell, 1996, Cytokine and Growth Factor Reviews, V7, P311, DOI 10.1016/S1359-6101(96)00039-1
   Graf U, 2011, GENES-BASEL, V2, P280, DOI 10.3390/genes2010280
   Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003
   Hamanaka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022008
   Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011
   Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007
   Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010
   Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245
   Kitisin K., 2007, SCI STKE, V2007
   Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880
   Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001
   Lemaitre JM, 1996, ADV CANCER RES, V70, P95, DOI 10.1016/S0065-230X(08)60873-8
   Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1
   LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0
   Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006
   Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014
   Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013
   LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0
   Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121
   Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002
   Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589
   Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008
   MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773
   Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028
   Nagy A., 2003, MANIPULATING MOUSE E
   Nakashima K, 1999, J NEUROSCI, V19, P5429
   Nichols J, 2001, DEVELOPMENT, V128, P2333
   Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893
   Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10
   Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048
   Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113
   O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025
   Ramos SD, 2001, J APPL PHYSIOL, V91, P667
   SAVATIER P, 1994, ONCOGENE, V9, P809
   Shatz M, 2008, INT J RADIAT BIOL, V84, P177, DOI 10.1080/09553000701745293
   Shen Y, 2011, CELL RES, V21, P1143, DOI 10.1038/cr.2011.98
   SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0
   SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0
   STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735
   Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675
   Wang YC, 2004, DEV DYNAM, V231, P72, DOI 10.1002/dvdy.20144
   Wray J, 2011, NATURE CELL BIOL
   Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012
   YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129
   Yang DH, 2009, DEV DYNAM, V238, P514, DOI 10.1002/dvdy.21856
   Yi F, 2011, NATURE CELL BIOL
   Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968
   Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X
NR 80
TC 7
Z9 8
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 15
PY 2012
VL 7
IS 10
AR e47107
DI 10.1371/journal.pone.0047107
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 022WO
UT WOS:000309995100061
PM 23077551
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Pasini, A
   Manenti, R
   Rothbacher, U
   Lemaire, P
AF Pasini, Andrea
   Manenti, Raoul
   Rothbaecher, Ute
   Lemaire, Patrick
TI Antagonizing Retinoic Acid and FGF/MAPK Pathways Control Posterior Body
   Patterning in the Invertebrate Chordate Ciona intestinalis
SO PLOS ONE
LA English
DT Article
ID PERIPHERAL NERVOUS-SYSTEM; EPIDERMAL SENSORY NEURONS; GENE REGULATORY
   NETWORKS; FGF SIGNALING CONTROLS; EVOLUTIONARY PLASTICITY; TRANSCRIPTION
   FACTORS; ASCIDIAN EMBRYO; AXIS EXTENSION; OPPOSING FGF; EXPRESSION
AB Vertebrate embryos exploit the mutual inhibition between the RA and FGF signalling pathways to coordinate the proliferative elongation of the main body axis with the progressive patterning and differentiation of its neuroectodermal and paraxial mesodermal structures. The evolutionary history of this patterning system is still poorly understood. Here, we investigate the role played by the RA and FGF/MAPK signals during the development of the tail structures in the tunicate Ciona intestinalis, an invertebrate chordate belonging to the sister clade of vertebrates, in which the prototypical chordate body plan is established through very derived morphogenetic processes. Ciona embryos are constituted of few cells and develop according to a fixed lineage; elongation of the tail occurs largely by rearrangement of postmitotic cells; mesoderm segmentation and somitogenesis are absent. We show that in the Ciona embryo, the antagonism of the RA and FGF/MAPK signals is required to control the anteroposterior patterning of the tail epidermis. We also demonstrate that the RA, FGF/MAPK and canonical Wnt pathways control the anteroposterior patterning of the tail peripheral nervous system, and reveal the existence of distinct subpopulations of caudal epidermal neurons with different responsiveness to the RA, FGF/MAPK and canonical Wnt signals. Our data provide the first demonstration that the use of the antagonism between the RA and FGF signals to pattern the main body axis predates the emergence of vertebrates and highlight the evolutionary plasticity of this patterning strategy, showing that in different chordates it can be used to pattern different tissues within the same homologous body region.
C1 [Pasini, Andrea; Rothbaecher, Ute; Lemaire, Patrick] Univ Aix Marseille, IBDML, UMR7288, CNRS, Marseille, France.
   [Manenti, Raoul] Univ Milan, Dipartimento Biol, Milan, Italy.
   [Lemaire, Patrick] Univ Montpellier, CRBM, UMR5237, CNRS, F-34059 Montpellier, France.
RP Pasini, A (reprint author), Univ Aix Marseille, IBDML, UMR7288, CNRS, Marseille, France.
EM andrea.pasini@univ-amu.fr
RI Rothbacher, Ute/G-2688-2013; Lemaire, Patrick/P-8228-2019; Manenti,
   Raoul/D-4419-2013; Manenti, Raoul/O-5166-2017; Lemaire,
   Patrick/B-5560-2012
OI Lemaire, Patrick/0000-0003-4925-2009; Manenti,
   Raoul/0000-0001-6071-8194; Manenti, Raoul/0000-0001-6071-8194; Lemaire,
   Patrick/0000-0003-4925-2009; Rothbacher, Ute/0000-0002-9989-6139
FU CNRS; Agence Nationale pour la Recherche (Programme Blanc
   "Chor-Evo-Net"); Erasmus fellowship
FX Work was financed by the CNRS and the Agence Nationale pour la Recherche
   (Programme Blanc "Chor-Evo-Net"). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; AP, UR and PL are CNRS staff members. RM
   was supported by an Erasmus fellowship. Thanks to C. Lamy, S. Fujiwara,
   H. Saiga and T. Kusakabe for the gift of reagents. Thanks to S. Choksi
   for help with cluster analysis and to C. Sunyach for help with Fig. S3.
   Thanks to C. Hudson, H. Yasuo, H. Saiga, R. Pennati, M. Schubert for
   sharing comments, criticisms, unpublished data etc.
CR Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679
   Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103
   Bertrand N, 2000, DEVELOPMENT, V127, P4837
   Bertrand S, 2012, P NATL ACAD SCI USA, V108, P9160
   Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241
   Canestro C, 2007, DEV BIOL, V305, P522, DOI 10.1016/j.ydbio.2007.02.032
   Canestro C, 2006, EVOL DEV, V8, P394, DOI 10.1111/j.1525-142X.2006.00113.x
   Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832
   Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336
   Diez del Corral R, 2003, NEURON, V40, P65
   Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080
   Diez del Corral R, 2002, DEVELOPMENT, V129, P1681
   Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065
   Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519
   Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8
   Escriva H, 2002, DEVELOPMENT, V129, P2905
   Holland LZ, 2003, BIOESSAYS, V25, P529, DOI 10.1002/bies.10302
   Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678
   Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188
   Hudson C, 2003, DEVELOPMENT, V130, P147, DOI 10.1242/dev.00200
   Hudson C, 2007, DEVELOPMENT, V134, P3527, DOI 10.1242/dev.002352
   Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101
   Ikuta T, 2010, DEVELOPMENT, V137, P1505, DOI 10.1242/dev.046938
   Imai JH, 2007, J COMP NEUROL, V501, P335, DOI 10.1002/cne.21247
   Imai K, 2000, DEVELOPMENT, V127, P3009
   Imai KS, 2002, MECH DEVELOP, V119, pS275, DOI 10.1016/S0925-4773(03)00128-X
   Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270
   Kanda M, 2009, DEV BIOL, V335, P454, DOI 10.1016/j.ydbio.2009.09.027
   Katsuyama Y, 1999, DEV BIOL, V213, P257, DOI 10.1006/dbio.1999.9403
   Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834
   Lemaire P, 2009, DEV BIOL, V332, P48, DOI 10.1016/j.ydbio.2009.05.540
   Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X
   Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535
   Meulemans D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000787
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7
   Nagatomo K, 2003, GENE EXPR PATTERNS, V3, P273, DOI 10.1016/S1567-133X(03)00051-6
   Ohtsuka Y, 2001, DEV GENES EVOL, V211, P252
   Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216
   Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225
   Passamaneck YJ, 2007, PLOS ONE, V8, pe714
   Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017
   Rothbacher U, 2007, DEVELOPMENT, V134, P4023, DOI 10.1242/dev.010850
   Sawada A, 2001, DEVELOPMENT, V128, P4873
   Schubert M, 2004, P NATL ACAD SCI USA, V101, P10320, DOI 10.1073/pnas.0403216101
   Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460
   Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457
   Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709
   Shi WY, 2009, DEVELOPMENT, V136, P23, DOI 10.1242/dev.029157
   Sobral D, 2009, CURR BIOL, V19, P2014, DOI 10.1016/j.cub.2009.10.036
   Terakubo HQ, 2010, DEV DYNAM, V239, P2278, DOI 10.1002/dvdy.22361
NR 51
TC 25
Z9 25
U1 2
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 25
PY 2012
VL 7
IS 9
AR e46193
DI 10.1371/journal.pone.0046193
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 016YP
UT WOS:000309556100151
PM 23049976
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Zhu, YC
   Tian, YH
   Du, J
   Hu, ZZ
   Yang, L
   Liu, JJ
   Gu, L
AF Zhu, Yichao
   Tian, Yinhui
   Du, Jun
   Hu, Zhenzhen
   Yang, Ling
   Liu, Jiaojing
   Gu, Luo
TI Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced
   Breast Cancer Cell Migration
SO PLOS ONE
LA English
DT Article
ID CONVERGENT EXTENSION MOVEMENTS; FRIZZLED-RELATED PROTEINS; CANONICAL WNT
   PATHWAY; TYROSINE KINASE ROR2; SIGNALING PATHWAY; TUMOR-SUPPRESSOR;
   DISHEVELLED PHOSPHORYLATION; VERTEBRATE GASTRULATION; UP-REGULATION;
   BETA-CATENIN
AB Background: The Dishevelled (Dvl) and Dishevelled-associated activator of morphogenesis 1 (Daam1) pathway triggered by Wnt5a regulates cellular polarity during development and tissue homoeostasis. However, Wnt5a signaling in breast cancer progression remains poorly defined.
   Methodology/Principal Findings: We showed here that Wnt5a activated Dvl2, Daam1 and RhoA, and promoted migration of breast cancer cells, which was, however, abolished by Secreted Frizzled-related protein 2 (sFRP2) pretreatment. Dominant negative Dvl2 mutants or Dvl2 siRNA significantly decreased Wnt5a-induced Daam1/RhoA activation and cell migration. Ectopic expression of N-Daam1, a dominant negative mutant, or Daam1 siRNA remarkably inhibited Wnt5a-induced RhoA activation, stress fiber formation and cell migration. Ectopic expression of dominant negative RhoA (N19) or C3 exoenzyme transferase, a Rho inhibitor, decreased Wnt5a-induced stress fiber formation and cell migration.
   Conclusions/Significance: Taken together, we demonstrated for the first time that Wnt5a promotes breast cancer cell migration via Dvl2/Daam1/RhoA.
C1 [Zhu, Yichao; Du, Jun; Gu, Luo] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.
   [Zhu, Yichao; Du, Jun; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China.
   [Tian, Yinhui; Hu, Zhenzhen; Liu, Jiaojing] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.
   [Yang, Ling] Suzhou Univ, Affiliated Hosp 3, Dept Cardiol, Changzhou, Jiangsu, Peoples R China.
RP Zhu, YC (reprint author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.
EM lgu@njmu.edu.cn
FU Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment,
   Cancer Center, Nanjing Medical University; Jiangsu Planned Projects for
   Postdoctoral Research Funds [0902023C]; National Natural Science
   Foundation of China [30872926, 81172002, 81101999]
FX This work was supported by grants from the National Natural Science
   Foundation of China (30872926 and 81172002) and a research grant from
   Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment,
   Cancer Center, Nanjing Medical University to Luo Gu, the National
   Natural Science Foundation of China (81101999), and the Jiangsu Planned
   Projects for Postdoctoral Research Funds (0902023C) to Yichao Zhu. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alberts AS, 2002, CURR BIOL, V12, pR796, DOI 10.1016/S0960-9822(02)01309-X
   Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610
   Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032
   Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115
   Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255
   Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007
   Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X
   Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096
   Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368
   Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056
   Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106
   Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104
   Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710
   Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Fernandez-Cobo M, 2007, ONCOL REP, V17, P903
   Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B
   Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004
   Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203
   Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6
   Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068
   Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871
   HUGUET EL, 1994, CANCER RES, V54, P2615
   Jonsson M, 2002, CANCER RES, V62, P409
   Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623
   Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262
   Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389
   Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370
   Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359
   Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464
   LEJEUNE S, 1995, CLIN CANCER RES, V1, P215
   Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X
   Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105
   Liu XH, 2008, DIGEST LIVER DIS, V40, P560, DOI 10.1016/j.dld.2007.12.011
   Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317
   McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174
   Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x
   Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Moreno-Aspitia A, 2010, FUTURE ONCOL, V6, P655, DOI [10.2217/fon.10.41, 10.2217/FON.10.41]
   Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x
   Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030
   Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200
   Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309
   Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103
   Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255
   Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250
   Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004
   Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200
   Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711
   Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769
   Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23
   Tada M, 2000, DEVELOPMENT, V127, P2227
   Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123
   Tsuji T, 2010, MOL BIOL CELL, V21, P3590, DOI 10.1091/mbc.E10-02-0095
   von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043
   Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670
   Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250
   Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008
   Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644
NR 64
TC 41
Z9 45
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 24
PY 2012
VL 7
IS 5
AR e37823
DI 10.1371/journal.pone.0037823
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959UB
UT WOS:000305338900049
PM 22655072
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Ferguson, BW
   Gao, XS
   Kil, H
   Lee, JH
   Benavides, F
   Abba, MC
   Aldaz, CM
AF Ferguson, Brent W.
   Gao, Xinsheng
   Kil, Hyunsuk
   Lee, Jaeho
   Benavides, Fernando
   Abba, Martin C.
   Aldaz, C. Marcelo
TI Conditional Wwox Deletion in Mouse Mammary Gland by Means of Two Cre
   Recombinase Approaches
SO PLOS ONE
LA English
DT Article
ID CHROMOSOMAL FRAGILE SITE; TUMOR-SUPPRESSOR PROTEIN; GENE-EXPRESSION;
   BREAST-CANCER; TGF-BETA; WNT5A; FRA16D; TUMORIGENICITY; BIOINFORMATICS;
   IDENTIFICATION
AB Loss of WWOX expression has been reported in many different cancers including breast cancer. Elucidating the function of this gene in adult tissues has not been possible with full Wwox knockout models. Here we characterize the first conditional models of Wwox ablation in mouse mammary epithelium utilizing two transgenic lines expressing Cre recombinase, keratin 5-Cre (BK5-Cre) and MMTV-Cre. In the BK5-Cre model we observed very efficient Wwox ablation in KO mammary glands. However, BK5-Cre Wwox KO animals die prematurely for unknown reasons. In the MMTV-Cre model we observed significant ablation of Wwox in mammary epithelium with no effect on survival. In both of these models we found that Wwox deletion resulted in impaired mammary branching morphogenesis. We demonstrate that loss of Wwox is not carcinogenic in our KO models. Furthermore, no evidence of increase proliferation or development of premalignant lesions was observed. In none of the models did loss of a single Wwox allele (i.e. haploinsufficiency) have any observable phenotypic effect in mammary gland. To better understand the function of Wwox in the mammary gland, transcriptome profiling was performed. We observed that Wwox ablation results in the deregulation of genes involved in various cellular processes. We found that expression of the non-canonical Wnt ligand, Wnt5a, was significantly upregulated in Wwox KO mammary epithelium. Interestingly, we also determined that components of the Jak/Stat3 signaling pathway were upregulated in KO mice and this correlated with a very robust increase in phospho-Stat3 signaling, which warrants further testing. Even though the loss of Wwox expression in breast and other cancers is very well documented, our findings suggest that Wwox does not act as a classical tumor suppressor as previously thought.
C1 [Ferguson, Brent W.; Gao, Xinsheng; Kil, Hyunsuk; Lee, Jaeho; Benavides, Fernando; Aldaz, C. Marcelo] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.
   [Abba, Martin C.] Univ Nacl La Plata, Fac Med, CINIBA, La Plata, Buenos Aires, Argentina.
RP Ferguson, BW (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.
EM maaldaz@mdanderson.org
RI Aldaz, C. Marcelo/E-7868-2011
OI Aldaz, C. Marcelo/0000-0002-2453-2939; Benavides,
   Fernando/0000-0003-1275-4320; Abba, Martin/0000-0002-9206-2369
FU National Institutes of Health/National Cancer Institute [R01
   CA102444-6]; National Institute of Environmental Health Sciences (NIEHS)
   Center for Research on Environmental Disease [ES007784]; Cancer Center
   Support Grant [CA016672]; Research Training in Carcinogenesis and
   Mutagenesis [T32CA009480]
FX This study was supported by the National Institutes of Health/National
   Cancer Institute (grant number R01 CA102444-6; http://cancer.gov/) to
   CMA; the National Institute of Environmental Health Sciences (NIEHS)
   Center for Research on Environmental Disease (grant number ES007784;
   http://cred.mdanderson.org/); a Cancer Center Support Grant (grant
   number CA016672; http://cancer.gov/); and Research Training in
   Carcinogenesis and Mutagenesis (grant number T32CA009480;
   http://cancer.gov/) to BWF. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115
   Aldaz CM, 2002, ONCOGENE, V21, P6366, DOI 10.1038/sj.onc.1205816
   Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099
   Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081
   Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104
   Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150
   Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101
   Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055
   Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147
   Bednarek AK, 2000, CANCER RES, V60, P2140
   Bednarek AK, 2001, CANCER RES, V61, P8068
   Bouteille N, 2009, ONCOGENE, V28, P2569, DOI 10.1038/onc.2009.120
   Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604
   DEOME KB, 1959, CANCER RES, V19, P515
   Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175
   Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102
   GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gourley C, 2009, CANCER RES, V69, P4835, DOI 10.1158/0008-5472.CAN-08-2974
   Guler G, 2005, PATHOL INT, V55, P471, DOI 10.1111/j.1440-1827.2005.01855.x
   Guler G, 2009, CANCER-AM CANCER SOC, V115, P899, DOI 10.1002/cncr.24103
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023
   Katoh M, 2007, INT J MOL MED, V19, P273
   Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190
   Krummel KA, 2000, GENOMICS, V69, P37, DOI 10.1006/geno.2000.6321
   Krummel KA, 2002, GENE CHROMOSOME CANC, V34, P154, DOI 10.1002/gcc.10047
   Kurek KC, 2010, CANCER RES, V70, P5577, DOI 10.1158/0008-5472.CAN-09-4602
   Lewandowska U, 2009, J PHYSIOL PHARMACOL, V60, P47
   Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680
   Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844
   Ludes-Meyers JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007775
   Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080
   McCall KD, 2007, ENDOCRINOLOGY, V148, P4226, DOI 10.1210/en.2007-0459
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Nunez M, 2005, BREAST CANCER RES TR, V89, P99, DOI 10.1007/s10549-004-1474-x
   Pensa S, 2009, J MAMMARY GLAND BIOL, V14, P121, DOI 10.1007/s10911-009-9124-x
   Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956
   Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025
   Ramos D, 2006, ADV EXP MED BIOL, V587, P149
   Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651
   Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605
   Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496
NR 48
TC 21
Z9 21
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 4
PY 2012
VL 7
IS 5
AR e36618
DI 10.1371/journal.pone.0036618
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959WV
UT WOS:000305349800095
PM 22574198
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Hendaoui, I
   Lavergne, E
   Lee, HS
   Hong, SH
   Kim, HZ
   Parent, C
   Heuze-Vourc'h, N
   Clement, B
   Musso, O
AF Hendaoui, Ismail
   Lavergne, Elise
   Lee, Heun-Sik
   Hong, Seong Hyun
   Kim, Hak-Zoo
   Parent, Christelle
   Heuze-Vourc'h, Nathalie
   Clement, Bruno
   Musso, Orlando
TI Inhibition of Wnt/beta-Catenin Signaling by a Soluble Collagen-Derived
   Frizzled Domain Interacting with Wnt3a and the Receptors Frizzled 1 and
   8
SO PLOS ONE
LA English
DT Article
ID BETA-CATENIN; IN-VIVO; CELLS; BINDING; PROTEIN; DROSOPHILA; MODULE;
   LIGAND; GROWTH; XVIII
AB The Wnt/beta-catenin pathway controls cell proliferation, death and differentiation. Several families of extracellular proteins can antagonize Wnt/beta-catenin signaling, including the decoy receptors known as secreted frizzled related proteins (SFRPs), which have a cysteine-rich domain (CRD) structurally similar to the extracellular Wnt-binding domain of the frizzled receptors. SFRPs inhibit Wnt signaling by sequestering Wnts through the CRD or by forming inactive complexes with the frizzled receptors. Other endogenous molecules carrying frizzled CRDs inhibit Wnt signaling, such as V3Nter, which is proteolytically derived from the cell surface component collagen XVIII and contains a biologically active frizzled domain (FZC18) inhibiting in vivo cell proliferation and tumor growth in mice. We recently showed that FZC18 expressing cells deliver short-range signals to neighboring cells, decreasing their proliferation in vitro and in vivo through the Wnt/beta-catenin signaling pathway. Here, using low concentrations of soluble FZC18 and Wnt3a, we show that they physically interact in a cell-free system. In addition, soluble FZC18 binds the frizzled 1 and 8 receptors' CRDs, reducing cell sensitivity to Wnt3a. Conversely, inhibition of Wnt/beta-catenin signaling was partially rescued by the expression of full-length frizzled 1 and 8 receptors, but enhanced by the expression of a chimeric cell-membrane-tethered frizzled 8 CRD. Moreover, soluble, partially purified recombinant FZC18_CRD inhibited Wnt3a-induced beta-catenin activation. Taken together, the data indicate that collagen XVIII-derived frizzled CRD shifts Wnt sensitivity of normal cells to a lower pitch and controls their growth.
C1 [Hendaoui, Ismail; Lavergne, Elise; Lee, Heun-Sik; Clement, Bruno; Musso, Orlando] INSERM, U991, Rennes, France.
   [Hendaoui, Ismail; Lavergne, Elise; Lee, Heun-Sik; Clement, Bruno; Musso, Orlando] Univ Rennes 1, Rennes, France.
   [Parent, Christelle; Heuze-Vourc'h, Nathalie] INSERM, U618, Tours, France.
   [Hong, Seong Hyun; Kim, Hak-Zoo] Gyeonggi Bioctr, Gyeonggi Inst Sci & Technol Promot, Suwon, South Korea.
RP Hendaoui, I (reprint author), INSERM, U991, Rennes, France.
EM orlando.musso@inserm.fr
RI HEUZE-VOURC'H, Nathalie/P-8081-2016; Musso, Orlando/N-5756-2017;
   Clement, Bruno/E-5546-2016
OI Clement, Bruno/0000-0001-8827-146X
FU Institut National de la Sante et de la Recherche Medicale, Institut
   National du Cancer, Agence Nationale de la Recherche, Universite de
   Rennes 1, Region Bretagne
FX Institut National de la Sante et de la Recherche Medicale, Institut
   National du Cancer, Agence Nationale de la Recherche (Emergence-BIO
   Program 2008), Universite de Rennes 1, Region Bretagne. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096
   Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881
   Carmon KS, 2008, BIOCHEM BIOPH RES CO, V368, P285, DOI 10.1016/j.bbrc.2008.01.088
   Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009
   Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601
   DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266
   Elamaa H, 2003, MATRIX BIOL, V22, P427, DOI 10.1016/S0945-053X(03)00073-8
   Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017
   Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   Lavergne E, 2011, ONCOGENE, V30, P423, DOI 10.1038/onc.2010.432
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100
   Musso O, 2001, HEPATOLOGY, V33, P868, DOI 10.1053/jhep.2001.23189
   Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878
   Roman-Roman S, 2004, J BIOL CHEM, V279, P5725, DOI 10.1074/jbc.M309233200
   Sato A, 1999, DEVELOPMENT, V126, P4421
   Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1
   VALLET V, 1995, MOL CELL BIOL, V15, P5453
   Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048
   Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069
   Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200
NR 24
TC 15
Z9 16
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 27
PY 2012
VL 7
IS 1
AR e30601
DI 10.1371/journal.pone.0030601
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 911GB
UT WOS:000301704200025
PM 22303445
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Boyer, A
   Yeh, JR
   Zhang, XF
   Paquet, M
   Gaudin, A
   Nagano, MC
   Boerboom, D
AF Boyer, Alexandre
   Yeh, Jonathan R.
   Zhang, Xiangfan
   Paquet, Marilene
   Gaudin, Aurore
   Nagano, Makoto C.
   Boerboom, Derek
TI CTNNB1 Signaling in Sertoli Cells Downregulates Spermatogonial Stem Cell
   Activity via WNT4
SO PLOS ONE
LA English
DT Article
ID BETA-CATENIN; SELF-RENEWAL; UNDIFFERENTIATED SPERMATOGONIA; MOUSE
   SPERMATOGENESIS; HEMATOPOIETIC-CELLS; WNT/BETA-CATENIN; FEMALE
   FERTILITY; UP-REGULATION; SEX-REVERSAL; GERM-CELLS
AB Constitutive activation of the WNT signaling effector CTNNB1 (beta-catenin) in the Sertoli cells of the Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) mouse model results in progressive germ cell loss and sterility. In this study, we sought to determine if this phenotype could be due to a loss of spermatogonial stem cell (SSC) activity. Reciprocal SSC transplants between Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) and wild-type mice showed that SSC activity is lost in Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) testes over time, whereas the mutant testes could not support colonization by wild-type SSCs. Microarray analyses performed on cultured Sertoli cells showed that CTNNB1 induces the expression of genes associated with the female sex determination pathway, which was also found to occur in Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) testes. One CTNNB1 target gene encoded the secreted signaling molecule WNT4. We therefore tested the effects of WNT4 on SSC-enriched germ cell cultures, and found that WNT4 induced cell death and reduced SSC activity without affecting cell cycle. Conversely, conditional inactivation of Wnt4 in the Ctnnb1(tm1Mmt/+); Amhr2(tm3(cre)Bhr/+) model rescued spermatogenesis and male fertility, indicating that WNT4 is the major effector downstream of CTNNB1 responsible for germ cell loss. Furthermore, WNT4 was found to signal via the CTNNB1 pathway in Sertoli cells, suggesting a self-reinforcing positive feedback loop. Collectively, these data indicate for the first time that ectopic activation of a signaling cascade in the stem cell niche depletes SSC activity through a paracrine factor. These findings may provide insight into the pathogenesis of male infertility, as well as embryonic gonadal development.
C1 [Boyer, Alexandre; Gaudin, Aurore; Boerboom, Derek] Univ Montreal, Fac Med Vet, Anim Reprod Res Ctr CRRA, St Hyacinthe, PQ J2S 7C6, Canada.
   [Yeh, Jonathan R.; Zhang, Xiangfan; Nagano, Makoto C.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada.
   [Paquet, Marilene] McGill Univ, Comparat Med & Anim Resources Ctr, Montreal, PQ, Canada.
RP Boyer, A (reprint author), Univ Montreal, Fac Med Vet, Anim Reprod Res Ctr CRRA, St Hyacinthe, PQ J2S 7C6, Canada.
EM derek.boerboom@umontreal.ca
RI Paquet, Marilene/L-3414-2019
OI Paquet, Marilene/0000-0002-3562-4636
FU Canadian Institutes of Health Research (CIHR) [MOP-102508, MOP-86532];
   Natural Sciences and Engineering Research Council of Canada (NSERC)
   [340902-07]; Canada Research Chair in Ovarian Molecular Biology and
   Functional
FX This work was supported by the Canadian Institutes of Health Research
   (CIHR) operating grants MOP-102508 and MOP-86532, and by a Natural
   Sciences and Engineering Research Council of Canada (NSERC) discovery
   grant (340902-07) and the Canada Research Chair in Ovarian Molecular
   Biology and Functional. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68
   Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627
   Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789
   Boyer A, 2009, CARCINOGENESIS, V30, P869, DOI 10.1093/carcin/bgp051
   Brandon C, 2000, BLOOD, V96, P4132
   Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572
   Chang H, 2009, BIOL REPROD, V81, P842, DOI 10.1095/biolreprod.109.077446
   de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842
   DEJONG FH, 1988, PHYSIOL REV, V68, P555
   FLEISCHMAN RA, 1993, TRENDS GENET, V9, P285, DOI 10.1016/0168-9525(93)90015-A
   Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2
   Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102
   Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931
   Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8
   Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003
   Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591
   Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125
   Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301
   Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400
   Krausz C, 1999, FRONT BIOSCI, V4, P1
   Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101
   Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611
   Li Q, 2005, J BIOL CHEM, V280, P2831, DOI 10.1074/jbc.M405680200
   Liu CF, 2010, CURR TOP DEV BIOL, V90, P263, DOI 10.1016/S0070-2153(10)90007-0
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002
   Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193
   Mandel H, 2008, AM J HUM GENET, V82, P39, DOI 10.1016/j.ajhg.2007.08.005
   Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miller JR, 2001, GENOME BIOL, V3, P3001, DOI 10.1186/gb-2001-3-1-reviews3001
   Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135
   Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023
   Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429
   Nagano M, 2004, SPERMATOGONIAL TRANS, P334
   Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355
   Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496
   Ogawa T, 1997, INT J DEV BIOL, V41, P111
   Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650
   Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319
   Schlessinger D, 2010, J ANDROL, V31, P16, DOI 10.2164/jandrol.109.008201
   Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894
   SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9
   Shahid M, 2011, EUR J HUM GENET, V19, P23, DOI 10.1038/ejhg.2010.151
   Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655
   Simon L, 2010, STEM CELLS, V28, P1882, DOI 10.1002/stem.508
   Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335
   Tyagi G, 2009, BIOL REPROD, V81, P258, DOI 10.1095/biolreprod.108.075200
   Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021
   Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068
   Yeh JR, 2007, BIOL REPROD, V77, P897, DOI 10.1095/biolreprod.107.063057
   Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903
   Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885
   Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789
   Zhang XF, 2003, BIOL REPROD, V69, P1872, DOI 10.1095/biolreprod.103.019273
NR 55
TC 31
Z9 33
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 12
PY 2012
VL 7
IS 1
AR e29764
DI 10.1371/journal.pone.0029764
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 906OY
UT WOS:000301357100020
PM 22253774
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Bordonaro, M
   Tewari, S
   Cicco, CE
   Atamna, W
   Lazarova, DL
AF Bordonaro, Michael
   Tewari, Shruti
   Cicco, Catherine E.
   Atamna, Wafa
   Lazarova, Darina L.
TI A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug
   Resistance in Colon Cancer Cells
SO PLOS ONE
LA English
DT Article
ID ACID PHENETHYL ESTER; FAMILIAL ADENOMATOUS POLYPOSIS;
   HISTONE-DEACETYLASE ACTIVITY; RECEPTOR TYROSINE KINASES; BETA-CATENIN;
   COLORECTAL-CANCER; IN-VIVO; PROSTATE-CANCER; PHOSPHATIDYLINOSITOL
   3-KINASE/AKT; COMPENSATORY PROLIFERATION
AB Butyrate, a fermentation product of fiber in the colon, acts as a histone deacetylase inhibitor (HDACi) and induces apoptosis in colon cancer (CC) cells in vitro. We have reported that the apoptotic effects of butyrate are dependent upon the hyperactivation of the Wnt/beta-catenin pathway. However, prolonged exposure of CC cells to increasing concentrations of butyrate results in the acquisition of resistance to the Wnt/beta-catenin- and apoptosis-inducing effects of this agent, as well as cross-resistance to structurally different HDACis. Here we report that one mechanism whereby HDACi resistance arises is through the increase of beta-catenin-independent (noncanonical) Wnt signaling. Compared to HDACi-sensitive HCT-116 CC cells, HDACi-resistant HCT-R cells exhibit higher levels of AKT/PKB cell survival signaling, which is in part induced by WNT5A and its receptor ROR2. The induction of AKT signaling by HDACis is also detected in other CC cell lines, albeit to a lesser extent than in the drug-resistant HCT-R cells. The observations suggested that the apoptotic effect of butyrate and other HDACis in CC cells can be augmented by inhibitors of pAKT. In agreement with the hypothesis, the combination of MK2206, a pAKT inhibitor, and a HDACi (butyrate or LBH589) induced higher apoptosis in CC cells compared to each agent alone. The exposure to both agents also re-sensitized the HCT-R cells to apoptosis. Finally, the concept of simultaneously inducing canonical Wnt activity and suppressing AKT signaling was translated into a combination of diet-derived agents. Diet-derived pAKT inhibitors (caffeic acid phethyl ester, sulforaphane, dilallyl trisulfide) suppressed the butyrate-induced levels of pAKT, and increased the apoptotic effects of butyrate in both drug-sensitive and drug-resistant CC cells. Our findings can be translated into (a) CC therapy employing combinations of synthetic HDACis and inhibitors of pAKT, as well as (b) CC prevention based upon diets that result in sufficient amounts of butyrate and pAKT inhibitors.
C1 [Bordonaro, Michael; Tewari, Shruti; Cicco, Catherine E.; Atamna, Wafa; Lazarova, Darina L.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.
RP Bordonaro, M (reprint author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.
EM dlazarova@tcmedc.org
FU NIH/NCI [1R15CA152852-01]; Commonwealth Medical College (Scratnon, PA);
   AICR [09A002]; NIH/NCI-NIDDK [1R15CA149589-01]
FX Darina Lazarova is supported by NIH/NCI grant #1R15CA152852-01 and
   institutional funds from The Commonwealth Medical College (Scratnon,
   PA). Michael Bordonaro is supported by AICR grant #09A002, NIH/NCI-NIDDK
   #1R15CA149589-01, and institutional funds from The Commonwealth Medical
   College (Scratnon, PA). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abramova MV, 2010, INT J BIOCHEM CELL B, V42, P1847, DOI 10.1016/j.biocel.2010.08.001
   Abramova MV, 2006, J BIOL CHEM, V281, P21040, DOI 10.1074/jbc.M511059200
   Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602
   Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502165200
   Barbier A, 2010, B CANCER, V97, pE9, DOI 10.1684/bdc.2010.1033
   Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7
   Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008
   Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363
   Celli N, 2007, J AGR FOOD CHEM, V55, P3398, DOI 10.1021/jf063477o
   Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106
   Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025
   De Angelis Paula M, 2004, Mol Cancer, V3, P11, DOI 10.1186/1476-4598-3-11
   Denlinger CE, 2005, J THORAC CARDIOV SUR, V130, P1422, DOI 10.1016/j.jtcvs.2005.06.051
   Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003
   Feike AC, 2010, BIOCHEM BIOPH RES CO, V400, P500, DOI 10.1016/j.bbrc.2010.08.074
   Fyrst H, 2009, CANCER RES, V69, P9457, DOI 10.1158/0008-5472.CAN-09-2341
   Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017
   Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018
   GRANT S, 2002, FRONT BIOSCI, V7, P376
   Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006
   Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07
   He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652
   He X, 2011, CANCER LETT, V301, P168, DOI 10.1016/j.canlet.2010.11.012
   Henderson-Jackson EB, 2010, INT J CLIN EXP PATHO, V3, P768
   Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012
   Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220
   Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200
   Hu R, 2006, CARCINOGENESIS, V27, P2038, DOI 10.1093/carcin/bgl049
   Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015
   Izuishi K, 2000, CANCER RES, V60, P6201
   Kawasaki A, 2007, CELL SIGNAL, V19, P2498, DOI 10.1016/j.cellsig.2007.07.023
   Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1
   Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022
   Kong JS, 2010, ARTHRITIS RHEUM-US, V62, P159, DOI 10.1002/art.25017
   Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152
   Lazarova DL, 2001, CELL GROWTH DIFFER, V12, P319
   Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3
   MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258
   Mahmoud NN, 2000, CARCINOGENESIS, V21, P921, DOI 10.1093/carcin/21.5.921
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715
   Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991
   Miyaki M, 1999, CANCER RES, V59, P4506
   Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787
   Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x
   Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200
   O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305
   Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432
   Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8
   Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019
   Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027
   Schmidt-Ullrich RK, 2000, RADIAT RES, V153, P245, DOI 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2
   Sela U, 2008, NUTR CANCER, V60, P412, DOI 10.1080/01635580701733083
   Shankar S, 2007, INT J ONCOL, V30, P905
   Shen G, 2007, CANCER RES, V67, P9937, DOI 10.1158/0008-5472.CAN-07-1112
   Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178
   Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721
   The Associations between Food Nutrition Physical Activitythe Risk of Colorectal Cancer, WCRF AICR SYST LIT R
   Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC
   Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002
   Wang LC, 2010, CLIN EXP IMMUNOL, V160, P223, DOI 10.1111/j.1365-2249.2009.04067.x
   Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282
   Wesley CS, 1999, MOL CELL BIOL, V19, P5743
   Weyant MJ, 2000, CLIN CANCER RES, V6, P949
   Xiao D, 2006, CARCINOGENESIS, V27, P533, DOI 10.1093/carcin/bgi228
   Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560
   ZHENG ZS, 1995, ONCOL RES, V7, P445
NR 69
TC 38
Z9 39
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 3
PY 2011
VL 6
IS 11
AR e27308
DI 10.1371/journal.pone.0027308
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 850LV
UT WOS:000297197000047
PM 22073312
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Zhang, ZC
   Wlodarczyk, BJ
   Niederreither, K
   Venugopalan, S
   Florez, S
   Finnell, RH
   Amendt, BA
AF Zhang, Zichao
   Wlodarczyk, Bogdan J.
   Niederreither, Karen
   Venugopalan, Shankar
   Florez, Sergio
   Finnell, Richard H.
   Amendt, Brad A.
TI Fuz Regulates Craniofacial Development through Tissue Specific Responses
   to Signaling Factors
SO PLOS ONE
LA English
DT Article
ID PLANAR CELL POLARITY; CRANIAL NEURAL CREST; PRIMARY CILIA FORMATION;
   AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; SONIC-HEDGEHOG; MECKELS
   CARTILAGE; EMBRYONIC-DEVELOPMENT; CONVERGENT EXTENSION; CAMPOMELIC
   DYSPLASIA
AB The planar cell polarity effector gene Fuz regulates ciliogenesis and Fuz loss of function studies reveal an array of embryonic phenotypes. However, cilia defects can affect many signaling pathways and, in humans, cilia defects underlie several craniofacial anomalies. To address this, we analyzed the craniofacial phenotype and signaling responses of the Fuz(-/-) mice. We demonstrate a unique role for Fuz in regulating both Hedgehog (Hh) and Wnt/beta-catenin signaling during craniofacial development. Fuz expression first appears in the dorsal tissues and later in ventral tissues and craniofacial regions during embryonic development coincident with cilia development. The Fuz(-/-) mice exhibit severe craniofacial deformities including anophthalmia, agenesis of the tongue and incisors, a hypoplastic mandible, cleft palate, ossification/skeletal defects and hyperplastic malformed Meckel's cartilage. Hh signaling is down-regulated in the Fuz null mice, while canonical Wnt signaling is up-regulated revealing the antagonistic relationship of these two pathways. Meckel's cartilage is expanded in the Fuz(-/-) mice due to increased cell proliferation associated with the up-regulation of Wnt canonical target genes and decreased non-canonical pathway genes. Interestingly, cilia development was decreased in the mandible mesenchyme of Fuz null mice, suggesting that cilia may antagonize Wnt signaling in this tissue. Furthermore, expression of Fuz decreased expression of Wnt pathway genes as well as a Wnt-dependent reporter. Finally, chromatin IP experiments demonstrate that beta-catenin/TCF-binding directly regulates Fuz expression. These data demonstrate a new model for coordination of Hh and Wnt signaling and reveal a Fuz-dependent negative feedback loop controlling Wnt/beta-catenin signaling.
C1 [Zhang, Zichao; Venugopalan, Shankar; Florez, Sergio; Amendt, Brad A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA.
   [Wlodarczyk, Bogdan J.; Niederreither, Karen; Finnell, Richard H.] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA.
RP Amendt, BA (reprint author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA.
EM bamendt@ibt.tamhsc.edu
RI Finnell, Richard/D-8174-2018
OI Finnell, Richard/0000-0002-5962-8754; Wlodarczyk, Bogdan
   J./0000-0001-5249-5832
FU National Institutes of Health [DE016315, DE13941, DE18885]
FX This work was supported by the National Institutes of Health grants
   DE016315 to RHF, DE13941 and DE18885 to BAA. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5
   Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047
   Amendt BA, 1999, MOL CELL BIOL, V19, P7001
   Aoto K, 2009, DEV BIOL, V327, P106, DOI 10.1016/j.ydbio.2008.11.022
   Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100
   Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231
   Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025
   Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198
   Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595
   Brugmann SA, 2010, AM J MED GENET A, V152A, P2995, DOI 10.1002/ajmg.a.33727
   Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030
   Carda C, 2005, TISSUE CELL, V37, P247, DOI 10.1016/j.tice.2005.03.002
   Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227
   Chai Y, 2000, DEVELOPMENT, V127, P1671
   Chai Y, 1998, INT J DEV BIOL, V42, P87
   Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833
   CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T
   Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501
   Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002
   Collier S, 1997, DEVELOPMENT, V124, P4029
   Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670
   Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448
   DAI D, 2010, J INVEST DERMATOL, V131, P302
   Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025
   Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684
   Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0
   Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802
   Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977
   FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0
   Franco B, 2008, INBORN ERRORS DEV, P1379
   FROMMER J, 1971, J DENT RES, V50, P1260, DOI 10.1177/00220345710500052801
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12
   Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023
   Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198
   Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774
   Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796
   Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301
   Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966
   HALL BK, 1980, J EMBRYOL EXP MORPH, V56, P71
   Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053
   Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9
   Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130
   Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013
   Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102
   Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104
   Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000
   Kolpakova-Hart E, 2007, DEV BIOL, V309, P273, DOI 10.1016/j.ydbio.2007.07.018
   Lee H, 2002, GENETICS, V160, P1535
   Lee J, 1997, DEVELOPMENT, V124, P2537
   Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717
   Lefebvre V, 1998, MATRIX BIOL, V16, P529
   Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048
   Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452
   Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383
   Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224
   May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050
   McDermott KM, 2010, CURR BIOL, V20, P731, DOI 10.1016/j.cub.2010.02.048
   Melnick M, 2005, CELLS TISSUES ORGANS, V179, P146, DOI 10.1159/000085950
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048
   Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618
   Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100
   Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305
   Murcia NS, 2000, DEVELOPMENT, V127, P2347
   Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979
   Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892
   Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025
   Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104
   Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753
   Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011
   Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x
   Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740
   Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644
   Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273
   SAVOSTIN.I, 1973, ANAT REC, V176, P345, DOI 10.1002/ar.1091760310
   Schneider FT, 2010, AM J PATHOL, V177, P404, DOI 10.2353/ajpath.2010.091079
   Strutt D, 2008, CURR BIOL, V18, pR898, DOI 10.1016/j.cub.2008.07.055
   Tamakoshi T, 2006, BIOCHEM BIOPH RES CO, V339, P932, DOI 10.1016/j.bbrc.2005.11.097
   Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010
   Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884
   Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8
   Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123
   Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077
   Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011
   Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347
   Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622
   Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102
   Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289
   Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441
   Zhao H, 2008, DEV BIOL, V320, P19, DOI 10.1016/j.ydbio.2008.03.045
NR 95
TC 59
Z9 59
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 14
PY 2011
VL 6
IS 9
AR e24608
DI 10.1371/journal.pone.0024608
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 822JC
UT WOS:000295039700030
PM 21935430
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Heinonen, KM
   Vanegas, JR
   Lew, D
   Krosl, J
   Perreault, C
AF Heinonen, Krista M.
   Vanegas, Juan Ruiz
   Lew, Deborah
   Krosl, Jana
   Perreault, Claude
TI Wnt4 Enhances Murine Hematopoietic Progenitor Cell Expansion Through a
   Planar Cell Polarity-Like Pathway
SO PLOS ONE
LA English
DT Article
ID STEM-CELLS; BETA-CATENIN; IN-VIVO; SELF-RENEWAL; NICHE; IDENTIFICATION;
   ACTIVATION; RECEPTOR; EVENTS; SIZE
AB Background: While the role of canonical (beta-catenin-mediated) Wnt signaling in hematolymphopoiesis has been studied extensively, little is known of the potential importance of non-canonical Wnt signals in hematopoietic cells. Wnt4 is one of the Wnt proteins that can elicit non-canonical pathways. We have previously shown that retroviral overexpression of Wnt4 by hematopoietic cells increased thymic cellularity as well as the frequency of early thymic progenitors and bone marrow hematopoietic progenitor cells (HPCs). However, the molecular pathways responsible for its effect in HPCs are not known.
   Methodology/Principal Findings: Here we report that Wnt4 stimulation resulted in the activation of the small GTPase Rac1 as well as Jnk kinases in an HPC cell line. Jnk activity was necessary, while beta-catenin was dispensable, for the Wnt4-mediated expansion of primary fetal liver HPCs in culture. Furthermore, Jnk2-deficient and Wnt4 hemizygous mice presented lower numbers of HPCs in their bone marrow, and Jnk2-deficient HPCs showed increased rates of apoptosis. Wnt4 also improved HPC activity in a competitive reconstitution model in a cell-autonomous, Jnk2-dependent manner. Lastly, we identified Fz6 as a receptor for Wnt4 in immature HPCs and showed that the absence of Wnt4 led to a decreased expression of four polarity complex genes.
   Conclusions/Significance: Our results establish a functional role for non-canonical Wnt signaling in hematopoiesis through a pathway involving Wnt4, Fz6, Rac1 and Jnk kinases.
C1 [Heinonen, Krista M.; Vanegas, Juan Ruiz; Lew, Deborah; Krosl, Jana; Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.
   [Heinonen, Krista M.; Vanegas, Juan Ruiz; Perreault, Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.
   [Perreault, Claude] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada.
RP Heinonen, KM (reprint author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.
EM c.perreault@videotron.ca
RI Heinonen, Krista/G-9769-2016; Perreault, Claude/A-7220-2008
OI Heinonen, Krista/0000-0002-2410-4432; Perreault,
   Claude/0000-0001-9453-7383
FU Canadian Institutes of Health Research (CIHR) [MOP42384]; Terry Fox
   Foundation; Canadian Center of Excellence in Commercialization and
   Research; Canada Foundation for Innovation; Fonds de la Recherche en
   Sante du Quebec
FX Grant #MOP42384 from the Canadian Institutes of Health Research (CIHR)
   supported this work. KMH was supported by a training grant from the
   Terry Fox Foundation. CP holds a Canada Research Chair in Immunobiology.
   The Institute for Research in Immunology and Cancer (IRIC) is supported
   in part by the Canadian Center of Excellence in Commercialization and
   Research, the Canada Foundation for Innovation, and the Fonds de la
   Recherche en Sante du Quebec. No additional external funding received
   for this study. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013
   Aguado R, 2010, BLOOD, V116, P1705, DOI 10.1182/blood-2009-10-246777
   Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717
   Baron C, 2007, PLOS MED, V4, P69, DOI 10.1371/journal.pmed.0040023
   BERNARD P, 2007, BIOL CELL, V100, P167
   Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009
   Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104
   Buckley S M, 2010, EXP HEMATOL
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200
   Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026
   Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459
   Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091
   Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209
   Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003
   Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001
   Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200
   Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101
   Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007
   Jiang Y, 2009, BLOOD, V114, P3773, DOI 10.1182/blood-2009-05-219840
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022
   Kokolus K, 2010, IMMUNOL RES, V46, P155, DOI 10.1007/s12026-009-8116-7
   Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714
   Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8
   Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013
   Louis I, 2008, IMMUNITY, V29, P57, DOI 10.1016/j.immuni.2008.04.023
   Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774
   Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036
   Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386
   Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107
   McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100
   Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104
   Nemeth MJ, 2009, STEM CELLS, V27, P1109, DOI 10.1002/stem.32
   Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017
   Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010
   Ranheim EA, 2005, BLOOD, V105, P2487, DOI 10.1182/blood-2004-06-2334
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317
   Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011
   Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726
   Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529
   Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360
   Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992
   TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Vijayaragavan K, 2009, CELL STEM CELL, V4, P248, DOI 10.1016/j.stem.2008.12.011
   Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052
   Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003
NR 54
TC 34
Z9 34
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 26
PY 2011
VL 6
IS 4
AR e19279
DI 10.1371/journal.pone.0019279
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 756NE
UT WOS:000290018400039
PM 21541287
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Sklepkiewicz, P
   Schermuly, RT
   Tian, X
   Ghofrani, HA
   Weissmann, N
   Sedding, D
   Kashour, T
   Seeger, W
   Grimminger, F
   Pullamsetti, SS
AF Sklepkiewicz, Piotr
   Schermuly, Ralph Theo
   Tian, Xia
   Ghofrani, Hossein Ardeschir
   Weissmann, Norbert
   Sedding, Daniel
   Kashour, Tarek
   Seeger, Werner
   Grimminger, Friedrich
   Pullamsetti, Soni Savai
TI Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial
   Smooth Muscle Cells in Pulmonary Hypertension
SO PLOS ONE
LA English
DT Article
ID SIGNAL-REGULATED KINASE; BETA-CATENIN; WNT/BETA-CATENIN; UP-REGULATION;
   CYCLIN D1; INHIBITION; THERAPY; GROWTH; PATHWAYS; SURVIVAL
AB Rationale: Pulmonary arterial hypertension (PAH) is a rare progressive pulmonary vascular disorder associated with vascular remodeling and right heart failure. Vascular remodeling involves numerous signaling cascades governing pulmonary arterial smooth muscle cell (PASMC) proliferation, migration and differentiation. Glycogen synthase kinase 3beta (GSK3 beta) is a serine/threonine kinase and can act as a downstream regulatory switch for numerous signaling pathways. Hence, we hypothesized that GSK3 beta plays a crucial role in pulmonary vascular remodeling.
   Methods: All experiments were done with lung tissue or isolated PASMCs in a well-established monocrotaline (MCT)-induced PAH rat model. The mRNA expression of Wnt ligands (Wnt1, Wnt3a, Wnt5a), upstream Wnt signaling regulator genes (Frizzled Receptors 1, 2 and secreted Frizzled related protein sFRP-1) and canonical Wnt intracellular effectors (GSK3 beta, Axin1) were assessed by real-time polymerase chain reaction and protein levels of GSK3 beta, phospho-GSK3 beta (ser 9) by western blotting and localization by immunohistochemistry. The role of GSK3 beta in PASMCs proliferation was assessed by overexpression of wild-type GSK3 beta (WT) and constitutively active GSK3 beta S9A by [3H]-thymidine incorporation assay.
   Results: Increased levels of total and phosphorylated GSK3 beta (inhibitory phosphorylation) were observed in lungs and PASMCs isolated from MCT-induced PAH rats compared to controls. Further, stimulation of MCT-PASMCs with growth factors induced GSK3 beta inactivation. Most importantly, treatment with the PDGFR inhibitor, Imatinib, attenuated PDGF-BB and FCS induced GSK3 beta phosphorylation. Increased expression of GSK3 beta observed in lungs and PASMC isolated from MCT-induced PAH rats was confirmed to be clinically relevant as the same observation was identified in human iPAH lung explants. Overexpression of GSK3 beta significantly increased MCT-PASMCs proliferation by regulating ERK phosphorylation. Constitutive activation of GSK3 beta (GSK3 beta S9A, 9th serine replaced to alanine) inhibited MCT-PASMCs proliferation by decreasing ERK phosphorylation.
   Conclusion: This study supports a central role for GSK3 beta in vascular remodeling processes and suggests a novel therapeutic opportunity for the treatment of PAH.
C1 [Sklepkiewicz, Piotr; Schermuly, Ralph Theo; Tian, Xia; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Seeger, Werner; Grimminger, Friedrich; Pullamsetti, Soni Savai] Univ Hosp, Med Clin 2 5, Giessen, Germany.
   [Schermuly, Ralph Theo; Seeger, Werner; Pullamsetti, Soni Savai] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany.
   [Sedding, Daniel] Univ Hosp, Med Clin 1, Giessen, Germany.
   [Kashour, Tarek] King Fahad Med City, Riyadh, Saudi Arabia.
RP Sklepkiewicz, P (reprint author), Univ Hosp, Med Clin 2 5, Giessen, Germany.
EM soni.pullamsetti@mpi-bn.mpg.de
OI Weissmann, Norbert/0000-0003-2675-3871; Ghofrani,
   Ardeschir/0000-0002-2029-4419; Seeger, Werner/0000-0003-1946-0894;
   Pullamsetti, Soni Savai/0000-0003-0440-8831; Schermuly,
   Ralph/0000-0002-5167-6970
FU Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 547, B11, C6]
FX This work was supported by the Deutsche Forschungsgemeinschaft,
   Sonderforschungsbereich 547 "Kardiopulmonales Gefasssystem'', Projekt
   B11 and C6 (http://www.dfg.de/index.jsp). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o
   Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006
   Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504
   BENDEY JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176
   Bonnet S, 2009, CIRCULATION, V120, P1231, DOI 10.1161/CIRCULATIONAHA.109.848911
   Chen XY, 2009, PHARMACOLOGY, V83, P67, DOI 10.1159/000178814
   Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4
   DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343
   Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499
   Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384
   Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597
   FIOL CJ, 1994, J BIOL CHEM, V269, P32187
   Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010
   George SJ, 2006, ATHEROSCLEROSIS, V188, P1, DOI 10.1016/j.atherosclerosis.2005.12.017
   GOODE N, 1992, J BIOL CHEM, V267, P16878
   Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9
   Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jaac.2004.02.029
   Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751
   Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC
   Laumanns IP, 2009, AM J RESP CELL MOL, V40, P683, DOI 10.1165/rcmb.2008-0153OC
   Li FH, 2009, PEDIATR CARDIOL, V30, P363, DOI 10.1007/s00246-008-9315-z
   McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203
   Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONHA.105.540542
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245
   Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200
   Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929
   Park KW, 2003, ARTERIOSCL THROM VAS, V23, P1364, DOI 10.1161/01.ATV.0000081633.53390.B4
   Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049
   Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC
   Pullamsetti S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-128
   Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje
   Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452
   Rubin Lewis J, 2006, Proc Am Thorac Soc, V3, P111, DOI 10.1513/pats.200510-112JH
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023
   Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020
   Savai R, 2005, INT J ONCOL, V27, P393
   Schermuly RT, 2007, CIRCULATION, V115, P2331, DOI 10.1161/CIRCULATIONAHA.106.676809
   Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838
   Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041
   Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E
   Tsakiridis T, 2001, BIOCHEM BIOPH RES CO, V288, P205, DOI 10.1006/bbrc.2001.5762
   van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150
   Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004
   Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466
   Wedgwood S, 2007, PEDIATR RES, V61, P32, DOI 10.1203/01.pdr.0000250013.77008.28
   Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2
   Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC613, DOI 10.1152/ajpcell.00421.2006
NR 49
TC 25
Z9 31
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 18
PY 2011
VL 6
IS 4
AR e18883
DI 10.1371/journal.pone.0018883
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 751LS
UT WOS:000289620100027
PM 21533110
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Ekstrom, EJ
   Sherwood, V
   Andersson, T
AF Ekstrom, Elin J.
   Sherwood, Victoria
   Andersson, Tommy
TI Methylation and Loss of Secreted Frizzled-Related Protein 3 Enhances
   Melanoma Cell Migration and Invasion
SO PLOS ONE
LA English
DT Article
ID WNT ANTAGONIST; EPIGENETIC INACTIVATION; BETA-CATENIN; EXPRESSION;
   CANCER; GENES; INHIBITION; PATHWAY; GROWTH; TRANSCRIPTION
AB Background: Wnt signaling is important in development and can also contribute to the initiation and progression of cancer. The Secreted Frizzled Related Proteins (SFRPs) constitute a family of Wnt modulators, crucial for controlling Wnt signaling. Here we investigate the expression and role of SFRP3 in melanoma.
   Methodology/Principal Findings: We show that SFRP3 mRNA is down-regulated in malignant melanoma tumors as compared to normal/benign tissue. Furthermore, we found that SFRP3 expression was lost in the malignant melanoma cell lines, A2058, HTB63 and A375, but not in the non-transformed melanocyte cell line, Hermes 3A. Methylated CpG rich areas were detected in the SFRP3 gene in melanoma cell lines and their SFRP3 expression could be restored using the demethylating agent, 5'aza-deoxycytidine. Addition of recombinant SFRP3 to melanoma cells had no effect on viable cell numbers, but decreased cell migration and invasion. Wnt5a signaling has been shown to increase the migration and invasion of malignant melanoma cells, and high expression of Wnt5a in melanoma tumors has been connected to a poor prognosis. We found that recombinant SFRP3 could inhibit Wnt5a signaling, and that it inhibited melanoma cell migration and invasion in a Wnt5a-dependent manner.
   Conclusion/Significance: We conclude that SFRP3 functions as a melanoma migration and invasion suppressor by interfering with Wnt5a signaling.
C1 [Ekstrom, Elin J.; Sherwood, Victoria; Andersson, Tommy] Lund Univ, Skane Univ Hosp, Clin Res Ctr, Dept Lab Med, Malmo, Sweden.
RP Ekstrom, EJ (reprint author), Lund Univ, Skane Univ Hosp, Clin Res Ctr, Dept Lab Med, Malmo, Sweden.
EM Tommy.Andersson@med.lu.se
OI Sherwood, Victoria/0000-0001-6193-2571; Andersson,
   Tommy/0000-0003-4032-5769; Pietras, Elin Josefina/0000-0003-1645-8916
FU Swedish Cancer Foundation; Swedish Research Council; Soderberg
   foundations; Malmo University Hospital Research Foundations; Gunnar
   Nilsson's Cancer Foundation; Royal Physiographic Society; Knut & Alice
   Wallenberg Foundation; Wellcome Trust Cell Bank
FX This work was supported by the Swedish Cancer Foundation, the Swedish
   Research Council, the Soderberg foundations, Malmo University Hospital
   Research Foundations, the Gunnar Nilsson's Cancer Foundation (to TA),
   the Royal Physiographic Society (to EE and VS), the Knut & Alice
   Wallenberg Foundation, and the Wellcome Trust Cell Bank. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636
   Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096
   Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445
   Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106
   Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200
   Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104
   Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601
   Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05
   Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200
   Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283
   Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220
   Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7
   Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106
   Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136
   Jonsson M, 2002, CANCER RES, V62, P409
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32
   Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831
   Larue L, 2003, PIGM CELL RES, V16, P312, DOI 10.1034/j.1600-0749.2003.00050.x
   Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881
   Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427
   Liu W, 2008, GROWTH FACTORS, V26, P343, DOI 10.1080/08977190802442013
   Mandal D, 2007, GENE, V386, P131, DOI 10.1016/j.gene.2006.08.030
   Marsit CJ, 2010, PLOS ONE, V5
   McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715
   O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x
   OCONNELL MP, 2009, ONCOGENE, V29, P34, DOI DOI 10.1038/0NC.2009.305.PUBMED:19802008
   Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011
   Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840
   Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547
   Shi Y, 2007, ACTA PHARMACOL SIN, V28, P1499, DOI 10.1111/j.1745-7254.2007.00692.x
   Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165
   Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259
   Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330
   Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103
NR 44
TC 31
Z9 32
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 8
PY 2011
VL 6
IS 4
AR e18674
DI 10.1371/journal.pone.0018674
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 747AP
UT WOS:000289292800035
PM 21494614
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Blakely, BD
   Bye, CR
   Fernando, CV
   Horne, MK
   Macheda, ML
   Stacker, SA
   Arenas, E
   Parish, CL
AF Blakely, Brette D.
   Bye, Christopher R.
   Fernando, Chathurini V.
   Horne, Malcolm K.
   Macheda, Maria L.
   Stacker, Steven A.
   Arenas, Ernest
   Parish, Clare L.
TI Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance
SO PLOS ONE
LA English
DT Article
ID UNBIASED STEREOLOGICAL ESTIMATION; NEURAL STEM-CELLS; INT-1
   PROTOONCOGENE; NEURITE OUTGROWTH; BETA-CATENIN; TOTAL NUMBER; NEURONS;
   RECEPTOR; POLARITY; MICE
AB During development, precise temporal and spatial gradients are responsible for guiding axons to their appropriate targets. Within the developing ventral midbrain (VM) the cues that guide dopaminergic (DA) axons to their forebrain targets remain to be fully elucidated. Wnts are morphogens that have been identified as axon guidance molecules. Several Wnts are expressed in the VM where they regulate the birth of DA neurons. Here, we describe that a precise temporo-spatial expression of Wnt5a accompanies the development of nigrostriatal projections by VM DA neurons. In mice at E11.5, Wnt5a is expressed in the VM where it was found to promote DA neurite and axonal growth in VM primary cultures. By E14.5, when DA axons are approaching their striatal target, Wnt5a causes DA neurite retraction in primary cultures. Co-culture of VM explants with Wnt5a-overexpressing cell aggregates revealed that Wnt5a is capable of repelling DA neurites. Antagonism experiments revealed that the effects of Wnt5a are mediated by the Frizzled receptors and by the small GTPase, Rac1 (a component of the non-canonical Wnt planar cell polarity pathway). Moreover, the effects were specific as they could be blocked by Wnt5a antibody, sFRPs and RYK-Fc. The importance of Wnt5a in DA axon morphogenesis was further verified in Wnt5a(-/-) mice, where fasciculation of the medial forebrain bundle (MFB) as well as the density of DA neurites in the MFB and striatal terminals were disrupted. Thus, our results identify a novel role of Wnt5a in DA axon growth and guidance.
C1 [Blakely, Brette D.; Bye, Christopher R.; Fernando, Chathurini V.; Horne, Malcolm K.; Parish, Clare L.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia.
   [Blakely, Brette D.; Horne, Malcolm K.; Parish, Clare L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia.
   [Horne, Malcolm K.] St Vincents Hosp, Fitzroy, Vic 3065, Australia.
   [Macheda, Maria L.; Stacker, Steven A.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia.
   [Arenas, Ernest] Karolinska Inst, Mol Neurobiol Lab, Dept Biochem & Biophys, Stockholm, Sweden.
RP Blakely, BD (reprint author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia.
EM clare.parish@florey.edu.au
RI Parish, Clare/A-3380-2014; Bye, Chris R/D-6406-2011
OI Bye, Chris R/0000-0003-1714-5954; Blakely, Brette/0000-0002-8420-7396;
   Stacker, Steven/0000-0003-4096-9273; Macheda, Maria/0000-0002-8460-2046;
   Arenas, Ernest/0000-0003-0197-6577; Parish, Clare/0000-0001-8212-9884
FU Australian National Health and Medical Research Council (NHMRC)
   [566740]; Bethlehem Griffith Research Foundation (BGRF), Australia;
   Human Frontiers Science Program; NHMRC; Australian Postgraduate Award;
   Swedish Research Council [VR2008:2811]; Norwegian Research Council;
   Karolinska Institutet
FX This work was supported by grants from the Australian National Health
   and Medical Research Council (NHMRC #566740) and the Bethlehem Griffith
   Research Foundation (BGRF), Australia. C. L. P. was supported by a Human
   Frontiers Science Program Long-Term Training Fellowship, NHMRC CJ Martin
   Fellowship, and NHMRC Career Development Award. B. D. B. is supported by
   an Australian Postgraduate Award. S. A. S. is supported by an NHMRC
   Senior Research Fellowship. The work of E. A. was supported by grants
   from the Swedish Research Council (VR2008:2811 and DBRM), Norwegian
   Research Council and Karolinska Institutet. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128
   Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517
   BJORKLUND A, 1984, DOPAMINE CONTAINING, P55
   Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009
   Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592
   BRAENDGAARD H, 1990, J MICROSC-OXFORD, V157, P285, DOI 10.1111/j.1365-2818.1990.tb02967.x
   Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011
   Castelo-Branco GA, 2006, MOL CELL NEUROSCI, V31, P251, DOI 10.1016/j.mcn.2005.09.014
   Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100
   Castelo-Branco G, 2006, NEURODEGENER DIS, V3, P5, DOI 10.1159/000092086
   Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0
   Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x
   FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310
   Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010
   Fuentes EO, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-19
   Garcia C, 2008, J CLIN INVEST, V118, P2291, DOI [10.1172/JCI34508, 10.1172/JC134508]
   Glinka A, 1998, NATURE, V391, P357
   GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x
   Hammond R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007007
   HERNANDEZ CMA, 2007, REV ALERG MEX, V54, P162
   Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503
   Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2
   Kawano H, 2003, EXP NEUROL, V182, P103, DOI 10.1016/S0014-4886(03)00030-X
   Keeble TR, 2006, INT J BIOCHEM CELL B, V38, P2011, DOI 10.1016/j.biocel.2006.07.005
   Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006
   Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223
   Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009
   Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009
   Lin L, 2005, MOL CELL NEUROSCI, V28, P547, DOI 10.1016/j.mcn.2004.11.009
   Lin L, 2006, STEM CELLS, V24, P2504, DOI 10.1634/stemcells.2006-0119
   Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520
   Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019
   MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Nakamura S, 2000, J NEUROSCI, V20, P4112
   Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001
   Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181
   Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011
   Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032
   Richards AB, 2007, EUR J NEUROSCI, V25, P2619, DOI 10.1111/j.1460-9568.2007.05523.x
   SANCHEZCAMACHO C, 2009, BIOESSAYS
   Saueressig H, 1999, DEVELOPMENT, V126, P4201
   Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398
   Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x
   Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009
   SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P
   Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.033
   Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127
   STUEBNER S, 2009, DEV DYN
   THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0
   Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005
   Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003
   Wagner J, 1999, NAT BIOTECHNOL, V17, P653
   Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772
   Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006
   Wang YS, 2002, J NEUROSCI, V22, P8563
   WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102
   WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411
   Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250
   Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211
   Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522
   Yue Y, 1999, J NEUROSCI, V19, P2090
   Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006
   Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015
NR 66
TC 57
Z9 59
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 31
PY 2011
VL 6
IS 3
AR e18373
DI 10.1371/journal.pone.0018373
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 743YU
UT WOS:000289057200066
PM 21483795
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Ocbina, PJR
   Tuson, M
   Anderson, KV
AF Ocbina, Polloneal Jymmiel R.
   Tuson, Miquel
   Anderson, Kathryn V.
TI Primary Cilia Are Not Required for Normal Canonical Wnt Signaling in the
   Mouse Embryo
SO PLOS ONE
LA English
DT Article
AB Background: Sonic hedgehog (Shh) signaling in the mouse requires the microtubule-based organelle, the primary cilium. The primary cilium is assembled and maintained through the process of intraflagellar transport (IFT) and the response to Shh is blocked in mouse mutants that lack proteins required for IFT. Although the phenotypes of mouse IFT mutants do not overlap with phenotypes of known Wnt pathway mutants, recent studies report data suggesting that the primary cilium modulates responses to Wnt signals.
   Methodology/Principal Findings: We therefore carried out a systematic analysis of canonical Wnt signaling in mutant embryos and cells that lack primary cilia because of loss of the anterograde IFT kinesin-II motor (Kif3a) or IFT complex B proteins (Ift172 or Ift88). We also analyzed mutant embryos with abnormal primary cilia due to defects in retrograde IFT (Dync2h1). The mouse IFT mutants express the canonical Wnt target Axin2 and activate a transgenic canonical Wnt reporter, BAT-gal, in the normal spatial pattern and to the same quantitative level as wild type littermates. Similarly, mouse embryonic fibroblasts (MEFs) derived from IFT mutants respond normally to added Wnt3a. The switch from canonical to non-canonical Wnt also appears normal in IFT mutant MEFs, as both wild-type and mutant cells do not activate the canonical Wnt reporter in the presence of both Wnt3a and Wnt5a.
   Conclusions: We conclude that loss of primary cilia or defects in retrograde IFT do not affect the response of the midgestation embryo or embryo-derived fibroblasts to Wnt ligands.
RP Ocbina, PJR (reprint author), Sloan Kettering Inst, Dev Biol Program, New York, NY USA.
EM k-anderson@sloankettering.edu
OI Anderson, Kathryn/0000-0003-1657-2161
FU NIDDK NIH HHS [P30 DK074038]
CR AANSTAD P, 2009, CURR BIOL
   Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8
   Chazaud C, 2006, DEVELOPMENT, V133, P3379, DOI 10.1242/dev.02523
   Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558
   Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993
   Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021
   Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117
   Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670
   Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9
   Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034
   Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266
   Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249
   Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918
   Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089
   Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701
   Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12
   Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7
   Glinka A, 1998, NATURE, V391, P357
   Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019
   Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X
   Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200
   Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053
   Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732
   He X, 2008, NAT CELL BIOL, V10, P11, DOI 10.1038/ncb0108-11
   Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102
   Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061
   Ishikawa T, 2003, DEV BIOL, V253, P230, DOI 10.1016/S0012-1606(02)00020-9
   Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54
   Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081
   Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010
   Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100
   Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043
   May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7
   Murcia NS, 2000, DEVELOPMENT, V127, P2347
   Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195
   Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551
   Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892
   PERRY WL, 1995, GENETICS, V141, P321
   Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740
   Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644
   Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179
   Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111
   Sasaki H, 1997, DEVELOPMENT, V124, P1313
   Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318
   Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013
   Serluca FC, 2009, DEVELOPMENT, V136, P1621, DOI 10.1242/dev.020735
   Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009
   Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552
   Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825
   Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0
   Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4
NR 58
TC 84
Z9 84
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 31
PY 2009
VL 4
IS 8
AR e6839
DI 10.1371/journal.pone.0006839
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 489JH
UT WOS:000269415900012
PM 19718259
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Badders, NM
   Goel, S
   Clark, RJ
   Klos, KS
   Kim, S
   Bafico, A
   Lindvall, C
   Williams, BO
   Alexander, CM
AF Badders, Nisha M.
   Goel, Shruti
   Clark, Rod J.
   Klos, Kristine S.
   Kim, Soyoung
   Bafico, Anna
   Lindvall, Charlotta
   Williams, Bart O.
   Alexander, Caroline M.
TI The Wnt Receptor, Lrp5, Is Expressed by Mouse Mammary Stem Cells and Is
   Required to Maintain the Basal Lineage
SO PLOS ONE
LA English
DT Article
ID HAIR FOLLICLE DEVELOPMENT; HUMAN BREAST-TUMORS; GLAND DEVELOPMENT;
   GENE-EXPRESSION; BETA-CATENIN; SIGNALING PATHWAYS; CANCER; MICE; P63;
   DIFFERENTIATION
AB Background: Ectopic Wnt signaling induces increased stem/ progenitor cell activity in the mouse mammary gland, followed by tumor development. The Wnt signaling receptors, Lrp5/6, are uniquely required for canonical Wnt activity. Previous data has shown that the absence of Lrp5 confers resistance to Wnt1-induced tumor development.
   Methodology/Principal Findings: Here, we show that all basal mammary cells express Lrp5, and co-express Lrp6 in a similar fashion. Though Wnt dependent transcription of key target genes is relatively unchanged in mammary epithelial cell cultures, the absence of Lrp5 specifically depletes adult regenerative stem cell activity (to less than 1%). Stem cell activity can be enriched by >200 fold (over 80% of activity), based on high Lrp5 expression alone. Though Lrp5 null glands have apparent normal function, the basal lineage is relatively reduced (from 42% basal/total epithelial cells to 22%) and Lrp5(-/-) mammary epithelial cells show enhanced expression of senescence-associated markers in vitro, as measured by expression of p16(Ink4a) and TA-p63.
   Conclusions/Significance: This is the first single biomarker that has been demonstrated to be functionally involved in stem cell maintenance. Together, these results demonstrate that Wnt signaling through Lrp5 is an important component of normal mammary stem cell function.
C1 [Badders, Nisha M.; Goel, Shruti; Clark, Rod J.; Klos, Kristine S.; Kim, Soyoung; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA.
   [Bafico, Anna] Cardiff Univ, Dept Pathol, Cardiff, S Glam, Wales.
   [Lindvall, Charlotta; Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA.
RP Badders, NM (reprint author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.
EM alexander@oncology.wisc.edu
RI Williams, Bart/A-3539-2013
OI Williams, Bart/0000-0002-5261-5301
FU American Cancer Society [W81XWH-06-1-0491, PF-07-294-01-CNE]
FX This work was supported by an Era of Hope Scholars award to CMA
   (W81XWH-06-1-0491) and a post-doctoral award from the American Cancer
   Society to NMB (PF-07-294-01-CNE). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams PD, 2008, CANCER BIOL THER, V7, P1706, DOI 10.4161/cbt.7.11.6943
   Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108
   Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3
   Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005
   Benhaj K, 2006, ONCOL REP, V15, P701
   Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104
   Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243
   Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33
   Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061
   Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711
   BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009
   Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286
   Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797
   DasGupta R, 1999, DEVELOPMENT, V126, P4557
   Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545
   Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006
   Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2
   Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708
   He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117
   Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]
   Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76
   Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4
   Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907
   Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y
   Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816
   Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089
   Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750
   Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137
   Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305
   Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389
   Kordon EC, 1998, DEVELOPMENT, V125, P1921
   Lako M, 2001, MECH DEVELOP, V103, P49, DOI 10.1016/S0925-4773(01)00331-8
   Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593
   Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325
   Lee YJ, 1999, J BIOL CHEM, V274, P22401, DOI 10.1074/jbc.274.32.22401
   Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674
   Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200
   Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813
   Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101
   Liu BY, 2003, ONCOGENE, V22, P9243, DOI 10.1038/sj.onc.1207217
   Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370
   McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473
   Mi KH, 2007, J NEUROCHEM, V101, P517, DOI 10.1111/j.1471-4159.2007.04447.x
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Paguirigan A, 2007, CELL PROLIFERAT, V40, P106
   Pandur P, 2001, BIOESSAYS, V23, P207, DOI 10.1002/1521-1878(200103)23:3<207::AID-BIES1029>3.0.CO;2-0
   Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022
   Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394
   Reya T, 2003, RECENT PROG HORM RES, V58, P283, DOI 10.1210/rp.58.1.283
   Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250
   Ruzankina Y, 2007, BRIT J CANCER, V97, P1189, DOI 10.1038/sj.bjc.6604029
   Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979
   Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372
   Shibamoto S, 1998, GENES CELLS, V3, P659
   Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496
   Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457
   Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734
   van Dam AA, 2002, REV FISH BIOL FISHER, V12, P1, DOI 10.1023/A:1022639805031
   van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2
   WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x
   Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611
   WILLIAMS BO, 2008, J BONE MINER RES, V24, P171
   Wu GJ, 2003, CANCER RES, V63, P2351
   Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047
   Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015
   Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003
   Yang A, 1999, NATURE, V398, P714
   Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0
NR 76
TC 86
Z9 87
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 12
PY 2009
VL 4
IS 8
AR e6594
DI 10.1371/journal.pone.0006594
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 483BD
UT WOS:000268935900009
PM 19672307
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Arnsdorf, EJ
   Tummala, P
   Jacobs, CR
AF Arnsdorf, Emily J.
   Tummala, Padmaja
   Jacobs, Christopher R.
TI Non-Canonical Wnt Signaling and N-Cadherin Related beta-Catenin
   Signaling Play a Role in Mechanically Induced Osteogenic Cell Fate
SO PLOS ONE
LA English
DT Article
AB Background: Understanding how the mechanical microenvironment influences cell fate, and more importantly, by what molecular mechanisms, will enhance not only the knowledge of mesenchymal stem cell biology but also the field of regenerative medicine. Mechanical stimuli, specifically loading induced oscillatory fluid flow, plays a vital role in promoting healthy bone development, homeostasis and morphology. Recent studies suggest that such loading induced fluid flow has the potential to regulate osteogenic differentiation via the upregulation of multiple osteogenic genes; however, the molecular mechanisms involved in the transduction of a physical signal into altered cell fate have yet to be determined.
   Methods and Principal Findings: Using immuno-staining, western blot analysis and luciferase assays, we demonstrate the oscillatory fluid flow regulates beta-catenin nuclear translocation and gene transcription. Additionally, real time RT-PCR analysis suggests that flow induces Wnt5a and Ror2 upregulation, both of which are essential for activating the small GTPase, RhoA, upon flow exposure. Furthermore, although beta-catenin phosphorylation is not altered by flow, its association with N-cadherin is, indicating that flow-induced beta-catenin signaling is initiated by adherens junction signaling.
   Conclusion: We propose that the mechanical microenvironment of bone has the potential to regulate osteogenic differentiation by initiating multiple key molecular pathways that are essential for such lineage commitment. Specifically, non-canonical Wnt5a signaling involving Ror2 and RhoA as well as N-cadherin mediated beta-catenin signaling are necessary for mechanically induced osteogenic differentiation.
RP Arnsdorf, EJ (reprint author), VA Palo Alto Hlth Care Syst, Bone & Joint R&D Ctr, Palo Alto, CA USA.
EM emily.arnsdorf@gmail.com
FU NIAMS NIH HHS [AR45989, R01 AR045989]
CR Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.3.CO;2-D
   Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293
   Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0
   Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21907
   Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080
   Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5
   Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009
   Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4
   Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444
   BROWN TD, 1990, J BIOMECH, V23, P893, DOI 10.1016/0021-9290(90)90354-6
   Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286
   CARTER DR, 1989, J BIOMECH, V22, P231, DOI 10.1016/0021-9290(89)90091-2
   Carter DR, 1998, CLIN ORTHOP RELAT R, pS41
   Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460
   Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200
   Dehority W, 1999, AM J PHYSIOL-ENDOC M, V276, pE62
   Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656
   DU SJ, 1995, MOL CELL BIOL, V15, P2625
   El-Tanani M, 2001, CANCER RES, V61, P5619
   FROST HM, 1988, CALCIFIED TISSUE INT, V42, P145, DOI 10.1007/BF02556327
   FROST HM, 1987, BONE MINER, V2, P73
   Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2
   Hanai J, 2002, J CELL BIOL, V158, P529, DOI 10.1083/jcb.200203064
   Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08
   He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117
   Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Katoh M, 2005, ONCOL REP, V14, P1583
   Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151
   Katoh Y, 2005, INT J ONCOL, V27, P275
   Kim CH, 2006, BONE, V39, P1043, DOI 10.1016/j.bone.2006.05.017
   Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   KRAHL H, 1994, AM J SPORT MED, V22, P751, DOI 10.1177/036354659402200605
   Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551
   Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/S0168-9525(00)02028-X
   Lamb KJ, 2003, INT J EXP PATHOL, V84, P191, DOI 10.1046/j.1365-2613.2003.00353.x
   Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthes.2004.04.002
   Liu Y., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P323
   Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311
   Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630
   Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291
   Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y
   OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216
   OBERLENDER SA, 1994, DEVELOPMENT, V120, P177
   Orsulic S, 1999, J CELL SCI, V112, P1237
   Papkoff J, 1996, MOL CELL BIOL, V16, P2128
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200
   Ren XD, 2000, METHOD ENZYMOL, V325, P264
   Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005
   Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480
   Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371
   Saunders MM, 2003, BONE, V32, P350, DOI 10.1016/S8756-3282(03)00025-5
   Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200
   Shimokawa T, 2003, CANCER RES, V63, P6116
   Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627
   Spater D, 2006, EUR CELLS MATER, V12, P71
   Srinivasan S, 2000, MED ENG PHYS, V22, P127, DOI 10.1016/S1350-4533(00)00021-7
   Steck R, 2000, MED ENG PHYS, V22, P117, DOI 10.1016/S1350-4533(00)00017-5
   Tate MLK, 2000, J EXP BIOL, V203, P2737
   Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200
   Toyofuku T, 2000, J CELL BIOL, V150, P225, DOI 10.1083/jcb.150.1.225
   Triplett Jason W., 2007, Molecular & Cellular Biomechanics, V4, P13
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039
   Wang FS, 2007, BONE, V40, P485, DOI 10.1016/j.bone.2006.09.004
   Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6
   Wolff J, 1986, LAW BONE REMODELING
   Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200
   Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200
   Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200
   Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052
   You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200
   Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105
   Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008
   Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019
   Zou LJ, 2006, ADV EXP MED BIOL, V585, P431
NR 84
TC 101
Z9 104
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 29
PY 2009
VL 4
IS 4
AR e5388
DI 10.1371/journal.pone.0005388
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 439BG
UT WOS:000265601100022
PM 19401766
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Romanowska, M
   Evans, A
   Kellock, D
   Bray, SE
   McLean, K
   Donandt, S
   Foerster, J
AF Romanowska, Malgorzata
   Evans, Alan
   Kellock, David
   Bray, Susan E.
   McLean, Kathleen
   Donandt, Susanne
   Foerster, John
TI Wnt5a Exhibits Layer-Specific Expression in Adult Skin, Is Upregulated
   in Psoriasis, and Synergizes with Type 1 Interferon
SO PLOS ONE
LA English
DT Article
AB Background: Wnt5a is a member of the wingless-type patterning regulators important in pre-natal development. The expression and distribution of Wnt5a and its receptors frizzled (fzd) 3 and fzd 5 in adult human skin have not been comprehensively studied to date.
   Methodology/Principal Findings: We here show that Wnt5a, fzd3, fzd5, as well as fzd6 are restricted to specific layers in normal epidermis, analogous to their zonal distribution in hair follicles, suggesting a role in adult skin differentiation. In line, Wnt5a and fzd5 are both overexpressed and re-distributed in the epidermis of psoriasis which involves disturbed keratinocyte differentiation. Functionally, Wnt5a lowers the concentration of IFN required to induce target genes, and increases the magnitude of IFN target gene induction, suggesting a molecular mechanism underlying IFN hypersensitivity in psoriasis. Finally, we identify nedd8 and the amyloid precursor APP, previously shown to be upregulated in psoriasis, as targets of synergistic IFN alpha/Wnt5a induction.
   Conclusions/Significance: The present data (i) suggest that Wnt5a regulates epidermal differentiation even in adult skin and (ii) identify synergistic induction of type 1 IFN target genes as a novel mode of Wnt5a action. Targeting Wnt5a in the skin may reduce IFN hypersensitivity and be of therapeutical value.
RP Romanowska, M (reprint author), Univ Dundee, Div Expt Med, Dundee, Scotland.
EM j.foerster@dundee.ac.uk
FU Cancer Research UK
CR Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052
   Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046
   Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482
   Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051
   Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166
   Downs AMR, 2000, CLIN EXP DERMATOL, V25, P351, DOI 10.1046/j.1365-2230.2000.00655-4.x
   Eriksen KW, 2005, J INVEST DERMATOL, V125, P936, DOI 10.1111/j.0022-202X.2005.23864.x
   Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4
   Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101
   Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157
   Hampton PJ, 2007, BRIT J DERMATOL, V157, P1168, DOI 10.1111/j.1365-2133.2007.08195.x
   Herzog V, 2004, EUR J CELL BIOL, V83, P613, DOI 10.1078/0171-9335-00401
   Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9
   Hung BS, 2001, J INVEST DERMATOL, V116, P940, DOI 10.1046/j.1523-1747.2001.01336.x
   Ito M, 2004, J DERMATOL SCI, V36, P157, DOI 10.1016/j.jdermsci.2004.08.012
   Katoh M, 2007, INT J MOL MED, V19, P273
   KAWASAKI A, 2007, CELL SIGNAL
   Kowalzick L, 1997, J AM ACAD DERMATOL, V36, P501, DOI 10.1016/S0190-9622(97)80248-4
   Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382
   Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717
   Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x
   Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488
   Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250
   Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943
   Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200
   Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711
   Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162
   Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297
   Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.0.CO;2-L
   Siemes C, 2004, J INVEST DERMATOL, V123, P556, DOI 10.1111/j.0022-202X.2004.23320.x
   Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647
   Wang S, 2004, FOREST POLICY ECON, V6, P205, DOI 10.1016/j.forpol.2004.03.004
   Wolf R, 1999, ADV EXP MED BIOL, V455, P221
   YU JM, 2007, CANC LETT
NR 38
TC 39
Z9 41
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2009
VL 4
IS 4
AR e5354
DI 10.1371/journal.pone.0005354
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437VL
UT WOS:000265514900014
PM 19399181
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Maro, GS
   Klassen, MP
   Shen, K
AF Maro, Geraldine S.
   Klassen, Matthew P.
   Shen, Kang
TI A beta-Catenin-Dependent Wnt Pathway Mediates Anteroposterior Axon
   Guidance in C. elegans Motor Neurons
SO PLOS ONE
LA English
DT Article
AB Background: Wnts are secreted glycoproteins that regulate diverse aspects of development, including cell proliferation, cell fate specification and differentiation. More recently, Wnts have been shown to direct axon guidance in vertebrates, flies and worms. However, little is known about the intracellular signaling pathways downstream of Wnts in axon guidance.
   Methodology/Principal Findings: Here we show that the posterior C. elegans Wnt protein LIN-44 repels the axons of the adjacent D-type motor neurons by activating its receptor LIN-17/Frizzled on the neurons. Moreover, mutations in mig-5/Disheveled, gsk-3, pry-1/Axin, bar-1/beta-catenin and pop-1/TCF, also cause disrupted D-type axon pathfinding. Reduced BAR-1/beta-catenin activity in D-type axons leads to undergrowth of axons, while stabilization of BAR-1/beta-catenin in a lin-23/SCF beta-TrCP mutant results in an overextension phenotype.
   Conclusions/Significance: Together, our data provide evidence that Wnt-mediated axon guidance can be transduced through a beta-catenin-dependent pathway.
C1 [Maro, Geraldine S.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol & Pathol, Stanford, CA 94305 USA.
   [Klassen, Matthew P.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.
RP Maro, GS (reprint author), Stanford Univ, Howard Hughes Med Inst, Dept Biol & Pathol, Stanford, CA 94305 USA.
EM gmaro@stanford.edu; kangshen@stanford.edu
FU W. M. Keck Foundation; McKnight Endowment Fund; Searle Scholar Award;
   Human Frontier Science Program post-doctoral fellow
FX This work was supported by the W. M. Keck Foundation, the McKnight
   Endowment Fund and the Searle Scholar Award. GSM is a Human Frontier
   Science Program post-doctoral fellow. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797
   Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286
   Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096
   Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058
   Eisenmann DM, 1998, DEVELOPMENT, V125, P3667
   Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200
   Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363
   HERMAN MA, 1994, DEVELOPMENT, V120, P1035
   HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4
   Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6
   Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013
   Hunter CP, 1999, DEVELOPMENT, V126, P805
   Jiang LI, 1998, DEVELOPMENT, V125, P2337
   Jin YS, 1999, J NEUROSCI, V19, P539
   Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006
   Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029
   Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046
   Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099
   Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145
   Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83
   Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610
   Maloof JN, 1999, DEVELOPMENT, V126, P37
   MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0
   Mehta N, 2004, GENETICS, V166, P1253, DOI 10.1534/genetics.166.3.1253
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Natarajan L, 2004, DEV BIOL, V272, P536, DOI 10.1016/j.ydbio.2004.05.027
   Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291
   Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010
   Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357
   Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374
   Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033
   Sato M, 2006, NAT NEUROSCI, V9, P67, DOI 10.1038/nn1604
   Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334
   SCHNORRER F, 2004, CURR BIOL, V14, pR19, DOI DOI 10.1016/J.CUB.2003.12.016
   STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9
   Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428
   Walston T, 2006, DEV BIOL, V298, P485, DOI 10.1016/j.ydbio.2006.06.053
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056
   Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017
   Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270
   Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008
   Wu MF, 2007, DEV BIOL, V303, P650, DOI 10.1016/j.ydbio.2006.12.002
   Wu MF, 2006, DEV BIOL, V293, P316, DOI 10.1016/j.ydbio.2005.12.024
   Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899
   Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522
   Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006
   Zou YM, 2006, NEURON, V49, P787, DOI 10.1016/j.neuron.2006.03.004
   Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015
NR 55
TC 27
Z9 29
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 4
PY 2009
VL 4
IS 3
AR e4690
DI 10.1371/journal.pone.0004690
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437MB
UT WOS:000265490500009
PM 19259273
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Kam, Y
   Quaranta, V
AF Kam, Yoonseok
   Quaranta, Vito
TI Cadherin-Bound beta-Catenin Feeds into the Wnt Pathway upon Adherens
   Junctions Dissociation: Evidence for an Intersection between
   beta-Catenin Pools
SO PLOS ONE
LA English
DT Article
AB beta-catenin is an essential component of two cellular systems: cadherin-based adherens junctions (AJ) and the Wnt signaling pathway. A functional or physical connection between these beta-catenin pools has been suggested in previous studies, but not conclusively demonstrated to date. To further examine this intersection, we treated A431 cell colonies with lysophosphatidic acid (LPA), which forces rapid and synchronized dissociation of AJ. A combination of immunostaining, time-lapse microscopy using photoactivatable-GFP-tagged beta-catenin, and image analyses indicate that the cadherin-bound pool of beta-catenin, internalized together with E-cadherin, accumulates at the perinuclear endocytic recycling compartment (ERC) upon AJ dissociation, and can be translocated into the cell nucleus upon Wnt pathway activation. These results suggest that the ERC may be a site of residence for beta-catenin destined to enter the nucleus, and that dissociation of AJ may influence beta-catenin levels in the ERC, effectively affecting beta-catenin substrate levels available downstream for the Wnt pathway. This intersection provides a mechanism for integrating cell-cell adhesion with Wnt signaling and could be critical in developmental and cancer processes that rely on beta-catenin-dependent gene expression.
C1 [Kam, Yoonseok; Quaranta, Vito] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.
RP Kam, Y (reprint author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.
EM vito.quaranta@vanderbilt.edu
RI Quaranta, Vito/G-6512-2016
OI Quaranta, Vito/0000-0001-7491-8672; Kam, Yoonseok/0000-0003-4712-9058
FU NIH [RO1 GM067221]
FX Funding received from NIH RO1 GM067221 awarded to Vito Quaranta. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947
   Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0
   Ben-Ze'ev A, 2000, EXP CELL RES, V261, P75, DOI 10.1006/excr.2000.5045
   Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0
   Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104
   Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28
   Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509
   Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007
   Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604
   Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653
   Bryant DM, 2005, MOL BIOL CELL, V16, P14, DOI 10.1091/mbc.E04-09-0845
   Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007
   Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   Gavard J, 2005, BIOL CELL, V97, P921
   Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153
   Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1149/annurev.genom.3.022502.103043
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399
   Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536
   Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x
   Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089
   HUOT J, 1972, EXPERIENTIA, V28, P456, DOI 10.1007/BF02008338
   Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1
   Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319
   Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101
   Jourquin J, 2006, J CELL PHYSIOL, V206, P337, DOI 10.1002/jcp.20470
   Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001
   Kappes A, 2007, SURGERY, V141, P161, DOI 10.1016/j.surg.2006.12.005
   Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0
   Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315
   Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143
   Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702
   Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081
   Moolenaar Wouter H., 1994, Trends in Cell Biology, V4, P213, DOI 10.1016/0962-8924(94)90144-9
   Nathke I, 2004, J CELL SCI, V117, P4873, DOI 10.1242/jcs.01313
   Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291
   Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104
   Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735
   Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401
   Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952
   Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752
   Polakis P, 2000, GENE DEV, V14, P1837
   Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319
   Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004
   Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089
   Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806
   Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006
   THIERY JP, 2002, NATURE, V2, P444
   TOMOOKA Y, 1983, J CELL PHYSIOL, V117, P290, DOI 10.1002/jcp.1041170303
   Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294
   Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593
   Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207
   Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058
   Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102
   Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119
NR 60
TC 87
Z9 90
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2009
VL 4
IS 2
AR e4580
DI 10.1371/journal.pone.0004580
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437KW
UT WOS:000265487400012
PM 19238201
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Louie, SH
   Yang, XY
   Conrad, WH
   Muster, J
   Angers, S
   Moon, RT
   Cheyette, BNR
AF Louie, Sarah H.
   Yang, Xiao Yong
   Conrad, William H.
   Muster, Jeanot
   Angers, Stephane
   Moon, Randall T.
   Cheyette, Benjamin N. R.
TI Modulation of the beta-Catenin Signaling Pathway by the
   Dishevelled-Associated Protein Hipk1
SO PLOS ONE
LA English
DT Article
ID CONVERGENT EXTENSION MOVEMENTS; PLANAR CELL-POLARITY; NEURAL-TUBE
   CLOSURE; N-TERMINAL KINASE; XENOPUS-EMBRYOS; WNT/BETA-CATENIN; C-JUN;
   DIX DOMAIN; VERTEBRATE EMBRYOS; AXIS FORMATION
AB Background: Wnts are evolutionarily conserved ligands that signal through beta-catenin-dependent and beta-catenin-independent pathways to regulate cell fate, proliferation, polarity, and movements during vertebrate development. Dishevelled (Dsh/Dvl) is a multi-domain scaffold protein required for virtually all known Wnt signaling activities, raising interest in the identification and functions of Dsh-associated proteins.
   Methodology: We conducted a yeast-2-hybrid screen using an N-terminal fragment of Dsh, resulting in isolation of the Xenopus laevis ortholog of Hipk1. Interaction between the Dsh and Hipk1 proteins was confirmed by co-immunoprecipitation assays and mass spectrometry, and further experiments suggest that Hipk1 also complexes with the transcription factor Tcf3. Supporting a nuclear function during X. laevis development, Myc-tagged Hipk1 localizes primarily to the nucleus in animal cap explants, and the endogenous transcript is strongly expressed during gastrula and neurula stages. Experimental manipulations of Hipk1 levels indicate that Hipk1 can repress Wnt/beta-catenin target gene activation, as demonstrated by beta-catenin reporter assays in human embryonic kidney cells and by indicators of dorsal specification in X. laevis embryos at the late blastula stage. In addition, a subset of Wnt-responsive genes subsequently requires Hipk1 for activation in the involuting mesoderm during gastrulation. Moreover, either over-expression or knock-down of Hipk1 leads to perturbed convergent extension cell movements involved in both gastrulation and neural tube closure.
   Conclusions: These results suggest that Hipk1 contributes in a complex fashion to Dsh-dependent signaling activities during early vertebrate development. This includes regulating the transcription of Wnt/beta-catenin target genes in the nucleus, possibly in both repressive and activating ways under changing developmental contexts. This regulation is required to modulate gene expression and cell movements that are essential for gastrulation.
C1 [Louie, Sarah H.; Conrad, William H.; Muster, Jeanot; Angers, Stephane; Moon, Randall T.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA.
   [Louie, Sarah H.; Conrad, William H.; Muster, Jeanot; Angers, Stephane; Moon, Randall T.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.
   [Yang, Xiao Yong; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
   [Yang, Xiao Yong; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Program Biol Sci, Grad Program Dev Biol, San Francisco, CA 94143 USA.
RP Louie, SH (reprint author), Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA.
EM benjamin.cheyette@ucsf.edu
RI Angers, Stephane/E-1432-2014; Cheyette, Benjamin/K-5535-2014; Moon,
   Randall/B-1743-2014
OI Angers, Stephane/0000-0001-7241-9044; Cheyette,
   Benjamin/0000-0001-9934-7941; Moon, Randall/0000-0002-9352-1408
FU NIH [R01, MH01750 K08]; HHMI [fellow]; NARSAD/Browning Foundation Young
   Investigator Award;  [1R01HD055300]
FX This work was supported by an NIH R01. RTM is an investigator, and SA
   was a fellow of the HHMI. BNRC was supported by NIH MH01750 K08 and a
   NARSAD/Browning Foundation Young Investigator Award, and he and XYY are
   currently supported by 1R01HD055300 to BNRC. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273
   Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381
   Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139
   Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3
   Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610
   BLITZ IL, 1995, DEVELOPMENT, V121, P993
   Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X
   BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G
   Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359
   Brannon M, 1999, DEVELOPMENT, V126, P3159
   Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410
   Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056
   Carnac G, 1996, DEVELOPMENT, V122, P3055
   CHEYETTE BN, 2004, SCI STKE, pPE54
   Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194
   Copp AJ, 2003, TRENDS NEUROSCI, V26, P453, DOI 10.1016/S0166-2236(03)00212-1
   CUI YZ, 1995, DEVELOPMENT, V121, P2177
   DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374
   Djiane A, 2000, DEVELOPMENT, V127, P3091
   Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003
   Ewald AJ, 2004, DEVELOPMENT, V131, P6195, DOI 10.1242/dev.01542
   Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917
   Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050
   Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673
   Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203
   Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6
   Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22
   Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164
   Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068
   Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369
   Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805
   HORTON RM, 1990, BIOTECHNIQUES, V8, P528
   Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009
   HUANG HHEX, 2008, CURR OPIN CELL BIOL
   Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005
   Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006
   Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000
   Itoh K, 1997, MECH DEVELOP, V61, P113, DOI 10.1016/S0925-4773(96)00627-2
   Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20
   Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604
   Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006
   KELLER R, 1988, DEVELOPMENT, V103, P193
   KELLER R, 1991, METHOD CELL BIOL, V36, P61
   Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875
   Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303
   Kishida S, 1999, MOL CELL BIOL, V19, P4414
   KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118
   Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022
   Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100
   Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784
   Kuhl M, 2004, FRONT BIOSCI, V9, P967
   Kuhl M, 2002, SEMIN CELL DEV BIOL, V13, P243, DOI 10.1016/S1084-9521(02)00050-2
   Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6
   Kwan KM, 2003, DEVELOPMENT, V130, P1961, DOI 10.1242/dev.00412
   Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180
   Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123
   LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9
   Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129
   Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Makita R, 1998, MECH DEVELOP, V71, P165, DOI 10.1016/S0925-4773(98)00013-6
   Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0
   MCGREW LL, 1992, DEVELOPMENT, V115, P463
   McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3
   McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797
   Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.3.CO;2-0
   Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427
   Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9
   Moon Randall T, 2005, Sci STKE, V2005, pcm1
   Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7
   Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957
   Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399
   Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716
   Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062
   Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3
   ROTHBACHER U, 1995, DEV BIOL, V170, P717, DOI 10.1006/dbio.1995.1249
   Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010
   RUI Y, 2004, EMBO J
   SATER AK, 1993, DEV DYNAM, V197, P268, DOI 10.1002/aja.1001970405
   Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1
   Schohl A, 2003, EMBO J, V22, P3303, DOI 10.1093/emboj/cdg328
   Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247
   Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094
   Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2
   SIVE H. L., 2000, EARLY DEV XENOPUS LA
   Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005
   SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H
   SOKOL SY, 1995, DEVELOPMENT, V121, P3487
   Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6
   Sumanas S, 2000, DEVELOPMENT, V127, P1981
   Sumanas S, 2001, GENESIS, V30, P119, DOI 10.1002/gene.1044
   Tada M, 2000, DEVELOPMENT, V127, P2227
   Tahinci E, 2007, DEVELOPMENT, V134, P4095, DOI 10.1242/dev.010272
   THEISEN H, 1994, DEVELOPMENT, V120, P347
   Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355
   Vonica A, 2002, DEV BIOL, V250, P112, DOI 10.1006/dbio.2002.0786
   Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068
   Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123
   Wallingford JB, 2001, DEVELOPMENT, V128, P2581
   Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077
   Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520
   Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104
   Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869
   Wong CK, 2004, J BIOL CHEM, V279, P39366, DOI 10.1074/jbc.M404598200
   Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185
   Yamanaka H, 2007, GENES CELLS, V12, P961, DOI 10.1111/j.1365-2443.2007.01106.x
   YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087
   YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1
   Yokota C, 2003, DEVELOPMENT, V130, P2199, DOI 10.1242/dev.00434
   Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540
   Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200
NR 116
TC 22
Z9 22
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 2
PY 2009
VL 4
IS 2
AR e4310
DI 10.1371/journal.pone.0004310
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437JI
UT WOS:000265483200002
PM 19183803
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Andersson, ER
   Prakash, N
   Cajanek, L
   Minina, E
   Bryja, V
   Bryjova, L
   Yamaguchi, TP
   Hall, AC
   Wurst, W
   Arenas, E
AF Andersson, Emma R.
   Prakash, Nilima
   Cajanek, Lukas
   Minina, Eleonora
   Bryja, Vitezslav
   Bryjova, Lenka
   Yamaguchi, Terry P.
   Hall, Anita C.
   Wurst, Wolfgang
   Arenas, Ernest
TI Wnt5a Regulates Ventral Midbrain Morphogenesis and the Development of
   A9-A10 Dopaminergic Cells In Vivo
SO PLOS ONE
LA English
DT Article
AB Wnt5a is a morphogen that activates the Wnt/planar cell polarity (PCP) pathway and serves multiple functions during development. PCP signaling controls the orientation of cells within an epithelial plane as well as convergent extension (CE) movements. Wnt5a was previously reported to promote differentiation of A9-10 dopaminergic (DA) precursors in vitro. However, the signaling mechanism in DA cells and the function of Wnt5a during midbrain development in vivo remains unclear. We hereby report that Wnt5a activated the GTPase Rac1 in DA cells and that Rac1 inhibitors blocked the Wnt5a-induced DA neuron differentiation of ventral midbrain (VM) precursor cultures, linking Wnt5a-induced differentiation with a known effector of Wnt/PCP signaling. In vivo, Wnt5a was expressed throughout the VM at embryonic day (E) 9.5, and was restricted to the VM floor and basal plate by E11.5-E13.5. Analysis of Wnt5a-/- mice revealed a transient increase in progenitor proliferation at E11.5, and a precociously induced NR4A2+ (Nurr1) precursor pool at E12.5. The excess NR4A2+ precursors remained undifferentiated until E14.5, when a transient 25% increase in DA neurons was detected. Wnt5a-/- mice also displayed a defect in (mid) brain morphogenesis, including an impairment in midbrain elongation and a rounded ventricular cavity. Interestingly, these alterations affected mostly cells in the DA lineage. The ventral Sonic hedgehog-expressing domain was broadened and flattened, a typical CE phenotype, and the domains occupied by Ngn2+ DA progenitors, NR4A2+ DA precursors and TH+ DA neurons were rostrocaudally reduced and laterally expanded. In summary, we hereby describe a Wnt5a regulation of Wnt/PCP signaling in the DA lineage and provide evidence for multiple functions of Wnt5a in the VM in vivo, including the regulation of VM morphogenesis, DA progenitor cell division, and differentiation of NR4A2+ DA precursors.
C1 [Andersson, Emma R.; Cajanek, Lukas; Bryja, Vitezslav; Bryjova, Lenka; Wurst, Wolfgang; Arenas, Ernest] Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Prakash, Nilima; Minina, Eleonora] Tech Univ Munich, Inst Dev Genet, German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Munich, Germany.
   [Bryja, Vitezslav; Bryjova, Lenka] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, Brno, Czech Republic.
   [Bryja, Vitezslav; Bryjova, Lenka] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno, Czech Republic.
   [Yamaguchi, Terry P.] Natl Canc Inst Frederick, Canc & Dev Biol Lab, Frederick, MD USA.
   [Hall, Anita C.] Imperial Coll London, Div Cell & Mol Biol, London, England.
   [Wurst, Wolfgang] Max Planck Inst Psychiat, Munich, Germany.
RP Andersson, ER (reprint author), Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden.
EM wurst@helmholtz-muenchen.de; ernest.arenas@ki.se
RI Bryja, Vitezslav/P-4217-2019; Andersson, Emma/J-4236-2012; Bryja,
   Vit?zslav/H-1925-2014
OI Bryja, Vitezslav/0000-0002-9136-5085; Andersson,
   Emma/0000-0002-8608-625X; Bryja, Vit?zslav/0000-0002-9136-5085; Arenas,
   Ernest/0000-0003-0197-6577; Cajanek, Lukas/0000-0003-2914-8589
FU Swedish Foundation for Strategic Research; Swedish Royal Academy of
   Sciences; Knut and Alice Wallenberg Foundation; European Union
   (Eurostemcell); Swedish MRC; Karolinska Institutet; Federal Ministry of
   Education and Research (BMBF) [01GN0512]; National Genome Research
   Network (NGFN); Forderkennzeichen [01GS0476]; Deutsche
   Forschungsgemeinschaft (DFG) [WU 164/3-1, WU 164/3-2]; Bayerische
   Forschungsverbund ForNeuroCell; Helmholtz Virtual Institute of
   Neurodegeneration&Aging [VH-VI-252]; European Union (Eumorphia)
FX This work was supported by the Swedish Foundation for Strategic
   Research, Swedish Royal Academy of Sciences, Knut and Alice Wallenberg
   Foundation, European Union (Eurostemcell), Swedish MRC and Karolinska
   Institutet (to EA), and by the Federal Ministry of Education and
   Research (BMBF) in the framework of the National Genome Research Network
   (NGFN), Forderkennzeichen 01GS0476, the BMBF Forderkennzeichen 01GN0512,
   the Deutsche Forschungsgemeinschaft (DFG) WU 164/3-1 and WU 164/3-2, the
   Bayerische Forschungsverbund ForNeuroCell, the Helmholtz Virtual
   Institute of Neurodegeneration&Aging (VH-VI-252) and by European Union
   (Eumorphia) (to WW). The authors are responsible for the contents of
   this publication. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4
   Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]
   Brodski C, 2003, J NEUROSCI, V23, P4199
   Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368
   Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104
   BUSH KT, 1990, ANAT EMBRYOL, V181, P49
   Castelo-Branco GA, 2006, MOL CELL NEUROSCI, V31, P251, DOI 10.1016/j.mcn.2005.09.014
   Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100
   Cau E, 1997, DEVELOPMENT, V124, P1611
   Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   CONLON RA, 1993, METHOD ENZYMOL, V225, P373
   Copp AJ, 2003, TRENDS NEUROSCI, V26, P453, DOI 10.1016/S0166-2236(03)00212-1
   Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181
   Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9
   Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448
   Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8
   Djiane A, 2000, DEVELOPMENT, V127, P3091
   Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X
   Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796
   Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301
   Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X
   Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557
   Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203
   HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097
   Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223
   Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081
   Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2
   Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030
   Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miyoshi G, 2004, J NEUROSCI, V24, P3672, DOI 10.1523/JNEUROSCI.5327-03.2004
   Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618
   Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014
   Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870
   NEMETH MJ, 2007, P NATL ACAD SCI US
   Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100
   Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273
   Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181
   Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464
   Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107
   Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037
   Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011
   RAWAL N, 2006, EXP CELL RES
   Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032
   Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x
   Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042
   Shariatmadari M, 2005, MOL CELL NEUROSCI, V30, P437, DOI 10.1016/j.mcn.2005.08.008
   Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022
   Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041
   SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297
   Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183
   Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758
   van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464
   Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1
   VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0
   Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1
   Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123
   Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077
   Wallingford JB, 2001, INT J DEV BIOL, V45, P225
   Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772
   Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005
   WILSON PA, 1989, DEVELOPMENT, V105, P155
   Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7
   Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250
   Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59
   Wolff T, 1998, DEVELOPMENT, V125, P1149
   Wu MF, 2006, DEV BIOL, V293, P316, DOI 10.1016/j.ydbio.2005.12.024
   Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211
   Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008
   YBOTGONZALEZ P, 2007, CONVERGENT EXTENSION, P789
NR 71
TC 64
Z9 65
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 27
PY 2008
VL 3
IS 10
AR e3517
DI 10.1371/journal.pone.0003517
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 432JY
UT WOS:000265130500002
PM 18953410
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Morrell, NT
   Leucht, P
   Zhao, LD
   Kim, JB
   ten Berge, D
   Ponnusamy, K
   Carre, AL
   Dudek, H
   Zachlederova, M
   McElhaney, M
   Brunton, S
   Gunzner, J
   Callow, M
   Polakis, P
   Costa, M
   Zhang, XM
   Helms, JA
   Nusse, R
AF Morrell, Nathan T.
   Leucht, Philipp
   Zhao, Ludan
   Kim, Jae-Beom
   ten Berge, Derk
   Ponnusamy, Karthik
   Carre, A. Lyonel
   Dudek, Henryk
   Zachlederova, Marie
   McElhaney, Michael
   Brunton, Shirley
   Gunzner, Janet
   Callow, Marinella
   Polakis, Paul
   Costa, Mike
   Zhang, Xiaoyan M.
   Helms, Jill A.
   Nusse, Roel
TI Liposomal Packaging Generates Wnt Protein with In Vivo Biological
   Activity
SO PLOS ONE
LA English
DT Article
AB Wnt signals exercise strong cell-biological and regenerative effects of considerable therapeutic value. There are, however, no specific Wnt agonists and no method for in vivo delivery of purified Wnt proteins. Wnts contain lipid adducts that are required for activity and we exploited this lipophilicity by packaging purified Wnt3a protein into lipid vesicles. Rather than being encapsulated, Wnts are tethered to the liposomal surface, where they enhance and sustain Wnt signaling in vitro. Molecules that effectively antagonize soluble Wnt3a protein but are ineffective against the Wnt3a signal presented by a cell in a paracrine or autocrine manner are also unable to block liposomal Wnt3a activity, suggesting that liposomal packaging mimics the biological state of active Wnts. When delivered subcutaneously, Wnt3a liposomes induce hair follicle neogenesis, demonstrating their robust biological activity in a regenerative context.
C1 [Morrell, Nathan T.; Leucht, Philipp; Zhao, Ludan; Kim, Jae-Beom; Ponnusamy, Karthik; Carre, A. Lyonel; Helms, Jill A.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.
   [ten Berge, Derk; Nusse, Roel] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA USA.
   [Dudek, Henryk; Zachlederova, Marie; McElhaney, Michael; Zhang, Xiaoyan M.] Curis Inc, Cambridge, MA USA.
   [Brunton, Shirley] Evotec Ltd, Abingdon, Oxon, England.
   [Gunzner, Janet] Genentech Inc, Dept Med Chem, San Francisco, CA USA.
   [Callow, Marinella; Polakis, Paul; Costa, Mike] Genentech Inc, Dept Canc Targets, San Francisco, CA USA.
RP Morrell, NT (reprint author), Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.
EM jhelms@stanford.edu; rnusse@stanford.edu
RI Leucht, Philipp/H-7238-2019; ten Berge, Derk/C-1967-2012
OI Leucht, Philipp/0000-0002-8409-8513; 
FU NIH [RO1 PA-02-011]; Air Force Office of Research [FOS-2004-0025A];
   Howard Hughes Medical Institute
FX NIH RO1 PA-02-011 and Air Force Office of Research FOS-2004-0025A (JAH);
   R. Nusse is a Howard Hughes Medical Institute Investigator. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR BENERJEE R, 2001, J BIOMATER APPL, V16, P3
   Cattel L, 2004, J CHEMOTHERAPY, V16, P94, DOI 10.1179/joc.2004.16.Supplement-1.94
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266
   Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6
   Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116
   Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802
   Koning GA, 2006, ARTHRITIS RHEUM-US, V54, P1198, DOI 10.1002/art.21719
   Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552
   Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509
   Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002
   Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933
   Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017
   Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2
   Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821
   Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007
   Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504
   Park John W, 2002, Breast Cancer Res, V4, P95, DOI 10.1186/bcr432
   Ponce AM, 2007, FUTURE LIPIDOL, V1, P25, DOI 10.2217/17460875.1.1.25
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319
   Schiffelers R, 2001, J ANTIMICROB CHEMOTH, V48, P333, DOI 10.1093/jac/48.3.333
   Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602
   Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013
   Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003
   VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x
   Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611
   Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200
   ZHANG Q, 2007, P NATL ACAD SCI US
NR 33
TC 47
Z9 50
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 13
PY 2008
VL 3
IS 8
AR e2930
DI 10.1371/journal.pone.0002930
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 422FK
UT WOS:000264412600016
PM 18698373
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

PT J
AU Akbarzadeh, S
   Wheldon, LM
   Sweet, SMM
   Talma, S
   Mardakheh, FK
   Heath, JK
AF Akbarzadeh, Shiva
   Wheldon, Lee M.
   Sweet, Steve M. M.
   Talma, Sonia
   Mardakheh, Faraz Khosravi
   Heath, John K.
TI The Deleted in Brachydactyly B Domain of ROR2 Is Required for Receptor
   Activation by Recruitment of Src
SO PLOS ONE
LA English
DT Article
AB The transmembrane receptor 'ROR2' resembles members of the receptor tyrosine kinase family of signalling receptors in sequence but its' signal transduction mechanisms remain enigmatic. This problem has particular importance because mutations in ROR2 are associated with two human skeletal dysmorphology syndromes, recessive Robinow Syndrome (RS) and dominant acting Brachydactyly type B (BDB). Here we show, using a constitutive dimerisation approach, that ROR2 exhibits dimerisation-induced tyrosine kinase activity and the ROR2 C-terminal domain, which is deleted in BDB, is required for recruitment and activation of the non-receptor tyrosine kinase Src. Native ROR2 phosphorylation is induced by the ligand Wnt5a and is blocked by pharmacological inhibition of Src kinase activity. Eight sites of Src-mediated ROR2 phosphorylation have been identified by mass spectrometry. Activation via tyrosine phosphorylation of ROR2 receptor leads to its internalisation into Rab5 positive endosomes. These findings show that BDB mutant receptors are defective in kinase activation as a result of failure to recruit Src.
C1 [Akbarzadeh, Shiva; Wheldon, Lee M.; Sweet, Steve M. M.; Talma, Sonia; Mardakheh, Faraz Khosravi; Heath, John K.] Univ Birmingham, Sch Biosci, CR UK Growth Factor Grp, Birmingham, W Midlands, England.
RP Akbarzadeh, S (reprint author), Univ Birmingham, Sch Biosci, CR UK Growth Factor Grp, Birmingham, W Midlands, England.
EM J.K.Heath@bham.ac.uk
RI Sweet, Steve/B-5528-2008
OI Sweet, Steve/0000-0002-3962-0421; Heath, John/0000-0003-4886-4070;
   Mardakheh, Faraz/0000-0003-3896-0827
FU Wellcome Trust; Cancer Research UK; Endotrack (EU FP6)
FX This research was funded by the Wellcome Trust (to JKH, Andrew Wilkie
   and Gillian Morriss-Kay) and Cancer Research UK. SMMS was funded by
   Endotrack (EU FP6).
CR Afzal AR, 2000, NAT GENET, V25, P419
   ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110
   Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240
   Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153
   DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488
   Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9
   GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q
   Hikasa H, 2002, DEVELOPMENT, V129, P5227
   Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001
   Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200
   Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725
   Liu Y, 2007, MOL ENDOCRINOL, V21, P3050, DOI 10.1210/me.2007-0323
   MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181
   Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005
   Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115
   Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127
   Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x
   Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x
   Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495
   Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x
   Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016
   Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084
   Stricker S, 2006, DEV DYNAM, V235, P3456, DOI 10.1002/dvdy.20993
   Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x
   van Bokhoven H, 2000, NAT GENET, V25, P423
   ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E
NR 26
TC 47
Z9 48
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2008
VL 3
IS 3
AR e1873
DI 10.1371/journal.pone.0001873
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 370KZ
UT WOS:000260762400024
PM 18365018
OA DOAJ Gold, Green Published
DA 2019-07-08
ER

EF